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ABSTRACT	  	  Jmjd3	   is	   a	  H3K27	  demethylase	   that	   is	   required	   for	   the	  neural	   commitment	   of	  ESCs	  and	   controls	   the	   expression	  of	   key	  drivers	   and	  markers	  of	  neurulation	   through	   the	  demethylation	  of	  H3K27me3.	  Previous	  work	  from	  our	  lab	  has	  demonstrated	  that	  loss	  of	   Jmjd3	   in	  mouse	   embryos	   causes	   a	   complex	   neurodevelopmental	   phenotype	   that	  results	  in	  perinatal	  death.	  Such	  lethality	  is	  due	  to	  a	  respiratory	  failure	  resulting	  from	  the	   lack	   of	   a	   functional	   pre-­‐Bötzinger	   complex,	   a	   small	   network	   of	   neurons	   that	   is	  responsible	   for	  respiratory	  rhythm	  generation.	  Rescue	  experiments	  performed	  with	  catalytically	  active	  or	  inactive	  Jmjd3	  have	  demonstrated	  that	  its	  demethylase	  activity	  is	   necessary	   for	   developing	   and	   maintaining	   the	   embryonic	   respiratory	   neuronal	  network.	  This	  unanticipated	   finding	  claims	  a	  broader	  role	   in	  brain	  development	   for	  Jmjd3,	   whose	   importance	   extends	   from	   early	   differentiation	   choices	   to	   the	   late	  development	  of	  neuronal	  networks.	  To	  investigate	  the	  effect	  of	  Jmjd3	  loss	  on	  neocortical	  development,	  we	  analyzed	  Jmjd3	  KO	  embryonic	  brains	  at	  different	  developmental	  stages	  using	  markers	  for	  stem	  cells	  and	  differentiated	  neurons.	  We	  found	  that	  loss	  of	  Jmjd3	  causes	  a	  late-­‐onset	  increase	  in	  the	  number	  of	  ventricular	  zone	  (VZ)	  neural	  precursor	  cells	  (NPCs)	  and	  a	  reduction	  in	   the	   cortical	  neuronal	  production.	   Jmjd3	  KO	  VZ	  NPCs	  display	  a	  higher	   rate	  of	   cell	  cycle	  re-­‐entry	  than	  their	  WT	  counterpart,	  and	  have	  an	  overall	  longer	  cell	  cycle.	  	  In	   order	   to	   pinpoint	   the	   mechanism	   by	   which	   Jmjd3	   is	   causally	   linked	   to	   the	  lengthening	   of	   the	   NPC	   cell	   cycle	   and	   to	   the	   VZ	   expansion,	   we	   investigated	   the	  transcriptional	  effect	  of	   Jmjd3	   loss	  by	  performing	  RNAseq	  on	  mRNA	  extracted	   from	  WT	   and	  KO	   cultured	   E13.5	   primary	  NPCs.	   A	   detailed	  molecular	   characterization	   at	  the	   transcriptional	   level	   revealed	   that	   the	  phenotype	   that	  we	  observed	  both	   in	  vivo	  and	  in	  vitro	  in	  Jmjd3	  KO	  NPCs	  is	  linked	  to	  supraphysiological	  activation	  of	  the	  Wnt/B-­‐
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catenin	   and	   Notch	   pathways,	   two	   known	   regulators	   of	   the	   choice	   between	   self-­‐renewal	   and	   differentiation	   in	   the	   VZ	   NPCs	   of	   the	   developing	   brains,	   whose	  upregulation	   has	   already	   been	   shown	   to	   correlate	   with	   an	   increased	   proliferative	  potential	  and	  hampered	  neuronal	  differentiation.	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Some	  of	  the	  results	  presented	  in	  this	  thesis	  appear	  in	  the	  following	  publication:	  Park,	  D.	  H.,	  Hong,	  S.	  J.,	  Salinas,	  R.	  D.,	  Liu,	  S.	  J.,	  Sun,	  S.	  W.,	  Sgualdino,	  J.,	  Testa,	  G.,	  Matzuk,	  M.	  M.,	  Iwamori,	  N.,	  and	  Lim,	  D.	  A.	  (2014).	  Activation	  of	  Neuronal	  Gene	  Expression	  by	  the	  JMJD3	  Demethylase	  Is	  Required	  for	  Postnatal	  and	  Adult	  Brain	  Neurogenesis.	  Cell	  reports.	  	   	  
	   5	  
TABLE	  OF	  CONTENTS	  	  ABSTRACT	  .......................................................................................................................................................	  2	  TABLE	  OF	  CONTENTS	  ................................................................................................................................	  5	  ACRONYMS	  AND	  ABREVIATIONS	  .........................................................................................................	  9	  1	  INTRODUCTION	  ......................................................................................................................................	  13	  1.1	  Epigenetics	  and	  chromatin	  .............................................................................................................	  13	  1.1.1	  Definition	  of	  epigenetics	  ..........................................................................................................	  13	  1.1.2	  Chromatin	  and	  histones	  ..........................................................................................................	  14	  1.1.3	  Covalent	  modifications	  affecting	  chromatin	  function	  ................................................	  14	  1.1.4	  Chromatin	  and	  gene	  transcription	  ......................................................................................	  17	  1.1.5	  Proteins	  responsible	  for	  histone	  tail	  modifications	  ....................................................	  18	  1.1.6	  The	  discovery	  of	  histone	  demethylases	  ............................................................................	  19	  1.1.7	  Jmjd3	  ................................................................................................................................................	  21	  1.2	  Neocortical	  development	  ................................................................................................................	  23	  1.2.1	  Radial	  glial	  cells	  dynamics	  and	  differentiation	  ..............................................................	  23	  1.2.2	  Cell	  cycle	  regulation	  in	  mammalian	  neocortical	  development	  ..............................	  25	  1.2.3	  Epigenetic	  regulation	  of	  transcription	  in	  neocortical	  development	  ....................	  28	  1.3	  Jmjd3	  and	  neural	  differentiation	  ..................................................................................................	  30	  1.4	  Aim	  of	  the	  thesis	  ..................................................................................................................................	  31	  2	  MATERIALS	  AND	  METHODS	  .............................................................................................................	  32	  2.1	  Cell	  culture	  .............................................................................................................................................	  32	  2.1.1	  Mouse	  embryonic	  stem	  cells	  (ES	  cells)	  .............................................................................	  32	  2.1.2	  Derivation	  and	  culture	  conditions	  of	  cortical	  neural	  precursor	  cells	  (NPCs)	  ..	  33	  2.1.3	  Growth	  curves	  ..............................................................................................................................	  33	  2.1.4	  EdU/PI	  staining	  for	  the	  determination	  of	  cell	  cycle	  distribution	  ..........................	  34	  2.1.5	  Double	  thymidine	  block	  and	  release	  ..................................................................................	  34	  
	   6	  
2.1.6	  Time-­‐lapse	  videomicroscopy	  of	  NPCs	  ...............................................................................	  35	  2.1.7	  Derivation	  and	  culture	  of	  post-­‐natal	  SVZ	  radial	  glial	  cells	  (RGCs)	  ........................	  35	  2.2	  Molecular	  biology	  techniques	  ........................................................................................................	  36	  2.2.1	  Isolation	  of	  genomic	  DNA	  from	  cells	  and	  tails	  ...............................................................	  36	  2.2.2	  Polymerase	  Chain	  Reaction	  (PCR)	  ......................................................................................	  36	  2.2.3	  RNA	  Extraction	  ............................................................................................................................	  37	  2.2.4	  cDNA	  synthesis	  ............................................................................................................................	  37	  2.2.5	  Real	  Time	  Quantitative	  PCR	  (qRT-­‐PCR)	  ...........................................................................	  38	  2.2.6	  RNAseq	  library	  preparation	  ..................................................................................................	  38	  2.3	  Bionformatic	  analysis	  .......................................................................................................................	  39	  2.3.1	  RNAseq	  analysis	  ..........................................................................................................................	  39	  2.3.2	  ChIPseq	  analysis	  .........................................................................................................................	  39	  2.4	  Biochemistry	  Techniques	  ................................................................................................................	  40	  2.4.1	  Protein	  extraction	  ......................................................................................................................	  40	  2.4.2	  CSK	  fractionation	  ........................................................................................................................	  40	  2.4.3	  Chromatin	  immunoprecipitation	  (ChIP)	  ..........................................................................	  41	  2.4.4	  Immunoblotting	  ..........................................................................................................................	  42	  2.5	  Histology	  techniques	  .........................................................................................................................	  43	  2.5.1	  Brain	  dissection	  ...........................................................................................................................	  43	  2.5.2	  Determination	  of	  cell	  cycle	  parameters	  in	  vivo	  .............................................................	  45	  2.6	  Mouse	  strains	  ........................................................................................................................................	  46	  2.6.1	  PGK-­‐Cre	  deleter	  strain	  .............................................................................................................	  47	  2.6.2	  Rosa26-­‐Cre	  inducible	  deleter	  strain	  ..................................................................................	  47	  2.6.3	  Generation	  of	  the	  XB814	  Jmjd3	  KO	  mouse	  strain	  ........................................................	  47	  2.6.4	  Generation	  of	  the	  R26.Jmjd3.fl.stop	  mouse	  strain	  .......................................................	  47	  2.6.5	  Generation	  of	  the	  BAC	  Transgenic	  Jmjd3mut	  mouse	  strain	  ....................................	  48	  
	   7	  
2.6.6	  Generation	  of	  the	  Jmjd3.fl	  mouse	  strain	  ...........................................................................	  49	  2.6.7	  Generation	  of	  the	  Jmjd3.Venus	  mouse	  strain	  .................................................................	  50	  3	  RESULTS	  .....................................................................................................................................................	  52	  3.1	  Validation	  of	  the	  XB814	  mouse	  strain	  as	  suitable	  loss-­‐of-­‐function	  model	  for	  Jmjd3	  in	  the	  developing	  cortex	  ..........................................................................................................................	  52	  3.2	  Loss	  of	  Jmjd3	  causes	  a	  late-­‐onset	  expansion	  of	  NPCs	  in	  the	  developing	  mouse	  brain	  .................................................................................................................................................................	  55	  3.2.1	  The	  expansion	  of	  the	  stem	  population	  in	  Jmjd3	  KO	  brains	  is	  not	  restricted	  to	  cortical	  NPCs	  ............................................................................................................................................	  56	  3.3	  Loss	  of	  Jmjd3	  causes	  a	  late-­‐onset	  reduction	  in	  the	  neuronal	  production	  in	  the	  developing	  mouse	  neocortex	  ................................................................................................................	  57	  3.3.1	  The	  Tbr2+	  population	  of	  cortical	   intermediate	  progenitors	  is	  not	  affected	  by	  the	  loss	  of	  Jmjd3	  in	  the	  developing	  neocortex	  ..........................................................................	  58	  3.4	  The	  demethylase	  activity	  of	  Jmjd3	  is	  necessary	  for	  proper	  development	  of	  the	  mouse	  neocortex	  ........................................................................................................................................	  60	  3.5	  In	  vivo	  characterization	  of	  the	  Jmjd3	  KO	  NPC	  population	  ................................................	  62	  3.5.1	   Jmjd3	   KO	  NPCs	   proliferate	   actively	   and	   have	   a	   higher	   rate	   of	   cell	   cycle	   re-­‐entry	  after	  completing	  mitosis	  ........................................................................................................	  62	  3.5.2	  Jmjd3	  KO	  NPCs	  do	  not	  display	  aberrantly-­‐localized	  mitoses	  ..................................	  63	  3.5.3	  The	  timing	  of	  neuronal	  subtype	  production	  is	  not	  altered	  by	  loss	  of	  Jmjd3	  ....	  64	  3.6	  In	  vitro	  characterization	  of	  Jmjd3	  KO	  brain-­‐derived	  NPCs	  ..............................................	  66	  3.6.1	   In	   vitro-­‐cultured	   Jmjd3	   KO	   VZ	   NPCs	   can	   differentiate	   in	   the	   three	   neural	  lineages	  ......................................................................................................................................................	  67	  3.6.2	  Jmjd3	  KO	  NPCs	  show	  a	  lower	  proliferation	  rate	  upon	  serial	  passaging	  .............	  68	  3.6.3	  In	  vitro-­‐cultured	  Jmjd3	  KO	  VZ	  NPCs	  have	  a	  longer	  cell	  cycle	  .................................	  69	  
	   8	  
3.6.4	   Loss	   of	   Jmjd3	   causes	   a	   general	   lengthening	   of	   the	   cell	   cycle	   in	   in	   vitro-­‐cultured,	  brain-­‐derived	  NPCs	  ...........................................................................................................	  70	  3.6.5	  Cyclins	  and	  crucial	  cell	  cycle	  regulators	  are	  not	  affected	  at	  the	  protein	  level	  in	  in	  vitro-­‐cultured	  NPCs	  by	  the	  loss	  of	  Jmjd3	  ...............................................................................	  72	  3.6.6	   Synchronization	   and	   release	   of	   WT	   and	   KO	   NPCs	   shows	   similar	   S-­‐phase	  progression	  ..............................................................................................................................................	  73	  3.7	  VZ	  NPCs	  in	  the	  Jmjd3	  KO	  developing	  brain	  display	  a	  generalized	  lengthening	  of	  the	  cell	  cycle,	  dependent	  on	  the	  loss	  of	  the	  catalytic	  activity	  of	  Jmjd3	  ...............................	  75	  3.8	  Generation	  of	  a	  conditional	  Jmjd3	  KO	  strain	  ..........................................................................	  78	  3.8.1	   Constitutive	   deletion	   of	   Jmjd3.fl	   upon	   crossing	   with	   PGK.Cre	   strain	  recapitulates	  the	  cortical	  phenotype	  of	  XB814	  mice	  but	  to	  a	  slightly	  lesser	  degree	  of	  severity	  .......................................................................................................................................................	  79	  3.9	  Transcriptomic	  analysis	  shows	  differences	  between	  WT	  and	  Jmjd3	  KO	  mRNA	  extracted	  from	  in	  vitro-­‐cultured	  NPCs	  ..............................................................................................	  81	  3.9.1	   Bioinformatics	   analysis	   highlights	   enrichment	   of	   DEGs	   among	   pathways	  relevant	  to	  the	  phenotype	  of	  NPC	  expansion	  and	  cell	  cycle	  lengthening	  ......................	  82	  3.9.2	  Integration	  of	  RNAseq	  data	  with	  publicly	  available	  Jmjd3	  and	  H3K27	  ChIPseq	  profiles	  identifies	  a	  subset	  of	  putative	  direct	  Jmjd3	  targets	  ...............................................	  84	  3.9.3	  Transcriptomic	  analysis	  of	  E16.5	  cortical	  tissue	  reveals	  minor	  overlap	  with	  in	  vitro-­‐cultured	  NPCs	  ..............................................................................................................................	  85	  3.10	  Generation	  of	  a	  mouse	  strain	  harboring	  a	  Jmjd3-­‐Venus	  fusion	  protein	  ..................	  87	  3.10.1	   Derivation	   of	   NPCs	   from	  mouse	   ES	   cells	   harboring	   a	   human	   Jmjd3-­‐Venus	  fusion	  protein	  ..........................................................................................................................................	  88	  3.11	  Jmjd3	  binds	  to	  the	  Dlx2	  promoter	  in	  an	  in	  vitro	  model	  of	  adult	  neurogenesis	  .....	  89	  4	  DISCUSSION	  ..............................................................................................................................................	  92	  5.	  REFERENCES	  ...........................................................................................................................................	  98	  
	   9	  




AP	  Apical	  progenitor	  
BAC	  Bacterial	  artificial	  chromosome	  
BrdU	  Bromodeoxyuridine	  
bFGF	  Basic	  fibroblast	  growth	  factor	  
BP	  Basal	  progenitor	  
CdK	  Cyclin-­‐dependent	  kinase	  
Cdkn2a	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  kinase	  inhibitor	  2A	  
ChIP	  Chromatin	  Immunoprecipitation	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  nervous	  system	  
CP	  Cortical	  plate	  
DNMT	  DNA	  methyltransferase	  
EdU	  Ethynyl	  deoxyuridine	  
EGF	  Epidermal	  growth	  factor	  
ES	  cell	  Embryonic	  stem	  cell	  
Ezh2	  Enhancer	  of	  zeste	  homolog	  2	  
FAD	  Flavin	  adenine	  dinucleotide	  
FBS	  Fetal	  bovine	  serum	  
GSK3	  glycogen	  synthase	  kinase	  3	  
H2AK119	  lysine	  119	  of	  histone	  H2A	  
H3K4	  lysine	  4	  of	  histone	  H3	  
H3K27	  lysine	  27	  of	  histone	  H3	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HAT	  Histone	  acetyl	  transferase	  
HBSS	  Hank’s	  balanced	  salt	  solution	  
HDAC	  Histone	  de-­‐acetylase	  
HDM	  Histone	  de-­‐methylase	  
HE	  Hematoxylin	  and	  eosin	  
HMT	  Histone	  methyltransferase	  
Hox	  Homeotic	  genes	  
IdU	  Iododeoxyuridine	  
INM	  Interkinetic	  nuclear	  migration	  
IZ	  Intermediate	  zone	  
IP	  Immunoprecipitation	  
KDM	  Lysine	  de-­‐methylase	  
LGE	  Lateral	  ganglionic	  eminence	  
MBD	  Methyl	  binding	  domain	  
MEF	  mouse	  embryonic	  fibroblast	  
MLL	  Mixed	  lineage	  leukemia	  
NPC	  Neural	  precursor	  cell	  
pA	  Poly-­‐adenylation	  
PBC	  Pre-­‐Bötzinger	  complex	  
PBS	  Phosphate	  buffered	  saline	  
PcG	  Polycomb	  group	  
PCR	  Polymerase	  chain	  reaction	  
PFA	  Paraformaldehyde	  
pH3	  Phospho-­‐histone	  H3	  
PI	  Propidium	  iodide	  
PLO	  Poly-­‐L-­‐ornithine	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PRC1	  Polycomb	  repressive	  complex	  1	  
PRC2	  Polycomb	  repressive	  complex	  2	  
PTM	  Post-­‐translational	  modification	  
RGC	  Radial	  glial	  cell	  
RNAi	  RNA	  interference	  
RNAPII	  RNA	  polymerase	  II	  
RT	  room	  temperature	  
RTN/pFRG	  Retrotrapezoid	  nucleus/parafacial	  respiratory	  group	  
sA	  Splice	  acceptor	  
SVZ	  Sub-­‐ventricular	  zone	  
SWI/SNF	  SWItch/Sucrose	  NonFermentable	  
TET	  Ten-­‐eleven	  translocation	  
TrxG	  Trithorax	  group	  
VZ	  Ventricular	  zone	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1	  INTRODUCTION	  
	  
1.1	  Epigenetics	  and	  chromatin	  	  
1.1.1	  Definition	  of	  epigenetics	  The	  meaning	  of	  the	  term	  epigenetics	  has	  smoothly	  shifted	  in	  shape	  since	  its	  original	  coinage	  by	  Conrad	  Waddington	   in	  1942	  as	  “the	  branch	  of	  biology	  which	  studies	  the	  causal	   interactions	   between	   genes	   and	   their	   products,	   which	   bring	   the	   phenotype	  into	  being”	  (Waddington,	  1942).	  Recently,	  more	  rigorous	  definitions	  of	  epigenetics	  have	  been	  proposed,	  including	  that	  of	  Berger	  et	  al.	  (Berger	  et	  al.,	  2009),	  which	  states	  that:	  “an	  epigenetic	  trait	  is	  a	  stably	  heritable	  phenotype	  resulting	  from	  changes	  in	  a	  chromosome	  without	  alterations	  in	  the	   DNA	   sequence”	   and	   that	   by	   Riggs	   et	   al.	   (Riggs	   et	   al.,	   1996),	   which	   defines	  epigenetics	   as	   “the	   study	   of	   changes	   in	   gene	   function	   that	   are	   mitotically	   and/or	  meiotically	   heritable	   and	   that	   do	  not	   entail	   a	   change	   in	  DNA	   sequence”.	   A	   rigorous	  analysis	  of	  the	  meaning	  of	  the	  term	  epigenetics	  and	  of	  the	  history	  of	  its	  development	  is	   provided	   by	   several	   review	   articles	   (Boniolo	   and	   Testa,	   2012;	  Meloni	   and	   Testa,	  2014).	  However,	  as	  far	  as	  experimental	  practice	  and	  the	  common	  use	  of	  the	  word	  go,	  a	  more	  operative	   definition	   would	   state	   that	   epigenetics	   is	   essentially	   “the	   study	   of	   the	  mechanisms	  of	  temporal	  and	  spatial	  control	  of	  gene	  activity	  during	  the	  development	  of	  complex	  organisms”,	  as	  proposed	  by	  Robin	  Holliday	  back	  in	  1990	  (Holliday,	  1990).	  Indeed,	  the	  study	  of	  epigenetics	  nowadays	  mainly	  entails	  the	  study	  of	  the	  relationship	  between	  chromatin	  modifications	  and	  gene	  expression,	  and	  how	  chromatin	  modifiers	  can	  influence	  the	  expression	  of	  target	  genes	  upon	  certain	  stimuli	  or	  during	  cell	  state	  transitions.	   For	   the	   scope	   of	   this	   thesis,	   I	  will	   refer	   to	   epigenetics	   according	   to	   the	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more	   practical	   definition	   by	   Holliday,	   but	   without	   forfeiting	   the	   concepts	   of	  inheritability	  of	  a	  modification	  and	  absence	  of	  alterations	   in	   the	  DNA	  sequences,	   as	  summarized	  in	  the	  definition	  by	  Berger.	  	  
1.1.2	  Chromatin	  and	  histones	  In	   the	  nucleus	  of	   eukaryotic	   cells,	  DNA	   is	  packaged	   together	  with	  proteins	  and	   this	  complex	  is	  called	  chromatin.	  There	  are	  several	  levels	  of	  DNA	  compaction	  that	  can	  be	  achieved	  during	  different	  phases	  of	  the	  cell	  cycle,	  up	  to	  the	  hypercondensed	  state	  that	  is	  represented	  by	  metaphase	  chromosomes.	  However,	  the	  base	  unit	  of	  DNA	  packaging	  in	  eukaryotes	  is	  the	  nucleosome,	  which	  is	  composed	  by	  stretch	  of	  approximately	  147	  DNA	   base	   pairs	   wrapped	   around	   a	   globular	   octameric	   protein	   core,	   formed	   by	   2	  copies	  each	  of	  the	  histone	  proteins	  H2A,	  H2B,	  H3,	  H4.	  The	  H1	  linker	  histone	  and	  its	  isoforms	   also	   participate	   in	   chromatin	   compaction	   by	   interacting	   with	   the	  nucleosome	  near	  the	  entry	  and	  exit	  points	  of	  the	  DNA.	  The	  N-­‐terminal	  tail	  of	  histones	  is	   the	   substrate	   of	   several	   covalent	   modifications,	   which	   can	   alter	   the	   structural	  organization	   of	   the	   nucleosome	   and	   ultimately	   influence	   DNA	   access	   and	  conformation,	   or	   function	   as	   docking	   sites	   for	   proteins	   and	   complexes.	   More	  specifically,	   post-­‐translational	   modifications	   of	   histone	   tails	   can	   contribute	   to	   the	  establishment	   of	   global	   chromatin	   domains	   that	   are	   functional	   to	   the	   execution	   of	  different	   DNA-­‐based	   programs,	   such	   as	   genomic	   imprinting,	   transcription,	   DNA	  repair,	  DNA	  replication	  and	  chromosome	  condensation	  (Kouzarides,	  2007).	  	  
1.1.3	  Covalent	  modifications	  affecting	  chromatin	  function	  The	   most	   characterized	   covalent	   modifications	   that	   can	   affect	   chromatin	   function	  include	  DNA	  methylation	  and	  histone	  post-­‐translational	  modifications.	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In	   mammals,	   DNA	   methylation	   on	   the	   fifth	   position	   of	   cytosine	   (5mc)	   is	   mainly	  restricted	  to	  the	  CpG	  dinucleotides,	  and	  commonly	  occurs	  at	  centromeres,	  telomeres,	  and	   repeated	   sequences.	   CpG-­‐rich	  DNA	   stretches,	   or	   CpG	   islands,	   are	   usually	   about	  1000-­‐bp	   long	  and	   frequently	  unmethylated.	  CpG	   islands	  are	  usually	  associated	  with	  regulatory	  functions	  and	  located	  at	  the	  5’	  of	  genes,	  and	  can	  be	  identified	  in	  about	  70%	  of	  all	  mammalian	  promoters.	  The	  methylation	  of	  CpG	  islands	  plays	  an	  important	  role	  in	  transcriptional	  regulation	  as	  it	  is	  normally	  associated	  with	  transcriptional	  silencing	  (Deaton	   and	   Bird,	   2011),	   and	   it	   can	   be	   performed	   by	   three	   different	   DNA	  methyltransferases	  (DNMTs)	  in	  higher	  eukaryotes	  (Li	  et	  al.,	  1992;	  Okano	  et	  al.,	  1999).	  DNA	   methylation	   has	   been	   regarded	   as	   a	   stable	   DNA	   modification	   until	   5-­‐hydroxymethylcytosine	   (5hmC)	   was	   discovered,	   suggesting	   for	   the	   first	   time	   that	  5mC	  could	  be	  further	  processed	  (Kriaucionis	  and	  Heintz,	  2009;	  Tahiliani	  et	  al.,	  2009).	  Hydroxylation	   of	   5mC	   can	   recruit	   Methyl	   Binding	   Domains	   (MBDs)-­‐containing	  “readers”,	  which	   in	   turn	  can	  exert	  critical	   roles	   in	  host	  defense,	  genome	   imprinting,	  and	   X	   chromosome	   inactivation	   (Suzuki	   and	   Bird,	   2008).	   It	   was	   subsequently	  demonstrated	   that	   the	   mammalian	   ten-­‐eleven	   translocation	   (TET	   1–3)	   family	   of	  proteins	   includes	   the	  DNA	   hydroxylases	   responsible	   for	   the	   catalytic	   conversion	   of	  5mC	  to	  5hmC.	  	  The	  N-­‐terminal	   tails	  of	  histones	   emerge	   from	  the	  octameric	  core	  and	  constitute	   the	  main	  regulatory	  domain	  of	  histones.	  Several	  post-­‐translational	  modifications	  mainly	  targeting	   lysines	   and	   arginines	   have	   been	   described,	   including	   acetylation,	  methylation,	   phosphorylation,	   ribosylation,	   ubiquitylation	   and	   sumoylation.	   One	   of	  the	   main	   consequences	   of	   these	   modifications	   is	   to	   alter	   the	   surface	   charge	   of	  histones	   and	   change	   the	   overall	   strength	   of	   histone-­‐histone	   and	   histone-­‐DNA	  interactions,	   with	   a	   profound	   effect	   on	   the	   compaction	   state	   of	   chromatin.	   As	   an	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example,	  phosphorylation	  (Wei	  et	  al.,	  1999)	  or	  acetylation	  (Gorisch	  et	  al.,	  2005)	  can	  loosen	  the	  chromatin	  fiber	  by	  reducing	  the	  overall	  positive	  charge	  of	  the	  histone	  tail,	  making	   the	   DNA	  more	   accessible	   to	   transcription	   factors	   and	   therefore	   potentially	  more	  transcriptionally	  active.	  Histone	  modifications	  can	  also	   favor	  or	  hinder	   the	   recruitment	  of	  other	  proteins	   to	  the	  modified	   histone	   tails.	   The	   concerted	   action	   of	   histone	  modifications	   and	   non-­‐histone	  proteins	  contributes	  to	  the	  recruitment	  of	  protein	  complexes	  that	  can	  allow	  RNA	   transcription,	   DNA	   repair	   or	   replication,	   and	   chromosome	   condensation	  (Kouzarides,	   2007)	   (summarized	   in	   fig.	   1).	   Importantly,	   most	   modifications	   are	  dynamic,	   and	  enzymes	  have	  been	   isolated	   that	   can	  add	  and	  remove	   residues.	  Thus,	  for	   example,	   histone	   acetylases	   (HATs)	   and	   de-­‐acetylases	   (HDACs)	   have	   been	  described,	  as	  well	  as	  histone	  methyltransferases	  (HMTs)	  and	  demethylases	  (KDMs).	  
	  
Figure	  1.	  Diagram	  of	  the	  main	  histone	  PTMs	  and	  their	  role	  in	  transcription	  (Zhou	  et	  al.,	  2011).	  Promoters,	   gene	   bodies,	   enhancers	   and	   boundary	   elements	   are	   shown.	   Active	   promoters	   are	  commonly	   marked	   by	   H3K4me2,	   H3K4me3,	   acetylation,	   and	   H2A.Z	   histone.	   Actively	   transcribed	  regions	   are	   enriched	   in	   H3K36me3	   and	   H3K79me2.	   Repressed	   genes	   are	   usually	   localized	   in	   large	  domains	  of	  H3K9me2/3	  or	  H3K27me3.	  Enhancers	  can	  be	  enriched	  in	  H3K4me1,	  H3K4me2,	  H3K27ac	  and	   the	  HAT	  p300.	   CTCF	   is	   localized	   at	  many	   sites	   that	  have	  been	  described	   as	  boundary	   elements,	  insulators	  or	  structural	  scaffolds.	  RNAPII,	  RNA	  polymerase	  II.	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1.1.4	  Chromatin	  and	  gene	  transcription	  The	  most	  widely	  used	  technique	  to	  investigate	  the	  association	  between	  proteins	  and	  specific	  DNA	  sequences	  is	  called	  Chromatin	  Immunoprecipitation	  (ChIP)	  (Shang	  et	  al.,	  2000;	  Solomon	  et	  al.,	  1988).	  DNA	  and	  its	  interacting	  proteins	  are	  covalently	  bound	  by	  the	  use	  of	  cross-­‐linking	  agents	  such	  as	  formaldehyde	  or	  disuccinimidyl	  glutarate,	  and	  antibodies	   specific	   for	   the	   peptide	   of	   interest,	   which	   can	   be	   a	   histone	   post-­‐translational	   modification	   or	   a	   transcription	   factor	   are	   used	   to	   precipitate	   the	  fragmented,	  cross-­‐linked	  chromatin.	  The	  interacting	  DNA	  is	  then	  de-­‐crosslinked	  and	  purified,	  and	  downstream	  techniques	  like	  qPCR	  or	  DNA	  sequencing	  are	  then	  used	  to	  identify	  the	  genomic	  loci	  that	  are	  preferentially	  bound	  by	  the	  protein	  of	  interest.	  ChIP	  has	  allowed	  scientists	   to	  associate	   the	  presence	  of	  particular	  histone	   tail	  post-­‐translational	  modification	  (PTM)	  to	  the	  transcriptional	  activity	  of	  a	  target	  gene.	  More	  recently,	   next-­‐generation	   sequencing	   techniques	   have	   granted	   the	   possibility	   to	  highlight	   genome-­‐wide	   roles	   for	   chromatin	   structures	   and	   elements	   that	   were	   not	  appreciated	   in	   gene-­‐centric	   studies.	   The	   resulting	   maps	   and	   data	   sets	   have	   linked	  particular	  modifications	  with	  gene	  activation	  or	  repression	  and	  with	  various	  genomic	  features,	  including	  promoters,	  transcribed	  regions	  and	  enhancers.	  Histone	  lysine	  methylation	  is	  central	  to	  processes	  of	  cellular	  differentiation,	  since	  the	  expression	   of	   genes	   involved	   in	   differentiation	   is	   dynamically	   regulated	   through	  changes	  in	  histone	  methylation	  at	  specific	  lysine	  residues,	  most	  notably	  lysine	  27	  on	  histone	   H3	   (H3K27),	   associated	   with	   transcriptional	   repression,	   and	   lysine	   4	   on	  histone	  H3	  (H3K4),	  associated	  with	  transcriptional	  activation.	  Genome-­‐wide	  analysis	  showed	   that	   tri-­‐methylayion	   of	   H3K27	   (H3K27me3)	   labels	   transcriptionally	  repressed	  domains	  that	  are	  present	  in	  embryonic	  stem	  cells	  (ES	  cells)	  and	  extend	  in	  differentiated	  cell	  types,	  to	  allow	  cell	  type-­‐specific	  repression	  (Hawkins	  et	  al.,	  2010).	  Functionally,	   these	  regions	  might	  serve	   for	   lineage	  restriction	  during	  differentiation	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as	   they	   cover	   only	   approximately	   4%	   of	   the	   genome	   in	   undifferentiated	  mouse	   ES	  cells,	   compared	   to	   31%	   in	   differentiated	   ES	   cells	   (Wen	   et	   al.,	   2009).	   “Bivalent	  domains”	  were	  identified	  at	  some	  promoters	  and	  deserve	  special	  description.	  These	  domains	  are	  marked	  by	  both	  H3K4me3	  and	  H3K27me3	  (Bernstein	  et	  al.,	  2006;	  Lee	  et	  al.,	   2006;	   Mikkelsen	   et	   al.,	   2008)	   and	   serve	   a	   specific	   function	   in	   the	   context	   of	  development.	  Bivalent	  genes	  are	  indeed	  transcriptionally	  silent,	  but	  lie	  in	  a	  “poised”	  state	   that	   is	   resolved	   either	   towards	   activation	   or	   definitive	   repression	   via	   the	  erasure	  of	  the	  H3K27	  or	  H3K4	  methylation,	  respectively.	  However,	  the	  very	  concept	  of	   bivalent	   domains	   has	   been	   recently	   challenged	   (Laugesen	   and	  Helin,	   2014).	   It	   is	  indeed	  not	  entirely	  certain	   that	   the	  co-­‐occurrence	  of	   the	   two	  marks,	  as	  assessed	  by	  ChIP-­‐qPCR	   or	   ChIPseq	   techniques,	   reflects	   the	   presence	   of	  methylation	   on	   both	  K4	  and	  K27	  of	   the	  very	  same	  H3	  histone	   tail.	  Rather,	   the	  bivalency	  might	  represent	  an	  artifact	  deriving	  from	  heterogeneity	  of	  the	  cell	  population	  under	  exam.	  Alternatively,	  the	   two	   marks	   might	   coexist	   on	   opposite	   H3	   tails	   of	   the	   same	   nucleosome,	   or	   on	  neighboring	  nucleosomes.	  	  
1.1.5	  Proteins	  responsible	  for	  histone	  tail	  modifications	  The	   proteins	   responsible	   for	   transferring	   the	   methyl	   groups	   onto	   the	   histone	   tail	  lysins	  K4	  and	  K27	  have	  been	  identified	  by	  seminal	  studies	  performed	  on	  Drosophila	  in	  virtue	  of	   their	  ability	   to	  regulate	   the	  expression	  pattern	  of	  homeotic	  (Hox)	  genes	  (Ingham,	  1985;	  Lewis,	  1978),	  but	  their	  biochemical	  activity	  in	  catalyzing	  the	  addition	  and	   removal	   of	   methyl	   groups	   on	   lysine	   residues	   has	   been	   elucidated	   only	   later	  (Schuettengruber	  et	  al.,	  2007;	  Steffen	  and	  Ringrose,	  2014)	  Some	  proteins	  belonging	  to	  the	  Trithorax	  group	  (TrxG	  proteins)	  are	  able	  to	  catalyze	  the	   methylation	   of	   lysine	   H3K4	   and	   confer	   an	   active	   transcriptional	   status	   to	   the	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target	   gene	   (Byrd	   and	   Shearn,	   2003),	   whereas	   the	   polycomb	   group	   (PcG)	   proteins	  repress	  gene	  transcription	  and	  act	  via	  two	  different	  complexes.	  The	  Polycomb	  Repressive	  Complex	  2	  (PRC2)	  act	  as	  a	  holoenzyme	  composed	  of	   four	  core	  members	  and	  other	  associated	  proteins.	  The	  catalytic	  subunit	  Enhancer	  of	  zeste	  homolog	   2	   (Ezh2)	   is	   responsible	   for	   imposing	   the	   H3K27me3	   mark	   via	   its	  methyltransferase	  activity	  (Cao	  and	  Zhang,	  2004),	  whereas	  the	  Eed	  subunit	  is	  able	  to	  recognize	  the	  H3K27me3	  mark	  and	  recruit	  the	  PRC2	  (Hansen	  et	  al.,	  2008;	  Margueron	  et	  al.,	  2009).	  This	  feed-­‐forward	  loop	  between	  the	  mark	  and	  the	  enzyme	  that	  catalyzes	  its	  addition	  allows	  H3K27me3	  to	  be	  maintained	  upon	  cell	  division,	  making	  it	  a	  bona	  
fide	   epigenetic	  mark	   (Morey	   and	  Helin,	   2010).	   The	  polycomb	   repressive	   complex	  1	  (PRC1),	  on	  the	  other	  hand,	  can	  ubiquitinate	  lysine	  119	  of	  histone	  H2A	  (H2AK119)	  via	  its	  RING	  protein	  subunits,	  and	  also	  recognize	  H3K27me3	  through	  its	  chromodomain-­‐containing	   subunits	   CBX	   and	   HPH.	   It	   has	   thus	   been	   proposed	   that	   PRC1	   can	   be	  recruited	  on	  chromatin	  by	  the	  activity	  of	  PRC2	  on	  H3K27,	  but	  there	  are	  instances	  in	  which	  this	  model	  does	  not	  hold	  true,	  as	  it	  has	  been	  shown	  that	  the	  two	  complexes	  can	  target	  different	  genes	  (Schoeftner	  et	  al.,	  2006;	  Sing	  et	  al.,	  2009).	  More	  recently,	  it	  has	  been	   demonstrated	   that	   variant	   PRC1	   complex	   occupancy	   can	   recruit	   the	   PRC2	  complex	   and	   lead	   to	   H3K27me3	   deposition	   in	   an	  H2AK119ub1-­‐dependent	  manner	  (Blackledge	   et	   al.,	   2014),	   shedding	   new	   light	   on	   the	   mechanisms	   that	   govern	  polycomb	  domain	  formation	  and	  transcriptional	  repression.	  	  
1.1.6	  The	  discovery	  of	  histone	  demethylases	  As	   discussed	   in	   the	   previous	   paragraph,	   evidences	   for	   the	   existence	   of	   histone	  methyltransferases	  date	  back	   to	   the	  1970’s	   (Lewis,	   1978),	   but	   until	   recently	   it	  was	  thought	   that	   histone	  methylation	  was	   a	   permanent	  modification	   that	   could	   only	   be	  reversed	  by	  histone	  eviction	  or	  dilution	  during	  DNA	  replication.	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This	   was	   until	   Shi	   and	   colleagues	   discovered	   the	   first	   lysine-­‐specific	   demethylase	  (LSD1)	  in	  2004	  (Shi	  et	  al.,	  2004).	  LSD1	  can	  demethylate	  H3K4	  and	  H3K9	  via	  a	  flavin	  adenine	   dinucleotide	   (FAD)-­‐dependent	   amine	   oxidation	   reaction	   and	   participate	   in	  the	   downregulation	   of	   target	   genes,	   also	   in	   complex	   with	   the	   CoREST	   silencing	  transcription	   factor	   (Lee	   et	   al.,	   2005).	   Soon	   after,	   proteins	   belonging	   to	   a	   family	   of	  histone	  demethylases	  that	  rely	  on	  an	  entirely	  different	  biochemical	  process	  for	  their	  catalytic	   activity	  were	   identified	   in	   several	   laboratories	   (Tsukada	  et	   al.,	   2005).	  This	  protein	   family	   is	   characterized	   by	   the	   presence	   of	   a	   JmjC	   domain,	   which	   can	  demethylate	   lysine	   in	   a	   dioxygenase	   reaction	   that	   depends	   on	   Fe(II)	   and	   α-­‐ketoglutarate	  (fig.	  2).	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1.1.7	  Jmjd3	  Jmjd3,	   or	   Kdm6b,	   is	   a	   member	   of	   the	   JmjC	   protein	   family	   and,	   together	   with	   its	  paralog	  Utx,	  is	  the	  only	  known	  protein	  that	  can	  mediate	  demethylation	  of	  di-­‐	  and	  tri-­‐methylated	  H3K27	  (Hong	  et	  al.,	  2007)	  (fig.	  3).	  Soon	  after	  the	  discovery	  of	  the	  family	  of	  JmjC-­‐domain	  demethylases,	  several	  groups	  independently	  published	  evidences	  of	  the	  function	  of	  Jmjd3	  as	  an	  H3K27-­‐specific	  demethylase,	  highlighting	  a	  role	  in	  Hox	  gene	  regulation	  (Agger	  et	  al.,	  2007;	  Lan	  et	  al.,	  2007)	  and	  inflammation-­‐response	  programs	  in	  macrophages	  (De	  Santa	  et	  al.,	  2007).	  
	  
Figure	   3.	   The	   Kdm6	   family	   of	   histone	   demethylases.	   UTX	   (KDM6A),	   JMJD3	   (KDM6B)	   and	   UTY	  (KDM6C).	  Tp,	  tetratricopeptide	  repeat;	  JmjC,	  jumonji	  C	  domain	  (Kooistra	  and	  Helin,	  2012).	  It	   was	   also	   shown	   by	   our	   lab	   and	   others	   that	   Jmjd3	   is	   involved	   in	   neural	  differentiation	   process	   (Burgold	   et	   al.,	   2008;	   Jepsen	   et	   al.,	   2007):	   its	   demethylase	  activity	  was	  indeed	  proven	  necessary	  for	  the	  transcriptional	  activation	  of	  genes	  that	  are	   responsible	   for	   the	  unwinding	  of	  neurogenic	  programs	  both	   in	  embryonic	   stem	  cells	  and	  in	  brain-­‐derived	  neural	  precursor	  cells.	  The	  observation	  that	  genome-­‐wide	  changes	  in	  H3K27me3	  accompany	  the	  entire	  process	  of	  neural	  fate	  acquisition	  (Mohn	  et	   al.,	   2008)	   further	   underscored	   the	   importance	   of	   a	   H3K27	   demethylase	   for	   the	  proper	   implementation	   of	   the	   neural	   development	   process,	   and	   potentially	   also	   of	  other	  developmental	  processes	   that	  require	   the	  activation	  of	   inactive	  genes	  marked	  by	  H3K27me3.	  In	  2009,	  two	  papers	  proposed	  that	  the	  demethylase	  activity	  of	  Jmjd3	  was	  needed	  for	  transcriptional	   activation	   of	   genes	   involved	   in	   tumorigenesis.	   Specifically,	   it	   was	  shown	  in	  mouse	  embryonic	  fibroblasts	  (MEFs)	  that	  Jmjd3	  counteracts	  the	  activity	  of	  PcG	  proteins	  on	  the	  Ink4a/Arf	   locus	  and	  participates	  in	  its	  activation	  in	  response	  to	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oncogene-­‐induced	  senescence,	  suggesting	  that	  Jmjd3	  might	  act	  as	  a	  tumor	  suppressor	  in	   some	   contexts	   (Agger	   et	   al.,	   2009;	   Barradas	   et	   al.,	   2009).	   A	   recent	   report	  corroborated	  these	  findings	  and	  extended	  them	  by	  showing	  that	  the	  Jmjd3-­‐mediated	  activation	  of	   the	   Ink4a/Arf	   locus	   constitutes	   an	  obstacle	   to	   cellular	   reprogramming	  (Zhao	  et	  al.,	  2013)	  The	  array	  of	  mechanisms	  of	  action	  of	   Jmjd3	  was	  significantly	  extended	  when	  it	  was	  demonstrated	  that	  Jmjd3	  is	  able	  to	  regulate	  the	  transcriptional	  activity	  of	  target	  genes	  also	   in	   a	   demethylase-­‐independent	   manner,	   and	   specifically	   by	   mediating	   the	  interaction	   of	   a	   T-­‐box	   family	  member	  with	   a	  Brg1-­‐containing	   SWI/SNF	   remodeling	  complex:	  this	  multi-­‐protein	  functions	  as	  a	  chromatin	  remodeler	  to	  enhance	  promoter	  accessibility	  and	  activate	  transcription	  (Miller	  et	  al.,	  2010).	  The	  activity	  of	  several	  non-­‐histone	  proteins	  can	  be	  regulated	  by	  methylation	  (Huang	  et	   al.,	   2007),	   and	   it	  has	  been	   suggested	   that	  histone	  demethylases	  might	  also	  affect	  the	  methylation	  levels	  of	  non-­‐histone	  targets.	  Indeed,	  JmjC	  proteins	  are	  also	  found	  in	  bacteria	   that	   do	   not	   contain	   histones,	   suggesting	   that	   these	   proteins	   have	   other	  functions	   besides	   histone	   demethylation.	   p53	   was	   one	   of	   the	   first	   non-­‐histone	  substrates	   shown	   to	  be	  post-­‐translationally	  modified	  by	  proteins	  with	  demethylase	  activity.	   LSD1	   is	   able	   to	   repress	   p53-­‐mediated	   transcriptional	   activation	   and	   p53-­‐induced	  apoptosis	  by	  demethylating	  K370me2	  on	  p53,	  thus	  inhibiting	  the	  interaction	  between	  p53	  and	  tumour	  suppressor	  p53-­‐binding	  protein	  1	  (TP53BP1).	  	  Along	  the	  same	  line,	  some	  studies	  have	  proposed	  that	  Jmjd3	  is	  able	  to	   interact	  with	  both	   p53	   and	   TAp63γ	   and	   demethylate	   an	   unspecified	   lysine	   residue,	   resulting	   in	  their	  nuclear	  accumulation	  and	  affecting	  their	   function	  (Ene	  et	  al.,	  2012;	  Fonseca	  et	  al.,	  2012;	  Solá	  et	  al.,	  2011).	  However,	   the	  evidences	  provided	   in	  these	  works	  do	  not	  amount	   to	  a	   compelling	  demonstration	   for	   the	  activity	  of	   Jmjd3	  on	  p53	  or	  TAp63γ,	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and	   more	   research	   ought	   to	   be	   performed	   to	   allow	   considering	   this	   result	   as	   a	  credible	  function	  of	  Jmjd3.	  	  
1.2	  Neocortical	  development	  The	  mammalian	  neocortex	  develops	  from	  the	  embryonic	  ectoderm,	  in	  and	  particular	  from	  the	  neural	  plate,	  which	   folds	  and	  coalesces	   forming	   the	  neural	   tube.	  From	  the	  most	  anterior	  part	  of	  the	  neural	  tube	  develops	  the	  telencephalon,	  which	  will	  give	  rise	  to	  the	  cerebral	  hemispheres	  and	  hence	  to	  the	  neocortex,	  while	  from	  the	  cavity	  inside	  the	   neural	   tube	   derives	   the	   ventricular	   system.	   In	   the	   mouse,	   neurogenesis	   takes	  place	   between	   embryonic	   days	   (E)	   E11	   and	   E19,	   and	   starts	   with	   a	   single	   layer	   of	  epithelial	   founder	  cells	  constituting	  the	  walls	  of	   the	  neural	   tube,	   the	  neuroepithelial	  cells.	  Neuroepithelial	  cells	  display	  an	  apico-­‐basal	  polarity	  and	  divide	  symmetrically	  in	  a	   self-­‐renewing	   fashion	   in	   order	   to	   increase	   their	   pool.	   When	   neurogenesis	   is	  initiated,	   neuroepithelial	   cells	   downregulate	   epithelial	   features	   (Aaku-­‐Saraste	   et	   al.,	  1997)	  and	  start	  displaying	  astroglial	  markers,	   transitioning	   into	  a	  distinct	   cell	   state	  known	  as	  radial	  glial	  cells	  (RGCs),	  which	  essentially	  represent	  a	  more	  fate-­‐restricted	  counterpart	   of	   neuroepithelial	   cells,	   and	   constituting	   the	   so-­‐called	   ventricular	   zone	  (VZ).	  	  
1.2.1	  Radial	  glial	  cells	  dynamics	  and	  differentiation	  The	   neocortex	   is	   formed	   by	   six	   layers	   of	   projection	   neurons,	   which	   are	   generated	  during	  corticogenesis	  by	  the	  radial	  glial	  cells	  (RGCs)	  following	  an	  inside-­‐out	  pattern,	  such	  that	  the	  first-­‐born	  neurons	  occupy	  the	  deepest	  layer	  and	  are	  closest	  do	  the	  VZ,	  whereas	  the	  late-­‐born	  neurons	  occupy	  the	  most	  superficial	  layer	  and	  are	  close	  to	  the	  meninges.	  RGCs	  can	  divide	  symmetrically	  or	  asymmetrically	  in	  the	  cortical	  VZ	  to	  self-­‐
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renew	  and	  generate	  neurons	  directly	  or,	  more	  frequently,	  indirectly	  via	  intermediate	  progenitor	  cells	  (Kriegstein	  and	  Álvarez-­‐Buylla,	  2009)	  (fig.	  4).	  
	  
Figure	  4.	  Model	  of	  neurogenesis	  in	  the	  developing	  mammalian	  neocortex.	  Neuroepithelial	  cells	  in	  early	  neocortical	  development	  divide	  symmetrically	  to	  expand	  their	  pool,	  and	  also	  likely	  produce	  early	  neurons.	   As	   development	   proceeds,	   neuroepithelial	   cells	   elongate	   and	   convert	   into	   radial	   glial	   (RG)	  cells.	   RG	   cells	   then	   start	   dividing	   asymmetrically	   to	   generate	   neurons	   directly	   or	   indirectly	   through	  intermediate	   progenitor	   cells	   (nIPCs).	   Oligodendrocytes	   are	   also	   produced	   by	   RG	   cells	   through	  intermediate	   progenitor	   cells	   that	   generate	   oligodendrocytes	   (oIPCs).	   RG	   cells	   have	   apical-­‐basal	  polarity:	   apically	   (down),	   RG	   cells	   contact	   the	   ventricle,	  where	   they	  project	   a	   single	   primary	   cilium;	  basally	   (up),	  RG	  cells	  contact	   the	  meninges,	  basal	   lamina,	  and	  blood	  vessels	   (Kriegstein	  and	  Álvarez-­‐Buylla,	  2009).	  The	  exact	  mechanisms	  that	  establish	  cellular	  diversity	  in	  the	  neocortex	  starting	  from	  a	   single	   founder	   cell	   population	   are	   not	   still	   completely	   elucidated,	   and	   two	   main	  paradigms	   have	   been	   proposed	   in	   the	   past	   years.	   The	   classic	   hypothesis	  maintains	  that	  a	   single	  RGC	   is	  able	   to	  generate	  all	   the	  neuronal	   subtypes	   through	  progressive	  lineage	  restriction,	  and	  following	  a	  temporal	  order	  that	   is	   largely	  cell-­‐autonomously	  determined	   (Desai	   and	   McConnell,	   2000;	   Hirabayashi	   et	   al.,	   2009;	   Mcconnell	   and	  Kaznowski,	   1991;	   Shen	   et	   al.,	   2006).	   Another	   hypothesis	   claims	   the	   presence	   of	  heterogeneous	   lineage-­‐restricted	  progenitors	   that	  are	  able	   to	  contribute	  specifically	  to	  subsets	  of	  projection	  neurons	  (Schuurmans	  et	  al.,	  2004),	  identifiable	  by	  molecular	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markers	   and	   belonging	   to	   a	   specific	   layer.	   A	   recent	   paper	   published	   on	   Science	  provided	  compelling	  evidence	  that	  a	  subpopulation	  of	  Cux2+	  RGCs,	  detectable	  since	  the	   beginning	   of	   neurogenesis,	   was	   indeed	   intrinsically	   specified	   to	   generate	   only	  late-­‐born,	   upper	   layer	   neurons	   (Franco	   et	   al.,	   2012).	   However,	   a	   research	   paper	  published	  in	  2013	  (Guo	  et	  al.,	  2013)	  challenged	  quite	  directly	  the	  findings	  of	  Franco	  and	  co-­‐workers,	  by	  demonstrating	  that	  Fezf2+	  RGCs	  can	  sequentially	  generate	  all	  the	  neuronal	   subtypes,	   including	  Cux2+	  neurons,	   and	   that	   the	   lineage	   tracing	  approach	  used	   in	   the	   Science	   2012	   paper	   suffered	   some	   flaws	   that	   made	   its	   conclusions	  unwarranted.	  Though	   these	   and	   other	   findings	   do	   not	   exclude	   that	   subsets	   of	   RGCs	   intrinsically	  restricted	   in	   their	   lineage	   potential	   may	   actually	   exist,	   the	   model	   entailing	  progressive	   lineage	   restriction	   of	   a	   single	  RGC	   seems	   to	   be	  more	   supported	   by	   the	  current	   literature.	  Along	   these	   lines,	   it	  has	  been	  proposed	   that	   the	  cell-­‐autonomous	  mechanisms	   that	   govern	   the	   production	   of	   different	   neuronal	   subtypes	   might	   be	  regulated	  by	   the	  progressive	  downregulation	  of	   epigenetic	   repressor	   (Testa,	  2011).	  This	   hypothesis	   is	   consistent	   with	   published	   data	   that	   report	   a	   progressive	  downregulation	   of	   the	  H3K27	  methyltransferase	   Ezh2	   as	   neurogenesis	   proceeds	   in	  
vivo	  (Pereira	  et	  al.,	  2010).	  	  	  
1.2.2	  Cell	  cycle	  regulation	  in	  mammalian	  neocortical	  development	  Seminal	  experiments	  that	  date	  back	  almost	  50	  years	  have	  demonstrated	  that	  the	  cell	  cycle	   of	   VZ	   neural	   progenitors	   lengthens	   as	   neurogenesis	   proceeds	   (Fujita,	   1962),	  from	   12	   hours	   at	   day	   11	   to	   18	   hours	   at	   day	   18.	  With	   the	   advent	   of	   more	   refined	  reagents	   and	   techniques	   such	   as	   differentially	   labelled	   thymidine	   analogues	  (Martynoga	   et	   al.,	   2005;	   Takahashi	   et	   al.,	   1995)	   and	   live	   imaging	   (Betizeau	   et	   al.,	  2013;	   Pilz	   et	   al.,	   2013),	   this	   notion	   has	   been	   extensively	   corroborated	   and	   more	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details	  on	  the	  cell	  cycle	  dynamics	  of	  RGCs	  have	  been	  gained.	  In	  particular,	  it	  has	  been	  demonstrated	  that	  the	  progressive	  lengthening	  on	  the	  cell	  cycle	  during	  the	  unwinding	  of	  neurogenesis	   is	  mainly	  due	  to	  a	  specific	   lengthening	  of	  the	  G1	  phase	  (Caviness	  et	  al.,	  1995;	  Dehay	  and	  Kennedy,	  2007;	  Salomoni	  and	  Calegari,	  2010).	  In	   tissues,	   the	   balance	   between	   self-­‐renewal	   and	   differentiation	   of	   the	   stem	  compartment	  determines	  the	  final	  composition	  of	  the	  tissues.	  In	  the	  case	  of	  the	  brain,	  if	   the	   VZ	   RGCs	  would	   exhaust	   their	   pool	   soon	   in	   neurogenesis	   through	   symmetric,	  differentiative	  divisions,	  the	  final	  thickness	  of	  the	  cortex	  would	  be	  reduced,	  and	  likely	  the	   complexity	   of	   neuronal	   subpopulations	   as	   well.	   The	   fine-­‐tuning	   of	   the	   mitotic	  choices	  in	  the	  VZ	  is	  hence	  of	  capital	  importance	  for	  a	  proper	  neocortical	  development.	  Several	   studies	   have	   found	   that	   cortical	   progenitor	   cells	   undergoing	   differentiative	  divisions	  tend	  to	  have	  a	  longer	  cell	  cycle	  than	  the	  ones	  that	  self-­‐renew,	  and	  that	  this	  lengthening	  is	  mainly	  due	  to	  a	  longer	  G1	  phase.	  Federico	   Calegari	   and	   coworkers	   established	   a	   causal	   link	   between	   G1	   phase	  lengthening	  and	  increased	  differentiation	  (Calegari	  et	  al.,	  2005;	  Lange	  et	  al.,	  2009),	  by	  modulating	  cdk4/cyclinD1	  (shortened	  in	  “4D”)	  in	  vivo	  via	  in	  utero	  electroporation.	  4D	  overexpression	   led	  to	  a	  shortening	  of	  both	  G1	  phase	  and	  total	  cell	  cycle	   length,	  and	  was	   associated	   to	   lower	   numbers	   of	   differentiative	   cell	   divisions,	   as	   assessed	   by	  positivity	  for	  Tis21,	  and	  increased	  numbers	  of	  Tbr2+	  basal	  progenitors;	  consistently,	  4D	  downregulation	  through	  an	  RNA	  interference	  (RNAi)	  approach	  induced	  opposite	  effects.	   Interestingly,	   the	   authors	   report	   that	   4D	   overexpression	   led	   to	   an	   overall	  shortening	  of	  the	  cell	  cycle	  despite	  a	  relative	  increase	  in	  S	  and	  G2+M	  phases:	  the	  G1	  shortening	  was	  indeed	  long	  enough	  to	  overcome	  the	  lengthening	  of	  the	  other	  phases,	  yielding	  a	  net	  shortening	  of	  the	  cell	  cycle.	  It	  is	  anyway	  worth	  noting	  that	  the	  shift	  of	  the	   balance	   towards	   self-­‐renewal	   at	   the	   expense	   of	   differentiation	   in	   VZ	   neural	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progenitors	  was	  associated	  not	  only	   to	  a	  G1-­‐phase	  shortening	  but	  also	   to	  a	  S-­‐phase	  increase.	  A	  follow	  up	  paper	  from	  the	  Huttner	  lab	  (Arai	  et	  al.,	  2011)	  reported	  a	  detailed	  analysis	  of	   the	   cell	   cycle	   parameters	   of	   differentiating	   versus	   self-­‐renewing	   neural	  progenitors,	   further	   breaking	   down	   the	   VZ	   neural	   progenitor	   population	   based	   on	  their	  positivity	  for	  Pax6	  (true	  RGCs)	  or	  Tbr2	  (intermediate	  progenitors).	  According	  to	  their	   analysis,	   expanding	   apical	   (Pax6+)	   (AP)	   and	   basal	   (Tbr2+)	   progenitors	   (BP)	  exhibited	  a	  two-­‐	  to	  three-­‐fold	  longer	  S-­‐phase	  than	  their	  neurogenic	  counterpart,	  and	  an	  overall	  longer	  cell	  cycle.	  It	  was	  also	  demonstrated	  that	  BP	  have	  an	  overall	  longer	  cell	   cycle	   (BP	  26.5	  hrs,	  AP	  19.1	  hrs)	  and	  a	   shorter	  S-­‐phase	   (BP	  3.2	  hrs,	  AP	  5.0	  hrs)	  than	  AP,	  and	  that	  the	  lengthening	  is	  due	  to	  a	  2-­‐fold	  increase	  of	  G1	  phase	  (AP	  11.6	  hrs,	  BP	  21.2	  hrs).	  Weaving	  together	  these	  and	  other	  experimental	  evidences,	  a	  unifying	  theory	  has	  been	  proposed	  under	  the	  name	  of	  “cell	  cycle	  hypothesis”	  (Arai	  and	  Pierani,	  2014;	  Calegari	  et	  al.,	  2005;	  Götz	  and	  Huttner,	  2005),	   aimed	  at	  explaining	   the	   relationship	  between	  cell	   cycle	   length	   and	   mitotic	   choice	   of	   neocortical	   progenitors.	   According	   to	   this	  hypothesis,	   “the	   ability	   of	   a	   cell	   fate	   determinant(s)	   to	   trigger	   a	   biologic	   effect	  depends	  on	   the	  amount	  of	   time	  given	   to	  such	  determinant(s)	   to	  act”	   (Salomoni	  and	  Calegari,	  2010),	  implying	  that	  the	  length	  of	  a	  specific	  cell	  cycle	  phase	  might	  influence	  the	  overall	   availability	   and	  hence	  activity	  of	   a	   cell	   fate	  determinant	   that	   is	   typically	  present	  during	  that	  phase,	  such	  as	  proteins	  belonging	  to	  the	  Wnt	  or	  Notch	  pathways,	  influencing	  the	  final	  choice	  between	  self	  renewal	  and	  differentiation.	  The	  experiments	  causally	  linking	  G1	  length	  to	  fate	  choice	  indeed	  strongly	  support	  this	  theory,	  at	   least	  as	   far	  as	  G1	   lengthening	   is	  concerned,	  although	  mechanistic	   insights	  are	   still	   lacking.	   Of	   course	   the	   big	   picture	   is	   likely	   a	   rather	   complex	   one,	   and	   the	  importance	  of	   the	  absolute	  and	  relative	   length	  of	  other	  phases	   to	  neural	  progenitor	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fate	   choice	   is	   yet	   to	   be	   determined.	   However,	   as	   outlined	   above,	   several	   evidences	  seem	  to	  link	  a	  self-­‐renewing	  behavior	  in	  neural	  precursor	  cells	  (NPCs)	  to	  a	   longer	  S	  phase,	  although	  the	  question	  whether	  the	  two	  events	  are	  causatively	  linked	  or	  simply	  correlated	  has	  not	  be	  addressed.	  	  
1.2.3	  Epigenetic	  regulation	  of	  transcription	  in	  neocortical	  development	  A	  tight	  control	  on	  the	  regulation	  of	  the	  chromatin	  state	  of	  developmental	  genes,	  and	  hence	  of	  their	  transcriptional	  activity,	  is	  critical	  to	  ensure	  that	  neurogenesis	  proceeds	  correctly,	   and	   that	   all	   the	   neuronal	   subtypes	   are	   generated	   with	   the	   right	   timing,	  sequence,	   and	   abundance.	   Given	   the	   necessity,	   in	   a	   developmental	   process	   that	  involves	  a	  sequence	  of	  cell	  fate	  switches,	  of	  a	  sequential	  activation	  of	  genes,	  it	  would	  be	   expected	   that	   the	   level	   of	   a	   transcriptional	   repressor	   goes	   down	   with	   time,	  allowing	   for	   the	   activation	   of	   genes	   that	   regulate	   the	   subsequent	   phases.	   This	   has	  been	   demonstrated	   to	   be	   the	   case	   for	   Ezh2	   in	   cortical	   development:	   its	   expression	  pattern	   has	   indeed	   been	   shown	   to	   decrease	   both	   in	   NPCs	   during	   time	   and	   in	  differentiating	   cells	   (Pereira	   et	   al.,	   2010).	   The	   role	   of	   H3K27	   modulation	   in	  corticogenesis	  has	  been	  investigated	  via	  conditional	  deletion	  of	  the	  catalytic	  subunit	  Ezh2,	   using	   two	   different	   deletion	   approaches	   that	   led	   to	   diverging	   conclusions.	  Deletion	   using	   the	   Emx1-­‐Cre	   driver,	   which	   expresses	   Cre	   from	   E9.5,	   caused	  acceleration	   of	   neuron	   production,	   due	   to	   the	   precocious	   de-­‐repression	   of	  transcription	  factors,	  eventually	  leading	  to	  exhaustion	  of	  the	  proliferative	  potential	  of	  NPCs	   and	   to	   a	   thinner	   cortical	   plate	   at	   birth	   (Pereira	   et	   al.,	   2010).	   In	   an	   opposing	  fashion,	  Ezh2	  deletion	  in	  an	  in	  vitro	  NPC	  culture	  mimicking	  the	  late	  phases	  (E14-­‐17)	  of	  cortical	  development	  led	  to	  a	  delay	  in	  the	  progression	  of	  neural	  development,	  due	  to	  a	  failure	  in	  repressing	  the	  Ngn1	  factor	  (Hirabayashi	  et	  al.,	  2009).	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These	   two	   apparently	   diverging	   lines	   of	   evidence	   can	   be	   weaved	   together	   in	   a	  unifying	  model	   that	   entails	   a	   redistribution	   of	   PRC2	   to	   new	   targets	   during	   the	   late	  phases	  of	  corticogenesis,	  despite	  the	  global	  reduction	  of	  Ezh2	  levels,	  and	  corroborate	  the	  idea	  that	  a	  fine-­‐tuning	  of	  H3K27	  methylation	  is	  required	  for	  the	  proper	  sequence	  of	  neuron	  and	  astrocyte	  production,	  which	  are	  produced	  following	  a	  precise	  temporal	  sequence	  that	  is	  mostly	  encoded	  cell-­‐autonomously	  (Testa,	  2011)	  (fig.	  5).	  
	  
Figure	   5.	   Diagram	   of	  mouse	   neocortical	   development	  with	   expression	   gradients	   of	   the	   PRC2	  
protein	   Ezh2.	   As	   neurogenesis	   proceeds	   (X-­‐axis),	   apical	   progenitors	   (AP)	   in	   the	   VZ	   generate,	   by	  asymmetric	   division,	   neurons	   (green)	   or	   intermediate	   progenitors,	   known	   also	   as	   basal	   progenitors	  (BP,	   pink)	   that	   occupy	   the	   SVZ.	   Neurons	   progressively	   constitute	   the	   six	   layers	   of	   the	   cortical	   plate	  (CP).	   A	   neurogenic-­‐to-­‐astrogenic	   switch	   at	   the	   end	   of	   neurogenesis	   enables	   the	   production	   of	  astrocytes	   (blue).	   The	   expression	   of	   the	   PRC2	   member	   Ezh2	   decreases	   progressively	   in	   neural	  progenitors	   as	  neurogenesis	  proceeds	   (X-­‐axis),	   as	  well	   as	  during	   the	  generation	  of	  neurons	   (Y-­‐axis).	  CP,	  cortical	  plate;	  SVZ,	  subventricular	  zone;	  VZ,	  ventricular	  zone.	  
 	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In	   such	   context,	   the	   evidence	   suggests	   that	   a	   H3K27	   demethylase	   might	   play	   a	  fundamental	   role	   in	   activating	   key	   genes	   that	   instruct	   cell	   fate	   decisions	   in	   neural	  differentiation.	  	  
1.3	  Jmjd3	  and	  neural	  differentiation	  As	  outlined	  above,	  our	  lab	  has	  demonstrated	  that	  Jmjd3	  is	  a	  H3K27	  demethylase	  that	  is	  required	  for	  the	  neural	  commitment	  of	  ES	  cells	  and	  controls	  the	  expression	  of	  key	  drivers	   and	   markers	   of	   neurulation	   through	   the	   demethylation	   of	   H3K27me3	  (Burgold	  et	  al.,	  2008).	  Moreover,	  Jmjd3	  expression	  is	  induced	  by	  retinoic	  acid	  (Jepsen	  et	   al.,	   2007),	   which	   is	   secreted	   from	   the	   meninges	   in	   the	   developing	   brain	   and	  regulates	   cortical	   neurogenesis	   (Siegenthaler	   et	   al.,	   2009).	   These	   lines	   of	   evidence	  prompted	  us	  to	  investigate	  the	  role	  of	  Jmjd3	  in	  embryonic	  cortical	  development	  and	  neural	  differentiation.	  To	  do	  so,	  we	  generated	  a	  loss-­‐of-­‐function	  hypomorphic	  mouse	  strain	   (XB814),	   which	   displays	   a	   reduction	   of	   the	   Jmjd3	  mRNA	   of	  more	   than	   90%	  during	  central	  nervous	  system	  (CNS)	  development,	  (Burgold	  et	  al.,	  2008).	  This	  mouse	  shows	   a	   complex	   neurodevelopmental	   phenotype	   that	   results	   in	   perinatal	   death.	  Previous	  work	  from	  our	  lab	  demonstrated	  that	  lethality	  is	  due	  to	  a	  respiratory	  failure	  resulting	   from	   the	   lack	   of	   a	   functional	   pre-­‐Bötzinger	   complex,	   a	   small	   network	   of	  neurons	  that	  is	  responsible	  for	  respiratory	  rhythm	  generation	  (Burgold	  et	  al.,	  2012).	  In	  KO	  mice,	   the	  pre-­‐Bötzinger	   complex	   is	   initially	   formed	  and	   functional,	  but	   Jmjd3	  loss	   leads	   to	   a	   selective	   failure	   to	  maintain	   it.	   Rescue	   experiments	   performed	  with	  catalytically	  active	  or	  inactive	  Jmjd3	  have	  demonstrated	  that	  its	  demethylase	  activity	  is	   necessary	   for	   developing	   and	   maintaining	   the	   embryonic	   respiratory	   neuronal	  network.	  This	  unanticipated	   finding	  claims	  a	  broader	  role	   in	  brain	  development	   for	  Jmjd3,	   whose	   importance	   extends	   from	   early	   differentiation	   choices	   to	   the	   late	  development	  of	  neuronal	  networks.	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1.4	  Aim	  of	  the	  thesis	  The	  work	  presented	  in	  this	  thesis	  stems	  from	  the	  characterization	  of	  the	  function	  of	  Jmjd3	  in	  the	  development	  of	  the	  pre-­‐Bötzinger	  complex	  that	  has	  previously	  published	  by	   our	   lab	   (Burgold	   et	   al.,	   2008;	   Burgold	   et	   al.,	   2012).	   As	   outlined	   in	   the	   thesis	  introduction,	  the	  work	  of	  our	  lab	  and	  several	  others	  has	  highlighted	  a	  role	  for	  Jmjd3	  in	  neural	  development	  and	  cell	  state	   transitions,	  mainly	  via	   its	  demethylase	  activity	  on	  the	  H3K27	  substrate,	  and	  hence	  on	  the	  transcriptional	  activation	  of	  neural-­‐specific	  genes.	  Furthermore,	   Jmjd3	  expression	   is	   induced	  by	  retinoic	  acid,	  which	   is	  secreted	  from	   the	   meninges	   in	   the	   developing	   brain	   and	   regulates	   cortical	   neurogenesis	  (Jepsen	  et	  al.,	  2007).	  These	   lines	  of	  evidence	  prompted	  us	   to	   investigate	   the	  role	  of	  Jmjd3	  in	  embryonic	  neocortical	  development	  and	  neural	  differentiation	  in	  vivo.	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2	  MATERIALS	  AND	  METHODS	  
	  
2.1	  Cell	  culture	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2.1.2	  Derivation	  and	  culture	  conditions	  of	  cortical	  neural	  precursor	  cells	  (NPCs)	  Pregnant	  mice	  were	  sacrificed	  at	  day	  E13.5	  according	  to	  standard	  procedures	  and	  in	  accordance	   to	   the	   Italian	   law.	  The	  protocol	   for	   the	  derivation	  of	   embryonic	   cortical	  NPC	  has	  ben	  adapted	  from	  (Ravin	  et	  al.,	  2008).	  The	  intact	  uterus	  was	  carefully	  extracted	  and	  transferred	  to	  a	  10	  cm	  dish	  containing	  sterile	   phosphate	   buffered	   saline	   (PBS).	   The	   embryos	   were	   extracted	   and	   kept	   in	  sterile	   Hank’s	   Balanced	   Salt	   Solution	   (HBSS),	   and	   the	   heads	   were	   separated	   using	  dissection	  scissors.	  Using	  Dumont	  no.5	  jeweler’s	  forcipes,	  the	  cortices	  were	  separated	  from	  the	  rest	  of	   the	  brain	  and	   form	  the	  basal	  ganglionic	  eminences,	  and	  kept	   in	  1.5	  tubes	   containing	   sterile	   HBSS.	   The	   cortices	   were	   mechanically	   triturated	   using	   a	  p1000	  until	  a	  single	  cell	  suspension	  was	  obtained.	  The	  cells	  were	  then	  pelleted	  using	  a	   tabletop	   microcentrifuge,	   and	   resuspended	   in	   DMEM/F12	   (MediaTech)	   with	   N2	  supplement	   using	   human	   apo-­‐transferrin	   (Sigma),	   basic	   fibroblast	   growth	   factor	  (bFGF)	   (Peprotech,	   30	   ng/ml),	   and	   insulin	   (Sigma,	   25	   ng/ml).	   The	   cells	   were	   then	  plated	  at	  a	  density	  of	  10,000-­‐20,000	  cells/cm2	  in	  poly-­‐L-­‐ornithine/fibronectin-­‐coated	  10	  cm	  tissue	  culture	  plates	  and	  grown	  for	  5-­‐6	  days	  prior	  to	  cryoconservation	   in	  N2	  medium	  with	  10%	  DMSO	  or	  further	  passaging.	  bFGF	  was	  added	  on	  a	  daily	  basis	  with	  complete	  medium	  replacement	  every	  second	  day.	  Upon	  reaching	  70-­‐80%	  confluence,	  plates	  were	  washed	  once	  with	  HBSS	  and	  the	  cells	  were	   mechanically	   detached	   prior	   to	   centrifugation	   and	   passaging	   into	   fresh	  N2+bFGF.	  	  
2.1.3	  Growth	  curves	  Growth	   curves	  were	  performed	  over	   serial	   re-­‐passaging	   of	   individual	  NPC	   lines.	  At	  each	  passage,	  1x106	  cells	  were	  plated	  onto	  in	  poly-­‐L-­‐ornithine/fibronectin-­‐coated	  10	  cm	   tissue	   culture	   plates.	   Three	   days	   later,	   cells	   were	   mechanically	   detached	   and	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counted,	  and	  1x106	  cells	  were	  re-­‐plated	  onto	  coated	  dishes.	  Cumulative	  cell	  numbers	  were	   obtained	   by	  multiplying	   the	   number	   of	   cells	   obtained	   at	   each	   passage	   by	   the	  cumulative	  number	  of	  cells	  counted	  at	  the	  end	  of	  the	  previous	  passage.	  	  
2.1.4	  EdU/PI	  staining	  for	  the	  determination	  of	  cell	  cycle	  distribution	  Ethynyl	   deoxyuridine	   (EdU)	   (Life	   Technologies)	   incorporation	   and	   detection	   was	  performed	   according	   to	   the	   manufacturer’s	   instructions.	   EdU	   powder	   was	  resuspended	  in	  DMSO	  and	  was	  added	  to	  the	  cultured	  cells	  at	  a	  final	  concentration	  of	  10	  uM.	  After	  30’	  of	   incorporation,	  cells	  were	  washed	  and	   fixed	  with	  PBS	  containing	  4%	   paraformaldehyde	   (PFA).	   The	   cells	   were	   harvested	   and	   EdU	   was	   detected	  according	   to	   the	   manufacturer’s	   instructions	   using	   an	   alexa	   488	   azide.	   After	   EdU	  detection,	   Propidium	   Iodide	   (PI)	   DNA	   staining	   was	   performed	   by	   overnight	  incubation	   at	   4°C	   in	   PBS	   with	   a	   final	   concentration	   of	   PI	   2.5	   μg/mL	   plus	   RNase	   8	  μg/mL.	   Flow	   cytometry	   analysis	   was	   performed	   on	   a	   BD	   FACSCALIBUR	   (BD	  Biosciences)	  machine,	  using	  low	  or	  medium	  pressure	  to	  enable	  reliable	  recording	  of	  the	   events.	   At	   least	   20,000	   events	   per	   sample	   were	   acquired,	   and	   the	   data	   were	  analyzed	  using	  FlowJo	  software.	  	  
2.1.5	  Double	  thymidine	  block	  and	  release	  The	  block	  in	  G1/S	  and	  release	  were	  performed	  by	  double	  thymidine	  administration.	  1x106	  NPCs	  were	  plated	  and	  grown	  for	  24	  hours	  in	  N2+bFGF,	  after	  which	  a	  first	  block	  was	  performed	  by	  adding	  thymidine	  to	  the	  culture	  medium	  to	  a	  final	  concentration	  of	  2	  uM	  for	  13	  hours.	  Cells	  were	  released	  by	  complete	  medium	  change	  and	  wash	  for	  10	  hours,	   and	   then	   a	   second	   block	   of	   13	   hours	   was	   performed.	   The	   cells	   were	   then	  released	  and	  time	  course	  samples	  were	  taken	  every	  hour	  by	  fixing	  with	  PBS	  4%	  PFA.	  EdU	  detection	  and	  PI	  staining	  were	  performed	  as	  described	  above.	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2.1.6	  Time-­‐lapse	  videomicroscopy	  of	  NPCs	  Frozen	   E13.5	   brain-­‐derived	   NPCs	   were	   thawed	   on	   poly-­‐L-­‐ornithine	  (PLO)/fibronectin-­‐coated	  10cm	  dishes	  in	  N2	  medium,	  as	  described	  above.	  Cells	  were	  grown	  to	  70%	  confluence	  at	  37°C,	  5%	  CO2,	  5%O2	  and	  then	  passaged	  onto	  coverslip-­‐bottom,	  PLO/fibronectin-­‐coated,	  dishes	  (Advanced	  TC	  35	  mm,	  Greiner	  Bio-­‐one,	  cat#	  627965)	  for	  imaging.	  	  20,000	  cells	  for	  each	  genotype	  were	  seeded	  in	  the	  N2	  medium	  described	   above	   (10	   ng/ml	   bFGF,	   25	   µg/ml	   Insulin)	   and	   10-­‐12	   hours	   after	   plating,	  plates	  were	  etched	  with	  a	  custom	  etching	  device	  to	  create	  restricted	  growth	  areas	  of	  300	   x	   300	   um.	   	   Then,	   imaging	  was	   performed	   at	   37°C,	   5%	   CO2	   and	   5%	  O2.	   	   Four	  restricted	   growth	   area	   both	   for	  wild	   type	   and	  mutant	   cells	  were	   captured	   every	   2	  minutes	   for	  48	  hours.	   	  Lineage	  data	  was	  derived	  using	  BioCell	   (SIMI	  Reality	  Motion	  Systems),	   and	   the	   cell	   cycle	   length	  was	  measured	  as	  difference	   in	   time	   (ΔT)	  of	   two	  subsequent	  mitoses	  occurring	  in	  the	  recorded	  time	  frame.	  Statistics	  were	  performed	  with	   GraphPad	   (Prism)	   and	   mean	   and	   standard	   deviation	   were	   calculated.	   The	   p-­‐value	  was	  calculated	  using	  Mann-­‐Whitney	  U	  test.	  	  
2.1.7	  Derivation	  and	  culture	  of	  post-­‐natal	  SVZ	  radial	  glial	  cells	  (RGCs)	  Mouse	   SVZ	   monolayer	   cultures	   were	   derived	   as	   previously	   described	   (scheffler	  2005).	  Postnatal	  SVZ	  were	   isolated	  from	  P7	  mouse	  brains,	  and	  were	  dissociated	  via	  mechanical	   trituration	   in	   presence	   of	   0.25%	   trypsin.	   Cells	   were	   plated	   at	  30,000 cells/cm2	  in	  10cm	  culture	  dishes	  in	  N5	  proliferation	  medium	  (DMEM/F12,	  N2	  supplement	   (Life	   Technologies),	   5%	   FCS	   (Gibco),	   20 ng/ml	  EGF	   (Peprotech),	  20 ng/ml	  bFGF	   (Peprotech),	   35 μg/ml	  bovine	   pituitary	   extract	   (BPE)	   (Life	  Technologies).	  Non-­‐attached	  cells	  were	  collected	  after	  1 day	  and	  replated	  into	  10cm	  dishes.	   After	   7 days,	   the	   cells	   were	   confluent	   and	   could	   be	   passaged	   1:2,	   after	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detachment	   with	   0.25%	   trypsin.	   Cells	   were	   passaged	   4–6	   times	   before	   use	   in	  experiments.	   Neural	   differentiation	   was	   induced	   by	   removal	   of	   epidermal	   growth	  factor	  (EGF),	  bFGF	  and	  fetal	  bovine	  serum	  (FBS)	  from	  the	  medium	  (N6	  medium).	  For	  cryopreservation,	  cells	  were	  resuspended	  in	  cryoconservation	  medium	  (N5,	  10%	  DMSO,	  10%	  FCS),	   stored	   in	   cryovials	   and	  kept	   at	   -­‐80°C	   for	   three	  days	   in	   a	   cryobox	  prior	  to	  storage	  in	  liquid	  nitrogen.	  
	  
2.2	  Molecular	  biology	  techniques	  
	  
2.2.1	  Isolation	  of	  genomic	  DNA	  from	  cells	  and	  tails	  	  Cells	  or	  tails	  were	   lysed	  in	   lysis	  buffer	  consisting	  of	  100	  mM	  Tris-­‐HCl	  pH	  8.5,	  5	  mM	  EDTA,	  0.2%	  sodium	  dodecyl	  sulphate	  (SDS),	  200	  mM	  NaCl	  and	  100	  µg/ml	  proteinase	  K.	  The	  lysate	  was	  incubated	  overnight	  at	  55°C.	  The	  DNA	  was	  then	  precipitated	  with	  isopropanol	   according	   to	   a	   previously	   published	   protocol	   (laird	   1991)	   and	   then	  centrifugated	  at	  16000	  ×	  g	  for	  20’.	  	  The	  DNA	  pellet	  was	  washed	  with	  70%	  ethanol	  and	  centrifuged	  again.	  The	  DNA	  was	  finally	  resuspended	  in	  TE	  (10	  mM	  Tris-­‐HCl	  pH	  8.0,	  1	  mM	  EDTA)	  or	  water.	  Lysates	  from	  tails	  can	  be	  used	  directly	  for	  genotyping,	  after	  one	  step	  of	  proteinase	  k	  heat	  inactivation,	  performed	  at	  94°C	  for	  10	  minutes.	  Before	  use,	  the	  crude	  extract	  was	  diluted	  1:5	  in	  water	  in	  order	  to	  reduce	  interference	  by	  SDS	  in	  the	  polymerase	  chain	  reaction	  (PCR).	  For	  specific	  purposes,	  like	  copy	  number	  assay,	  DNA	   was	   also	   purified	   using	   Qiagen	   DNeasy®	   blood	   and	   tissue	   kit	   according	   to	  manufacturer	  instructions.	  	  
2.2.2	  Polymerase	  Chain	  Reaction	  (PCR)	  PCR	  reactions	  were	  carried	  out	  in	  a	  total	  volume	  of	  20	  µl	  with	  0.2	  mM	  dNTPs	  (each	  dNTP),	  0.5	  mM	  primers,	  DNA	  template	  (in	  various	  amounts	  depending	  on	  the	  source),	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0.01	   U/µl	   Phusion®	   DNA	   polymerase	   (Finnzymes)	   or	   GoTaq	   (Promega)	   and	   the	  appropriate	   buffer	   provided	   by	   the	   supplier.	   The	   reaction	   protocol	   varies	   between	  experiments	   but	   follows	   this	   general	   scheme:	   30’’	   initial	   denaturation	   at	   98°C,	   35	  cycles	  consisting	  of	  10’’	  denaturation	  at	  98°C,	  15’’	  of	  annealing	  at	  the	  for	  each	  primer	  combination	   optimized	   temperature	   and	   variable	   times	   of	   extension	   depending	   on	  amplicon	   length	   and	   complexity	   at	   72°C.	   The	   last	   cycle	   was	   followed	   by	   a	   final	  extension	  step	  for	  10’	  at	  72	  °C.	  	  PCR	   reactions	   were	   separated	   by	   electrophoresis	   in	   agarose	   gels	   at	   different	  concentrations	  based	  on	   the	  band	  size	   (1-­‐3%)	   in	  Tris-­‐acetate-­‐EDTA	  buffer	  with	  0.5	  µg/ml	   ethidium	   bromide.	   For	   downstream	   applications	   the	   PCR	   products	   were	  purified	   using	   the	   QIAquick	   PCR	   purification	   kit	   or	   QIAquick	   Gel	   Extraction	   kit	  (Qiagen).	  	  
2.2.3	  RNA	  Extraction	  Total	  RNA	  was	  extracted	  from	  cells	  using	  Qiagen	  RNeasy®	  Plus	  Mini	  kit	  according	  to	  the	  instructions	  of	  the	  manufacturer.	  The	  procedure	  comprises	  a	  step	  of	  DNA	  removal	  via	  gDNA	  eliminator	  column.	  Low-­‐density	  agarose	  gel	  electrophoresis	  was	  performed	  to	  exclude	  gDNA	  contamination.	  Finally	  RNA	  was	  resuspended	   in	  RNAse-­‐free	  water	  and	   quantified	   using	   a	   NanoDrop	   ND-­‐1000	   Spectrophotometer	   (Thermo	   Fisher	  Scientific).	  	  
2.2.4	  cDNA	  synthesis	  cDNA	   synthesis	   was	   performed	   using	   SuperScript®	   VILO™	   cDNA	   Syntesis	   kit	  according	  to	  the	  manufacturer’s	  instructions.	  Briefly,	  the	  reaction	  takes	  place	  in	  20	  μl	  with:	   4	   μl	   of	   5X	   VILO™	   reaction	   mix	   (which	   includes	   random	   primers,	   MgCl2	   and	  dNTPs)	   2	   μl	   of	   10X	   SuperScript®	   enzyme	   mix	   (which	   includes	   SuperScript®	   III	  
	   38	  
reverse	  transcriptase,	  RNaseOUT™	  recombinant	  ribonuclease	  inhibitor	  and	  an	  helper	  protein),	  300ng-­‐1μg	  of	  RNA	  and	  water.	  The	  reaction	   is	   incubated	  at	  25°C	   for	  10’,	  at	  42°C	  for	  60’	  and	  finally	  at	  85°C	  for	  5’	   to	  terminate	  the	  reaction.	  The	  resulting	  cDNA	  can	  be	  used	  diluted	  or	  undiluted	  in	  qPCR	  analysis.	  	  
2.2.5	  Real	  Time	  Quantitative	  PCR	  (qRT-­‐PCR)	  qRT-­‐PCR	   was	   performed	   on	   7900HT	   Fast	   Real-­‐Time	   PCR	   system	   (Applied	  Biosystems)	   using	   TaqMan®	   Gene	   expression	   assays	   (Applied	   Biosystems).	   Each	  sample	  was	   analyzed	   in	   triplicates	   and	  normalized	   to	  TATA-­‐Binding	  Protein	   (TBP).	  Normalization	   was	   used	   to	   correct	   variations	   in	   RNA	   concentration	   and	   integrity	  among	   samples.	   Relative	  mRNA	   amounts	  were	   calculated	   by	   the	   comparative	   cycle	  threshold	  (Ct)	  method	  using	  the	  formula	  2-­‐ΔCt.	   	  In	  the	  case	  of	  Taqman	  Assays	  5	  ng	  of	  cDNA	   was	   amplified	   (in	   triplicate)	   in	   a	   reaction	   volume	   of	   15	   μl	   containing	   the	  following	   reagents:	   7.5	   μl	   of	   TaqMan®	   PCR	   Mastermix	   2x	   No	   UNG	   (Applied	  Biosystems),	  0.75	  μl	  of	  TaqMan®	  Gene	  Expression	  Assay	  20x	  (Applied	  Biosystems).	  The	   cycling	   steps	   are:	   10’	   at	   95°C,	   followed	  by	  40	   cycles	   of	   15’’	   at	   95°C	   and	  60’’	   at	  60°C.	   A	   control	   for	   DNA	   contamination	  was	   prepared	   using	   samples	   that	  were	   not	  subjected	   to	   the	   reverse	   transcription	   step	   and	   therefore	   would	   not	   produce	   any	  amplification.	  	  
2.2.6	  RNAseq	  library	  preparation	  RNAseq	  libraries	  were	  prepared	  with	  the	  TruSeq	  Stranded	  Total	  RNA	  with	  Ribo-­‐Zero	  Human/Mouse/Rat	   kit,	   according	   to	   the	   manufacturer’s	   instructions.	   1	   μg	   of	   total	  RNA	  was	   used	   as	   starting	  material	   for	   the	   library	   preparation	  procedure.	   The	   final	  library	   product	   was	   quantified	   using	   the	   NanoDrop	   ND-­‐1000	   Spectrophotomer	  (Thermo	  Fisher	  Scientific)	  and	  the	  Qubit®	  2.0	  Fluorometer	  (Life	  Technologies).	  The	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size	  of	  the	  resulting	  fragments	  was	  assessed	  using	  the	  2100	  Bioanalyzer	  and	  the	  DNA	  HS	  Kit	  (Agilent).	  	  
2.3	  Bionformatic	  analysis	  	  
2.3.1	  RNAseq	  analysis	  RNAseq	  sequence	  reads	  were	  aligned	  to	  the	  mm9	  transcriptome	  using	  TopHat	  2.0.10,	  disabling	   coverage	   search.	   The	   alignment	   was	   first	   performed	   on	   the	   RefSeq	  transcriptome	  to	  prioritize	  alignment	  to	  know	  transcripts.	  Then,	  all	  reads	  that	  had	  an	  edit	   distance	   above	   1	   (e.g.	   more	   than	   one	   mismatch/indel/break	   with	   respect	   to	  alignment	   location)	  were	  realigned	  on	   the	  whole	  genome.	  For	   the	   telencephali	  data	  (100bp	  unstranded	  paired-­‐end	   reads),	   only	   alignments	  with	   read	   edit	   distance	   and	  mismatches	   below	   or	   equal	   to	   3	   were	   retained.	   Because	   the	   data	   from	   in	   vitro-­‐cultured	   neural	   progenitors	   had	   a	   shorter	   read	   length	   (50bp	   stranded	   paired-­‐end	  reads),	  we	  tolerated	  only	  2	  mismatches/edit	  per	  read	  for	  this	  analysis	  (and	  used	  the	  fr-­‐firststrand	  library	  type).	  Quantification	   of	   reads	   over	   the	   RefSeq	   transcriptome	   (masking	   ribosomal	   RNAs)	  was	   performed	   with	   Cufflinks	   2.2.1	   using	   sequence-­‐bias,	   multi-­‐read,	   and	   length	  corrections.	   Differential	   gene	   expression	   was	   estimated	   with	   Cufflinks	   2.2.1	   using	  pooled	  dispersion	  models	  and	  geometric	  normalization.	  	  
2.3.2	  ChIPseq	  analysis	  ChIPseq	   reads	   were	   trimmed	   for	   adapter	   contamination	   using	   Scythe	   0.981	  (requiring	   a	  minimum	  match	   of	   3	   for	   the	   sequence	   to	   be	   trimmed,	   and	   discarding	  trimmed	   sequences	   shorter	   than	   20bp),	   before	   being	   aligned	   to	   the	   mm9	   genome	  using	   Bowtie	   1.0	   (allowing	   2	   mismatches	   and	   discarding	   multiply	   aligning	   reads).	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Peaks	  were	   called	   using	  Macs	   1.4.2	  with	   default	   settings	   and	   discarding	   duplicated	  reads.	  Genes	  with	  a	  peak	  in	  a	  −2.5kb/+1kb	  region	  around	  (any	  of)	  their	  transcription	  start	  sites	  were	  considered	  target	  genes.	  	  
2.4	  Biochemistry	  Techniques	  	  
2.4.1	  Protein	  extraction	  In	   order	   to	   avoid	   degradation	   of	   proteins	   and	   loss	   of	   information,	   proteins	   were	  always	  extracted	   from	  freshly	  pelleted	  cells.	  RIPA	  buffer	  (10	  mM	  Tris-­‐Cl	  (pH	  8.0),	  1	  mM	  EDTA,	   0.5	  mM	  EGTA,	   1%	  Triton	   X-­‐100,	   0.1%	   sodium	   deoxycholate,	   0.1%	   SDS,	  140	  mM	  NaCl),	  freshly	  supplemented	  with	  a	  protease	  inhibitor	  cocktail	  (Roche)	  was	  used	  to	  prepare	  total	  cell	  lysates.	  Lysed	  pellets	  were	  put	  for	  30’	  on	  a	  rotary	  wheel	  at	  +4°C	   and	   subsequently	   pelleted	   by	   25’	   centrifugation	   at	   +4°C	   and	   13000	   rpm	  on	   a	  refrigerated	  tabletop	  microcentrifuge	  to	  clear	  the	  lysate.	  	  
2.4.2	  CSK	  fractionation	  Triton	  X-­‐100	  extraction	  and	  release	  of	  chromatin-­‐bound	  material	  was	  performed	  as	  in	  (Groth	  et	  al.,	  2007)	  in	  multiwell	  plates.	  In	  brief,	  soluble	  proteins	  were	  extracted	  by	  CSK	  (10	  mM	  PIPES	  (Sigma)	  pH	  7,	  100	  mM	  NaCl	  (Sigma),	  300	  mM	  sucrose	  (Sigma),	  3	  mM	  MgCl2	  (Sigma))	   for	  5	  minutes	  on	   ice.	  The	  chromatin	  pellet	  was	  washed	  once	   in	  0.1%T	  CSK	  and	   resuspended	   in	  Laemmli	   sample	  buffer	  +	  100mM	  DTT	   for	  Western	  blotting.	   This	   insoluble	   fraction	   was	   called	   CSK	   fraction.	   All	   buffers	   were	  supplemented	  with	  protease	  inhibitor	  cocktail	  (Roche).	  Similarly	  to	  pre-­‐extracted,	  the	  respective	   total	   extracts	   were	   prepared	   for	   Western	   blotting	   by	   resuspension	   in	  Laemmli	  sample	  buffer	  1X	  +	  100	  mM	  DTT.	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2.4.3	  Chromatin	  immunoprecipitation	  (ChIP)	  Adherent	  cells	  were	  cross-­‐linked	  by	  adding	  formaldehyde	  to	  the	  culture	  medium	  at	  a	  final	  concentration	  of	  1%.	  After	  5	  min	  fixation	  the	  reaction	  was	  quenched	  by	  adding	  Glycine	  to	  a	  final	  concentration	  of	  125	  mM,	  cells	  were	  thoroughly	  washed	  in	  PBS	  and	  harvested	  by	  scraping.	  Cell	  membranes	  were	  disrupted	  in	  L1	  swelling	  buffer	  (50	  mM	  Tris-­‐HCl	   pH	   8.0,	   2	   mM	   EDTA,	   0,1%	   NP-­‐40,	   10%	   Glycerol,	   1×	   protease	   inhibitor	  cocktail	  (Roche)),	  900	  μl	  for	  a	  10	  cm	  dish.	  Nuclei	  were	  precipitated	  and	  resuspended	  in	  600	  μl	   of	   nuclear	   lysis	   buffer	   (50	  mM	  Tris-­‐HCl	   pH	  8.0,	   5	  mM	  EDTA,	   1%	  SDS,	   1×	  protease	   inhibitor	   cocktail).	   Shearing	   of	   genomic	   chromatin	  was	   performed	  with	   a	  Diagenode	  Bioruptor®	  sonicator	  (high	  power,	  four	  cycles	  of	  30’’	  pulse	  and	  30’’	  pause	  each)	   yielding	   DNA	   with	    an	   average	   fragment	   size	   from	   200	   to	   1000	   bp.	   DNA	  concentration	   was	   measured	   with	   NanoDrop	   ND-­‐1000	   Spectrophotomer	   (Thermo	  Fisher	  Scientific)	  and	  DNA	  of	  different	  samples	  was	  employed	  in	  equal	  quantities	  for	  the	   immunoprecipitation.	   Salt	   and	   detergent	   concentrations	   in	   the	  immunoprecipitation	  were	  adjusted	  for	  an	  optimal	  antibody	  performance	  by	  diluting	  the	  sonicated	  lysate	  with	  nine	  volumes	  of	  dilution	  buffer	  (50	  mM	  Tris-­‐HCl	  pH	  8.0,	  5	  mM	  EDTA,	  200	  mM	  NaCl,	  0.5%	  NP-­‐40)	  for	  ChIP	  assays	  on	  Jmjd3	  and	  total	  histone	  H3	  or	   by	   adding	   1/10	   volume	   of	   10%	   Triton	   X-­‐100	   for	   the	   immunoprecipitation	   of	  histone	  H3	  trimethyl-­‐lysine	  27	  (H3K24me3).	  Lysate	  was	  precleared	  with	  50	  μl	  slurry	  of	  salmon	  sperm	  DNA	  saturated	  protein	  A	  sepharose	  beads	  (GE	  Healthcare),	  rotating	  for	   1	   h	   at	   4	   °C.	   Beads	  were	   pelleted	   by	   centrifugation	   and	   antibody	  was	   added	   to	  precleared	  extract	  (Table	  5).	  Immunoprecipitation	  was	  carried	  out	  a	  4	  °C	  overnight.	  ChIP	   complexes	   were	   collected	   by	   incubating	   with	   20	   μl	   of	   salmon	   sperm	  DNA/protein	  A	  sepharose	  beads	   for	  30’	  at	  4°C.	  ChIP-­‐beads	  complexes	  were	  washed	  four	  times	  in	  washing	  buffer	  (20	  mM	  Tris-­‐HCl	  pH	  8.0,	  2	  mM	  EDTA,	  0.1%	  SDS,	  1%	  NP-­‐40,	  500	  mM	  NaCl)	  and	  three	  times	  in	  1×	  TE.	  ChIP	  complexes	  were	  eluted	  in	  120	  μl	  of	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1×	  TE	  containing	  2%	  SDS	  at	  65	  °C	  for	  15	  min	  and	  the	  crosslink	  of	  proteins	  to	  DNA	  was	  reversed	  at	  65	  °C	  overnight.	  DNA	  was	  purified	  with	  the	  QIAquick	  PCR	  Purification	  Kit	  (Qiagen),	  following	  the	  manufacturer’s	  instructions	  and	  eluted	  in	  100	  μl	  of	  provided	  buffer	  EB.	  5	  μl	  of	  DNA	  were	  used	  in	  a	  25	  μl	  qRT-­‐PCR	  reaction	  using	  the	  primers	  listed	  in	  Table	  1.	  The	  abundance	  of	  target	  genome	  DNA	  was	  normalized	  relative	  to	  that	  of	  input.	  	  
Table	  1.	  List	  of	  primers	  used	  for	  ChIP-­‐qPCR	  Primer	   Sequence	  Dlx2_60_F	   TTGGCTAAGGAAGGCCTAGA	  Dlx2_60_R	   CACCAGGGAGCGTTTCTAAT	  Dlx2_82_F	   CGGGACAGGAAAGAGCAC	  Dlx2_82_R	   GAAGGGACCCGGAGAGATA	  Olig2_89_F	   ACTAATGACTGCCTGGGTGTCT	  Olig2_89_R	   TCGCAACAGGAGTTATTGGA	  Mash1_3_F	   CCCTGGCCAGAAGTGAGA	  Mash1_3_R	   CTGGGTGTCCCATTGAAAAG	  	  
2.4.4	  Immunoblotting	  Proteins	   were	   separated	   by	   sodium	   dodecyl	   sulfate	   polyacrylamide	   gel	  electrophoresis	   (SDS-­‐PAGE).	   NuPage	   system	   (Invitrogen)	   was	   used	   to	   perform	  Western	   Blot,	   therefore	   the	   lysate	   was	   mixed	   with	   the	   loading	   buffer	   (4X	   LDS)	  supplied	  by	  the	  company.	  According	  to	  the	  size	  of	  the	  target	  protein,	  4-­‐12%	  Bis-­‐Tris	  or	   3-­‐8%	   Tris-­‐Acetate	   polyacrylamide	   gel	   were	   used	   to	   achieve	   protein	   separation.	  The	  gels	  were	  run	  using	  buffers	  supplied	  by	  the	  manufacturers	  according	  to	  the	  type	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of	  gel	  (MOPS	  or	  TA,	  Life	  Technologies),	  at	  constant	  170V	  for	  1-­‐3	  hours	  depending	  on	  the	  degree	  of	  separation	  needed.	  	  Proteins	  were	   transferred	   to	  a	  nitrocellulose	  membrane	  using	   the	  standard	  Towbin	  Buffer	   (25	  mM	  Tris	  base,	  190	  mM	  glycine,	  20%	  methanol)	   and	   the	  Mini	  Trans-­‐Blot	  equipment	   (BioRad).	   Efficiency	   of	   the	   transfer	   was	   assessed	   by	   Ponceau	   staining	  (VWR).	   The	   nitrocellulose	   membrane	   was	   blocked	   in	   5%	   (w/v)	   skimmed	   milk	  powder	   in	  TBS-­‐T	  buffer	   (25	  mM	  Tris,	  150	  mM	  NaCl,	  2	  mM	  KCl)	   for	  1	  hour	  at	   room	  temperature.	  All	  antibodies	  were	  then	  diluited	  in	  5%	  milk	  in	  TBS-­‐T.	  	  Primary	  antibodies	  were	  incubated	  overnight	  at	  4°C	  while	  species-­‐specific	  secondary	  antibodies,	  conjugated	  with	  horseradish	  peroxidase	  (BioRad)	  or	  with	  fluorochromes	  (LI-­‐COR	   Biosciences),	   were	   incubated	   for	   2	   hours	   at	   room	   temperature	   (RT).	  According	  to	  the	  type	  of	  secondary	  antibody	  used	  (HRP	  or	  fluorescent),	  the	  signal	  was	  acquired	   using	   the	   ECL	   plus	   reagent	   and	   chemiluminescent	   detection	   (HRP),	   or	  digitally	  processed	  using	   the	  LI-­‐COR	  Odissey	  platform	   (LI-­‐COR	  biosciences).	   ImageJ	  was	  used	  to	  process	  the	  raw	  images	  acquired	  with	  the	  LI-­‐COR	  Odissey	  platform.	  	  
2.5	  Histology	  techniques	  	  
2.5.1	  Brain	  dissection	  Brains	  (E16.5,	  E18.5)	  or	  intact	  heads	  (E13.5)	  were	  dissected	  in	  PBS,	  fixed	  overnight	  in	  PBS,	   4%	   PFA	   at	   4°C,	   cryoprotected	   in	   PBS,	   30%	   sucrose	   overnight	   at	   4°C	   and	  embedded	  in	  cryostat	  freezing	  medium	  (Bio-­‐Optica).	  Brains	  were	  coronally	  sectioned	  in	   10	   um-­‐thick	   slices	   and	   placed	   serially	   onto	   SuperFrost	   Ultra	   Plus	   glass	   slides	  (Thermo	   Fisher	   Scientific).	   Sections	   were	   post-­‐fixed	   for	   10’	   with	   4%	   PFA.	   For	   the	  detection	  of	  nuclear	  antigens	  an	  antigen	  enhancement	  step	  was	  performed	  by	  briefly	  boiling	  the	  slides	  in	  10	  mM	  sodium	  citrate	  pH	  6.0	  using	  a	  microwave.	  Sections	  were	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incubated	   in	   permeabilization/blocking	   solution	   (0.2%	   Triton	   X-­‐100,	   10%	   goat	  serum	  in	  PBS)	  for	  30	  min	  at	  RT	  and	  incubated	  with	  primary	  antibodies	  diluted	  in	  PBS	  plus	  2.5%	  goat	  serum,	  0.05%	  Triton	  X-­‐100	  at	  4	  C	  overnight.	  The	  antibodies	  and	  their	  dilutions	  used	  in	  this	  study	  are	  listed	  in	  Table	  2.	  Specimens	  were	  incubated	  with	  the	  appropriate	  species-­‐specific	  secondary	  antibodies	  conjugated	  to	  Alexa488,	  Alexa568,	  Alexa647	   (Life	   Technologies)	   at	   1:200	   dilution	   for	   3	   hr	   at	   RT,	   then	   incubated	  with	  DAPI	   (Sigma-­‐Aldrich)	   nuclear	   counterstain,	   and	   coverslipped	   with	   VectaMount	   AQ	  aqueous	  mounting	  medium	  (Vector	  Laboratories).	  Widefield	  microscope	  images	  were	  acquired	  with	   an	   Olympus	   fluorescence	  microscope	   equipped	  with	   a	   CoolSNAP	   EZ	  CCD	   camera	   (Photometrics)	   using	  MetaVue	   software	   (Molecular	   Devices).	   Confocal	  microscope	  images	  were	  acquired	  on	  a	  Leica	  SP5	  system,	  using	  a	  motorized	  stage	  and	  automated	  stitching	  for	  high-­‐content	  images.	  For	  clarity,	  images	  were	  adjusted	  for	  contrast	  and	  brightness	  using	  ImageJ	  software.	  Cell	  counts	  were	  manually	  performed	  using	  ImageJ	  softeware	  and	  CellCounter	  plugin.	  
Table	  2.	  List	  of	  primary	  antibodies	  used	  for	  immunofluorescence	  
Antigen	   cat.	  no	   Company	   Dilution	  Ki67	   ab15580	   Abcam	   1:500	  Ctip2	   ab18465	   Abcam	   1:300	  Tbr1	   ab31940	   Abcam	   1:500	  Brn2	   sc-­‐6029	   SantaCruz	   1:200	  Pax6	   PAX-­‐6	  (b)	   Hybridoma	  Bank	   1:1000	  Pax6	  (Alexa	  488)	   561664	   BD	  Biosciences	   1:200	  Tbr2	   ab23345	   Abcam	   1:200	  BrdU	   OBT0030G	   Serotec	   1:100	  IdU-­‐BrdU	   347580	   BD	  Biosciences	   1:50	  Sox2	   MAB2018	   R&D	  Systems	   1:100	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2.5.2	  Determination	  of	  cell	  cycle	  parameters	  in	  vivo	  In	  order	  to	  assess	  the	  length	  of	  S	  phase	  (Ts)	  and	  the	  total	  cell	  cycle	  length	  (Tc)	  in	  vivo,	  we	  performed	  the	  double	  thymidine	  analogue	  incorporation	  assay,	  as	  first	  described	  in	  (Martynoga	  et	  al.,	  2005).	  	  E13.5	  pregnant	  mice	  were	  intraperitoneally	  administered	  Iododeoxyuridine	  (IdU)	  at	  t=0h,	  followed	  by	  Bromodeoxyuridine	  (BrdU)	  at	  t=1.5h,	  and	  the	  mice	  were	  sacrificed	  at	   t=2h.	  For	  both	   thymidine	  analogues	  150	  ul	  of	  a	  solution	  at	  a	  concentration	  of	  10	  mg/ml	   were	   administered	   (approx.	   50	   mg	   IdU/BrdU	   per	   kg	   of	   body	   mass).	   The	  fraction	  of	  cells	  that	  are	  in	  S	  phase	  at	  both	  t=0h	  and	  t=1.5h,	  and	  thus	  incorporate	  both	  analogues,	  constitutes	  the	  Scells,	  whereas	  the	  fraction	  of	  cells	  that	  incorporate	  IdU	  but	  not	   BrdU	   constitutes	   the	   leaving	   fraction,	   or	   Lcells.	   The	   time	   interval	   between	   the	  administration	  of	  IdU	  and	  BrdU	  (=1.5	  h)	  is	  called	  Ti.	  The	  ratio	  of	   the	   length	  of	  any	   fraction	  of	   the	  cell	   cycle	   to	   that	  of	  another	   fraction	   is	  equal	  to	  the	  ratio	  of	  the	  number	  of	  cells	  in	  the	  first	  fraction	  to	  the	  number	  of	  cells	  in	  the	   second	   fraction.	   Hence,	   the	   ratio	   of	   the	   number	   of	   cells	   in	   the	   Lcells	   to	   the	   Scells	  fractions	  is	  equal	  to	  the	  ratio	  between	  Ti	  (which	  equals	  1.5	  h)	  and	  Ts.	  	   (1)	  Ti	  /Ts	  =	  Lcells/Scells	  ∴	  Ts=	  Ti/(Lcells/Scells)	  	  The	  calculated	  Ts	  in	  (1)	  can	  then	  be	  used	  to	  estimate	  Tc:	  	   (2)	  Ts/Tc	  =	  Scells/Pcells	  ∴	  Tc	  =	  Ts/(Scells/Pcells)	  	  In	  (2),	  Pcells	  represents	  the	  number	  of	  actively	  proliferating	  cells	  in	  the	  analyzed	  area.	  The	  number	  of	  Pcells	  is	  estimated	  by	  counting	  the	  total	  cell	  number	  in	  the	  ventricular	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zone	   (VZ),	   and	   is	   based	  on	   the	   assumption	   that	   98-­‐100%	  of	   the	   cells	   in	   the	  VZ	   are	  actively	  proliferating,	  as	  previously	  assessed	  (Caviness	  et	  al.,	  1995;	  Estivill-­‐Torrus	  et	  al.,	   2002;	   Takahashi	   et	   al.,	   1993;	   Takahashi	   et	   al.,	   1995).	   The	   cell	   numbers	   were	  counted	  in	  areas	  of	  constant	  width	  (200	  μm),	  and	  height	  determined	  by	  the	  thickness	  of	  the	  ventricular	  zone.	  Immunofluorescence	   staining	   was	   performed	   as	   previously	   described,	   with	   the	  exception	   of	   a	   shorter	   incubation	   time	   for	   the	   primary	   (2	   hours	   at	   RT	   instead	   of	  overnight	  at	  4°C),	  and	  the	  specific	  primary	  and	  secondary	  antibodies	  are	  listed	  below	  in	  Table	  3.	  	  
Table	  3.	  List	  of	  primary	  and	  secondary	  antibodies	  used	  for	  in	  vivo	  cell	  cycle	  analysis	  
Antigen	   Cat	  no.	   Company	   Dilution	  
Primary	  Abs	  BrdU	   OBT0030G	   Serotec	   1:100	  IdU-­‐BrdU	   347580	   BD	  Biosciences	   1:50	  
Secondary	  Abs	  Gt	  anti-­‐Ms,	  Alexa	  488	   A11029	   Life	  technologies	   	  1:200	  Gt	  anti-­‐Rt,	  Alexa	  568	   A11077	   Life	  Technolgies	   	  1:200	  	  
2.6	  Mouse	  strains	  All	  strains	  used	  in	  this	  study	  were	  bred	  into	  C57BL/6	  background.	  The	  day	  of	  vaginal	  plug	   was	   considered	   to	   be	   E0.5.	   Analysis	   of	   the	   phenotype	   and	   genotype	   were	  performed	  independently	  in	  blind	  experiments	  and	  compared	  afterward.	  The	   XB814,	   R26.Jmjd3.fl.stop	   and	   BAC.Jmjd3mut	   mouse	   strains	   were	   previously	  generated	   by	   our	   lab	   and	   have	   been	   described	   in	   (Burgold	   et	   al.,	   2012).	   For	  completeness,	  the	  detailed	  procedures	  used	  for	  their	  generation	  are	  reported	  below,	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together	   with	   the	   unpublished	   procedures	   for	   the	   generation	   of	   the	   Jmjd3.fl	   and	  Jmjd3.Venus	  mouse	  strains.	  	  
2.6.1	  PGK-­‐Cre	  deleter	  strain	  The	   PGK-­‐Cre	  mouse	   strain	   has	   been	   previously	   published	   (Lallemand	   et	   al.,	   1998).	  Genotypes	  were	  assessed	  by	  PCR	  on	  genomic	  DNA	  extracted	  from	  tail	  biopsies	  using	  the	  primers	  P19	  and	  P20	  (Table	  4).	  	  
2.6.2	  Rosa26-­‐Cre	  inducible	  deleter	  strain	  The	   Rosa26-­‐Cre	   inducible	   has	   been	   previously	   published	   (Seibler	   et	   al.,	   2003).	  Genotypes	  were	  assessed	  by	  PCR	  on	  genomic	  DNA	  extracted	  from	  tail	  biopsies	  using	  the	  primers	  R26_WTF,	  R26_WTR	  and	  R26_MUTR	  (Table	  4).	  	  
2.6.3	  Generation	  of	  the	  XB814	  Jmjd3	  KO	  mouse	  strain	  The	  mouse	   ESC	   line	   XB814	   harboring	   a	   gene	   trap	   insertion	   in	   Jmjd3	  was	   obtained	  from	  BayGenomics	  (http://www.mmrrc.org/catalog/overview_BG.php)	  (Stryke	  et	  al.,	  2003)	   and	   the	   insertion	   site	   of	   the	   trap	   cassette	  was	  mapped	   to	   Jmjd3	   intron	  1	   by	  sequence	   analysis.	   ES	   cells	   were	   injected	   into	   C57BL/6	   blastocysts	   to	   generate	  chimeras	   following	   standard	  procedures	   (Nagy	  et	   al.,	   2003).	  Germline	   transmission	  was	  confirmed	  by	  PCR	  on	  genomic	  DNA	  extracted	  from	  tail	  biopsies	  using	  the	  primers	  JBaygD2,	  JBaygR2,	  and	  GT3_rev	  (Table	  4).	  	  
2.6.4	  Generation	  of	  the	  R26.Jmjd3.fl.stop	  mouse	  strain	  To	  generate	   tissue-­‐specific	   conditional	   Jmjd3	  transgenic	  mice,	  we	   cloned	   full-­‐length	  mouse	  Jmjd3	  cDNA	  into	  the	  pR26	  loxP2STOP	  frt2	  IRES	  eGFP	  targeting	  vector	  (Sasaki	  et	   al.,	   2006).	   C57BL/6-­‐derived	   ES	   cells	   were	   transfected,	   cultured	   and	   selected	   as	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previously	   described	   (Casola,	   2004).	   Correctly	   targeted	   ESCs	   were	   injected	   into	  C57BL/6	   albino	   blastocysts	   to	   generate	   chimeras	   and	   germline	   transmission	   was	  confirmed	   by	   Southern	   blot.	   Expression	   of	   the	   Jmjd3	   transgene	   was	   induced	   upon	  breeding	  to	  the	  ubiquitous	  Cre-­‐deleter	  strain	  PGK-­‐Cre	  (Lallemand	  et	  al.,	  1998).	  For	   PCR	   genotyping	   of	   genomic	   DNA	   extracted	   from	   tail	   biopsies	   the	   primers	  R26.SA_Fw,	  Jmjd3.1_Rev	  and	  Neo_Fw	  were	  used	  (Table	  4).	  	  
2.6.5	  Generation	  of	  the	  BAC	  Transgenic	  Jmjd3mut	  mouse	  strain	  A	   mouse	   BAC	   (RP23-­‐107C10)	   containing	   the	   Jmjd3	   gene	   locus	   was	   engineered	   to	  insert	  a	  point	  mutation	  resulting	   in	   the	  Histidine	  to	  Alanine	  substitution	  at	  position	  1388	   (H1388A).	  Microinjection	   into	   fertilized	   oocytes	   and	   generation	   of	   transgenic	  mice	  was	   performed	   by	   standard	   techniques	   using	   oocytes	   derived	   from	  FVB	  mice	  (Muyrers	  et	  al.,	  2004;	  Testa	  et	  al.,	  2004b;	  Vintersten	  et	  al.,	  2004).	  Transgenic	  founder	  animals	  were	  selected	  by	  PCR	  of	  tail	  biopsies	  using	  primer	  pair	  8_F	  and	  8_R	  (Table	  4).	  Two	   transgenic	   founders	   (Jmjd3mut21	   and	   Jmjd3mut65)	  were	   selected	   for	   further	  characterization	  and	  the	  number	  of	  BAC	  integrations	  was	  assessed	  by	  Southern	  blot	  and	   real-­‐time	   PCR	   using	   a	   TaqMan	   copy	   number	   assay.	   In	   order	   to	   confirm	   the	  expression	   of	   the	   mutant	   Jmjd3	   allele	   brain	   cDNA	   of	   Jmjd3mut21	   and	   Jmjd3mut65	  transgenic	  mice	  was	  amplified	  by	  PCR	  using	  the	  primers	  FRTseq	  and	  RRTseq	   (Table	  4).	  PCR	  products	  were	  subcloned	  into	  pCR2.1-­‐TOPO	  vector	  (Invitrogen)	  and	  sequenced.	  In	   order	   to	   distinguish	   the	   Jmjd3	   trap	   allele	   from	   the	   Jmjd3mut	  BAC	   transgene	   in	  compound	  heterozygous	  crosses,	  a	  TaqMan	  copy	  number	  assay	  was	  designed	  based	  on	   a	   probe	   spanning	   the	   junction	   between	   intron	   1	   and	   the	   gene	   trap	   cassette	  (ProbecnTrap	  CACTTTCGCCCCCTCAGCCAG)	  along	  with	   the	  amplification	  with	  primers	  FcnTrap	  and	  RcnTrap	  (Table	  4).	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2.6.6	  Generation	  of	  the	  Jmjd3.fl	  mouse	  strain	  In	   order	   to	   generate	   a	   conditional	   strain	   for	   Jmjd3,	   a	   targeting	   vector	   (pACYC177-­‐Jmjd3-­‐FRTbgeok-­‐flox)	  has	  been	  generated	  in	  our	  lab	  to	  target	  ES	  cells	  by	  homologous	  recombination.	  This	  vector	  is	  based	  on	  the	  ‘knockout-­‐first’	  design	  (Testa	  et	  al.,	  2004a)	  and	   allows	   in	   a	   single	   ES	   cell	   targeting	   step	   to	   generate	   both	   a	   constitutive	   and	   a	  conditional	  knockout	  (fig.	  6),	  thanks	  to	  the	  presence	  of	  FRT	  sites	  surrounding	  a	  βgeok	  selection	  cassette	  placed	  in	  an	  intronic	  region,	  followed	  by	  loxP	  sites	  flanking	  one	  or	  more	   exons.	   The	   βgeok	   cassette	   generates	   a	   constitutive	   knockout	   based	   on	   the	  presence	  of	  a	  splice	  acceptor	  (sA)	  site	  and	  a	  poly-­‐adenylation	  (pA)	  signal,	  which	  cause	  a	   capture	   and	   truncation	  of	   the	   endogenous	  RNA	   transcript.	   As	   illustrated	   in	   fig.	   6,	  upon	   removal	   of	   the	   βgeok	   cassette	   by	   Flp	   recombinase,	   the	   constitutive	   knockout	  allele	  is	  converted	  into	  a	  conditional	  allele,	  which	  allows	  studying	  the	  loss-­‐of-­‐function	  phenotype	  in	  a	  spatially-­‐	  and	  temporally-­‐controlled	  manner.	  
	  
Figure	   6.	   The	   Jmjd3	   multipurpose	   allele,	   and	   the	   ‘knockout-­‐first’	   design.	   The	   strategy	   entails	  insertion	  of	  a	  FRT-­‐flanked	  reporter	  cassette,	  comprising	  a	  splice	  acceptor	  (sA),	  an	  internal	  ribosomal	  entry	  site	  (IRES),	  a	  lacZ-­‐neo	  fusion	  and	  a	  polyadenylation	  (pA)	  signal	  into	  the	  first	  intron	  of	  Jmjd3	  and	  the	  additional	  insertion	  of	  two	  loxP	  sites	  to	  flank	  exons	  two	  to	  four.	  C57BL/6	  ES	   cells	  were	   electroporated	  with	   the	   targeting	   construct	   and	   selected	  by	  addition	   of	   G418.	   Following	   G418	   selection	   the	   ESC	   clones	   were	   screened	   by	  Southern	   Blot,	   and	   two	   ES	   cell	   clones	   that	   displayed	   the	   correct	   integration	   of	   the	  targeting	   vector	   were	   injected	   into	   C57BL/6	  mouse	   blastocysts.	   11	  male	   chimeras	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were	   obtained,	   and	   have	   been	   bred	   to	   C57BL/6	   females	   to	   transmit	   the	   targeted	  Jmjd3.fl	   allele	   through	   the	   germline.	   Mice	   positive	   for	   the	   targeted	   allele	   were	  selected	  by	  PCR	  of	  tail	  biopsies	  using	  primers	  JBaygD2,	  JBaygR2	  and	  LoxP_R2	  (Table	  4).	  	  
2.6.7	  Generation	  of	  the	  Jmjd3.Venus	  mouse	  strain	  Based	  on	  a	  collaboration	  with	  the	  laboratory	  of	  Francis	  Stewart,	  we	  obtained	  the	  lab	  of	   a	  mouse	  BAC	   (RP24-­‐244F21)	   containing	   the	  whole	   Jmjd3	   locus,	  which	   has	   been	  engineered	  with	   a	   Venus	   fluorescent	   protein	   in-­‐frame	   at	   the	   C-­‐terminal	   end	   of	   the	  Jmjd3	  coding	  sequence.	  The	  resulting	  product	   is	  a	   fusion	  protein	  constituted	  by	   the	  WT	   protein	   sequence	   of	   Jmjd3,	   tagged	   at	   the	   C-­‐terminus	   by	   a	   Venus	   fluorescent	  protein.	  The	  Venus	  fluorescent	  protein	  is	  a	  derivative	  of	  YFP	  with	  faster	  folding	  time,	  allowing	   for	   immediate	   detection	   of	   the	   fusion	   product	   by	   direct	   or	   indirect	  immunofluorescence.	   The	   Venus	   tag	   has	   been	   successfully	   used	   for	   both	   live	   and	  fixed-­‐sample	   imaging,	  and	  for	   immunoprecipitation	  applications	  (Ciotta	  et	  al.,	  2011;	  Hofemeister	  et	  al.,	  2011).	  Microinjection	   into	   fertilized	   oocytes	   and	   generation	   of	   transgenic	   mice	   was	  performed	   by	   standard	   techniques	   by	   the	   Transgenics	   Facility	   at	   the	   IFOM-­‐IEO	  Campus	   using	   oocytes	   derived	   from	   C57BL/6	   mice	   (Van	   Keuren	   et	   al.,	   2009;	  Vintersten	   et	   al.,	   2008).	   Transgenic	   founder	   animals	   were	   selected	   by	   PCR	   of	   tail	  biopsies	   using	   primer	   pair	   VENfw01	   e	   VENrv01.	   One	   transgenic	   founder	   female	  (#889)	  was	  selected	  for	  further	  characterization	  and	  colony	  expansion.	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Table	  4.	  List	  of	  primers	  used	  for	  genotyping	  
Strain	   Primer	   Sequence	  XB814	   JBaygD2	   AGGATACAGGAGCCACGCG	  JBaygR2	   TGACTCTCCACTCGATCACCC	  GT3_rev	   TCCGGAGCGGATCTCAAAC	  R26	  WT/Cre	   R26_WT	  F	   AAAGTCGCTCTGAGTTGTTAT	  R26_WT	  R	   GGAGCGGGAGAAATGGATATG	  R26_MUT	  R	   CCTGATCCTGGCAATTTCG	  R26.Jmjd3.fl-­‐stop	   R26.SA_Fw	   CTCGCGGTTGAGGACAAACTCTTCGCGGTC	  Jmjd3.1_Rev	   GGTCCCAGCTCGGCGAAGCT	  Neo_Fw	   CCATCATGGCTGATGCAATGCG	  Cre	   P19	   GCCTGCATTACCGGTCGATGCAACGA	  P20	   GTGGCAGATGGCGCGGCAACACCATT	  Jmjd3.fl	   JBaygD2	   AGGATACAGGAGCCACGCG	  JBaygR2	   TGACTCTCCACTCGATCACCC	  LoxP_R2	   GGAGCTACTGCCATGAGATG	  BAC.Jmjd3	   8_F	   GCGTAAGCGGGGCACATTTCATT	  8_R	   CCGAAGGCAAGAGCAGAATGTGTG	  FRTseq	   CCACGTGGGCCACACCATCC	  RRTseq	   GGGCCAATGTTGATGTTGACTGAGC	  FcnTrap	   CGCAGCTTCCCAGAAGTTAGAG	  RcnTrap	   CCGCAAACTCCTATTTCTGAGAAAGA	  Jmjd3.Venus	   VENfw01	   AGTCTGCCATGCCTGAGGGCT	  	  VENrv01	   GGGAGCAGCACAGGGCCATC	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3	  RESULTS	  
	  
3.1	  Validation	  of	  the	  XB814	  mouse	  strain	  as	  suitable	  loss-­‐of-­‐function	  model	  for	  Jmjd3	  in	  
the	  developing	  cortex	  To	   study	   the	   role	   of	   Jmjd3	   in	   neocortical	   development,	   we	   took	   advantage	   of	   a	  constitutive	   Jmjd3	   loss-­‐of-­‐function	  mouse	   strain	   (XB814)	   that	   has	   been	   previously	  developed	  by	  our	   lab	  (Burgold	  et	  al.,	  2012).	  XB814	  Jmjd3-­‐/-­‐	  mice	  die	  of	  respiratory	  failure	  shortly	  after	  birth:	  it	  has	  been	  demonstrated	  by	  our	  lab	  that	  the	  lack	  of	  Jmjd3	  hinders	  the	  formation	  of	  a	  functional	  pre-­‐Bötzinger	  complex	  (PBC),	  a	  neuronal	  circuit	  located	   in	   the	   embryonic	   brainstem	   that	   dictates	   the	   respiratory	   rhythm,	   together	  with	   the	   retrotrapezoid	   nucleus/parafacial	   respiratory	   group	   (RTN/pFRG)	   (Fortin	  and	  Thoby-­‐Brisson,	  2009).	  In	  the	  XB814	  mouse	  strain,	  Jmjd3	  has	  been	  inactivated	  by	  inserting	  a	  splice	  acceptor-­‐based	  knockout	  cassette	  in	  the	  first	  intron	  of	  the	  Jmjd3	  gene,	  resulting	  in	  trapping	  of	  the	  first	  noncoding	  exon	  of	  the	  transcript.	  Gene	  expression	  and	  western	  blot	  analysis	  revealed	   that	   the	   trap	  cassette	  was	  not	  completely	  efficient	  and	  allowed	   for	  a	  small	  residual	  level	  of	  gene	  expression,	  around	  10%	  of	  the	  WT	  levels	  (Burgold	  et	  al.,	  2012).	  Hence,	  since	  this	  strain	  is	  hypomorphic	  rather	  than	  a	  complete	  knockout,	  we	  wanted	  to	  confirm	  that	  this	  mouse	  strain	  is	  a	  bona	  fide	  knockout	  in	  the	  developing	  brain.	  To	  do	   so,	   we	   first	   assessed	   the	   mRNA	   level	   of	   Jmjd3	   in	   the	   neocortex	   of	   developing	  mouse	  embryos	  at	  different	  days	  of	  embryonic	  development.	  TaqMan	  qPCR	  analysis	  shows	  more	  than	  90%	  reduction	  of	  the	  Jmjd3	  transcript	  at	  embryonic	  (E)	  days	  E13.5,	  E16.5	   and	   E18.5	   (fig.	   7A).	   	   Moreover,	   RNA	   in	   situ	   hybridization	   confirms	   that	   the	  Jmjd3	  mRNA	   is	   virtually	   absent	   in	   the	   E18.5	   developing	   cortex	   of	   XB814	  mice	   (fig.	  7B).	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Figure	   7.	   The	   XB814	   mouse	   strain	   displays	   reduced	   level	   of	   Jmjd3	   transcript	   in	   the	  
telencephalon.	  (A)	  qRT-­‐PCR	  on	  RNA	  extracted	  from	  WT	  or	  KO	  telencephali	  at	  E13.5,	  E16.5,	  E18.5.	  Tbp	  is	   used	   as	   reference	   gene.	   Mean	   ±SD	   of	   three	   biological	   replicates	   is	   shown.	   (B)	   RNA	   in	   situ	  hybridization	  on	  WT	  or	  Jmjd3	  KO	  mouse	  embryos	  at	  day	  E16.5.	  Regions	  of	  specific	  signal	  are	  indicated	  by	   the	   following	   abbreviations:	   bag:	   basal	   ganglia,	   cb:	   cerebellum,	   cx:	   cortex,	  Di:	   diencephalon,	  Mes:	  mesencephalon,	  oe:	  olfactory	  epithelium,	  pi:	  pineal	  gland,	  thy:	  thymus,	  to:	  tongue	  (from	  Burgold	  et	  al.,	  2012).	  
We	   next	   assessed	   the	   reduction	   of	   Jmjd3	   at	   the	   protein	   level,	   by	   western	   blot	   on	  lysates	   from	  cortical	   tissue	  and	   immunofluorescence	  on	  brain	  sections.	  To	   this	  end,	  we	  tested	  several	  commercially	  available	  antibodies	  but	  we	  were	  not	  able	  to	  obtain	  reliable	  and	  reproducible	  results	  for	  any	  of	  these	  applications	  with	  any	  of	  the	  tested	  antibodies.	   Based	   on	   these	   results	   and	   on	   the	   necessity	   of	   effectively	   detecting	   the	  Jmjd3	   protein,	   we	   developed,	   in	   collaboration	   with	   the	   CNIO	   institute	   in	   Madrid,	  several	   monoclonal	   antibodies,	   in	   order	   to	   choose	   the	   best	   one	   for	   several	  downstream	  applications.	  Mice	  were	   immunized	  with	   a	   peptide	   comprising	   aminoacids	   89-­‐246	   of	   the	  mouse	  protein.	  This	  portion	  of	   the	   Jmjd3	  protein	   shows	  a	  high	  degree	  of	  homology	   (98%)	  between	  the	  human	  and	  mouse	  orthologs,	  and	  we	  chose	  it	  since	  it	  would	  most	  likely	  raise	  antibodies	   that	  would	  work	  both	   in	  human	  and	   in	  mouse.	  8	  hybridomas	  were	  generated	  and	  after	  testing	  them	  by	  WB	  against	  several	  human	  cells	  lines,	  we	  chose	  the	  two	  best	  performing	  (clones	  C6	  and	  G2)	   for	  high-­‐scale	  antibody	  production	  and	  purification.	   After	   further	   testing,	  we	   chose	   clone	  G2	   as	   the	   best	   performing	   of	   the	  two	  clones.	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Using	   this	   antibody,	  we	  were	   able	   to	  demonstrate	   by	  western	  blot	   (fig.	   8A)	   and	  by	  immunohistochemistry	   (fig.	   8B)	   that	   the	   Jmjd3	   protein,	   despite	   a	   low	   level	   of	  remaining	  transcript,	  is	  virtually	  absent	  in	  the	  E13.5	  XB814	  developing	  cortex.	  
	  
Figure	  8.	  The	  XB814	  mouse	  strain	  displays	  reduced	  level	  of	  Jmjd3	  protein	  in	  the	  telencephalon.	  (A)	  Western	   blot	   on	   E13.5	   telencephalic	   lysates	   using	   in-­‐house	   developed	   anti-­‐Jmjd3	   antibody	   and	  anti-­‐Vinculin	   antibody	  as	   loading	   control.	   (B)	   Immunohistochemistry	  on	   coronal	   sections	  of	  muouse	  necortex	   from	  WT	   or	   Jmjd3	   KO	   embryos.	   The	   antibody	   used	   is	   the	   in-­‐house	   developed	   anti-­‐Jmjd3	  antibody.	  
Taken	  together,	  these	  data	  allowed	  us	  to	  consider	  the	  XB814	  mouse	  a	  bona-­‐fide	  Jmjd3	  KO	   in	   the	   developing	   cortex,	   supporting	   our	   initial	   idea	   of	   using	   it	   as	   a	   model	   to	  characterize	  the	  role	  of	  Jmjd3	  in	  neocortical	  development.	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3.2	  Loss	  of	  Jmjd3	  causes	  a	  late-­‐onset	  expansion	  of	  NPCs	  in	  the	  developing	  mouse	  brain	  To	   investigate	   the	   effect	   of	   Jmjd3	   loss	   on	   neocortical	   development,	   we	   analyzed	  coronal	   sections	   of	   KO	   embryonic	   brains	   at	   different	   developmental	   stages	   using	  markers	  for	  neural	  stem	  cells	  and	  differentiated	  neurons.	  As	  the	  earliest	  time	  point,	  we	   chose	  day	  E13.5:	   at	   this	   time,	   deep-­‐layer	   (Tbr1+)	   excitatory	  projection	  neurons	  have	  already	  colonized	  the	  cortical	  plate	  and	  constituted	  layer	  VI,	  and	  layer	  V	  Ctip2+	  neurons	  are	  being	  produced	  by	  VZ	  NPCs	  (Kriegstein	  and	  Álvarez-­‐Buylla,	  2009).	  As	  the	  latest	  time	  point,	  we	  chose	  day	  E18.5,	  when	  neurogenesis	  is	  essentially	  over	  and	  the	  NPC	  population	   is	  reduced	   in	  numbers	  and	  has	  mainly	  switched	  to	  astrogenesis.	  By	  analyzing	  the	  developing	  brain	  at	  these	  different	  time	  points,	  and	  also	  at	  day	  E16.5,	  we	  were	  able	  to	  assess	  whether	  the	   loss	  of	   Jmjd3	  impacts	  the	  generation	  of	  specific	  subtypes.	  We	  started	  our	  analysis	  by	  assessing	  how	  the	  loss	  of	  Jmjd3	  impacts	  the	  VZ	  stem	  cell	  compartment.	  To	  do	  so,	  we	  chose	  to	  quantify	  the	  number	  of	  Pax6+	  cells	  at	  differential	  developmental	  stages:	  Pax6	  is	  a	  transcription	  factor	  that	  is	  central	  to	  embryonic	  brain	  development	  and	  that	  specifically	  marks	  cortical	  neural	  stem	  cells,	  which	  give	  rise	  to	  excitatory	   glutamatergic	   neurons.	   Immunofluorescence	   analysis	   of	   coronal	   sections	  of	   brains	   at	   different	   stages	   of	   embryonic	   development	   shows	   an	   increase	   in	   the	  number	  of	  Pax6+	  NPCs	  in	  the	  ventricular	  zone	  of	  Jmjd3	  KO	  mice	  with	  respect	  to	  WT	  littermates	  (fig.	  9A).	  Such	  a	  difference	  becomes	  apparent	  starting	   from	  E16.5	  and	  is	  maintained	  up	  to	  the	  late	  phases	  of	  development	  (E18.5),	  whereas	  it	  is	  not	  detectable	  at	   early	  phases	  of	  neocortical	  development	   (E13.5).	   In	  order	   to	   further	   confirm	   the	  expansion	   of	   the	   NPC	   compartment	   following	   loss	   of	   Jmjd3,	   we	   also	   assessed	   the	  expression	  of	  Sox2,	  a	   transcription	   factor	   that	   is	  present	   in	  NPCs	  of	  both	   the	  dorsal	  (cortical)	  and	  ventral	  (ganglionic	  eminence)	  telencephalon.	  As	  shown	  in	  figure	  9B,	  the	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Sox2+	  population	  is	  expanded	  in	  Jmjd3	  KO	  mice	  starting	  at	  E16.5,	  mirroring	  and	  thus	  confirming	  the	  finding	  obtained	  with	  the	  Pax6	  staining.	  
	  
Figure	  9.	  Immunofluorescence	  stainings	  for	  NPC	  markers	  in	  the	  VZ	  of	  WT	  and	  Jmjd3	  KO	  mice.	  (A-­‐B)	  Representative	   immunofluorescence	  stainings	  and	  graphs	  for	  Pax6,	  Sox2	  in	  coronal	  sections	  of	  WT	  or	  KO	  brains	  at	  days	  E13.5,	  E16.5,	  E18.5.	  Graphs	  show	  percentage	  of	  positive	  cells	  over	  DAPI,	  in	  a	  window	  of	  constant	  width	  and	  height	  set	  based	  on	  the	  thickness	  of	  VZ	  in	  KO	  brains.	  Graphs	  show	  mean	  ±SD	  of	  three	  biological	  replicates.	  (ns	  =	  P>0.05,	  *	  =	  P≤0.05,	  **	  =	  P≤0.01,	  ***	  =	  P≤0.001)	  
	  
3.2.1	   The	   expansion	   of	   the	   stem	   population	   in	   Jmjd3	   KO	   brains	   is	   not	   restricted	   to	  
cortical	  NPCs	  In	   addition	   to	   the	   cortical	   phenotype,	  we	  decided	   to	   investigate	   the	   effect	   of	   Jmjd3	  loss	  on	  other	  telencephalic	  regions.	  Based	  on	  a	  previous	  report	  that	   Jmjd3	  activates	  Mash1	   (Dai	   et	   al.,	   2010),	   a	  marker	  of	   ventral	   telencephalic	   stem	  cells	   that	   generate	  GABAergic	   neurons,	  we	   probed	  Mash1	   expression	   in	   the	   ventricular	   portion	   of	   the	  lateral	  ganglionic	  eminence	  (LGE).	  In	  contrast	  with	  such	  report,	  but	  coherently	  with	  the	  NPC	  expansion	   that	  we	  see	   in	   the	  cortical	  VZ,	   immunostaining	  shows	   increased	  number	   of	   Mash1+	   progenitor	   cells	   in	   the	   LGE	   of	   Jmjd3	   KO	   at	   E16.5	   (fig.	   10A).	  Consistently,	   Hematoxylin	   and	   Eosin	   (HE)	   staining	   demonstrate	   that	   loss	   of	   Jmjd3	  causes	   a	   thickening	   of	   the	   LGE	   (fig.	   10B),	   suggesting	   that	   the	   function	   of	   Jmjd3	   in	  embryonic	  NPCs	  is	  not	  restricted	  to	  the	  cortical,	  glutamatergic	  progenitors.	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Figure	   10.	   Jmjd3	  KO	  mouse	   embryonic	   brains	   show	   increase	   in	   the	   proliferating	   zone	   of	   the	  
lateral	  ganglionic	  eminence	  (LGE).	  (A)	  Representative	  immunofluorescence	  stainings	  and	  graphs	  for	  Mash1	  in	  coronal	  sections	  of	  WT	  or	  KO	  brains	  at	  day	  E16.5.	  (B)	  Representative	  HE	  stainings	  of	  E18.5	  WT	  or	  KO	  brains.	  Black	  arrowheads	  indicate	  the	  LGE.	  Graphs	  show	  total	  numbers	  of	  positive	  cells	  in	  a	  100x50	  um	  area.	  Graphs	  show	  mean	  ±SD	  of	  three	  biological	  replicates.	  (ns	  =	  P>0.05,	  *	  =	  P≤0.05,	  **	  =	  P≤0.01,	  ***	  =	  P≤0.001)	  	  
3.3	   Loss	   of	   Jmjd3	   causes	   a	   late-­‐onset	   reduction	   in	   the	   neuronal	   production	   in	   the	  
developing	  mouse	  neocortex	  In	  the	  developing	  brain,	  cortical	  NPCs	  produce	  the	  different	  subtypes	  of	  glutamatergic	  neurons	  following	  a	  timed	  sequence,	  and	  the	  newly	  generated	  neurons	  populate	  and	  form	  the	  cortical	  plate	  in	  an	  inside-­‐out	  fashion:	  the	  early-­‐born	  neurons	  contribute	  to	  the	  innermost	  layers	  and	  the	  late-­‐born	  end	  up	  constituting	  the	  more	  superficial	  layers	  (Kriegstein	  and	  Álvarez-­‐Buylla,	  2009).	  	  After	   determining	   that	   loss	   of	   Jmjd3	   causes	   a	   generalized	   expansion	   of	   the	   NPC	  population	  in	  the	  developing	  neocortex,	  we	  proceeded	  to	  assess	  whether	  the	  cortical	  post-­‐mitotic	  neuronal	  populations	  were	  also	  affected.	  	  To	  do	  so,	  we	  performed	  multiple	  staining	  for	  markers	  of	  neuronal	  subtypes	  and	  we	  found	   that,	   in	   Jmjd3	  KO	  brains,	   the	  early-­‐born	  Tbr1+	  (layer	  6)	  and	  Ctip2+	  (layer	  5)	  neurons	   are	   reduced	   starting	   from	   E16.5	   whereas	   the	   late-­‐born	   Brn2+	   (layer	   2-­‐4)	  neurons	  show	  no	  apparent	  defect	  at	  any	  time	  point	  of	  development	  (fig.	  11A-­‐B).	  The	  fact	  that	  production	  of	  late-­‐born	  neurons	  is	  not	  affected	  by	  Jmjd3	  loss	  might	  seem	  in	  contrast	  with	  the	  reduced	  numbers	  of	  early-­‐born	  neurons.	  We	  reasoned	  that	  this	  might	  be	  explained	  by	  the	   fact	   that	  Brn2+	  neurons	  are	  produced	  at	  a	   time	   in	  which	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the	   pool	   of	   NPCs	   is	   already	   expanded:	   the	   higher	   number	   of	   NPCs	   might	   thus	  compensate	  for	  their	  lower	  efficiency	  in	  neuronal	  production.	  
Figure	   11.	   Loss	   of	   Jmjd3	   causes	   a	   late-­‐onset	   reduction	   in	   the	   neuronal	   production	   in	   the	  
developing	  mouse	  neocortex.	  (A)	  Representative	  immunofluorescence	  stainings	  for	  Tbr1	  in	  coronal	  sections	  of	  WT	  or	  KO	  brains	  at	  days	  E13.5,	  E16.5,	  E18.5.	  Graphs	  show	  percentage	  of	  positive	  cells	  over	  DAPI,	  in	  a	  window	  of	  constant	  width	  and	  height	  set	  based	  on	  the	  thickness	  of	  VZ	  in	  KO	  brains.	  Graphs	  show	  mean	  ±SD	  of	   three	  biological	   replicates.	   (B)	  Representative	   immunofluorescence	  stainings	  and	  graph	   for	  Tbr1,	  Ctip2,	  Brn2	   in	   coronal	   sections	  of	  WT	  or	  KO	  brains	  at	  day	  E18.5.	  Graphs	   show	   total	  numbers	  of	  positive	  cells	  in	  a	  window	  spanning	  the	  entire	  cortex	  and	  50	  um	  wide.	  Graphs	  show	  mean	  ±SD	  of	  three	  biological	  replicates.	  (ns	  =	  P>0.05,	  *	  =	  P≤0.05,	  **	  =	  P≤0.01,	  ***	  =	  P≤0.001)	  
	  
3.3.1	  The	  Tbr2+	  population	  of	   cortical	   intermediate	  progenitors	   is	  not	  affected	  by	   the	  
loss	  of	  Jmjd3	  in	  the	  developing	  neocortex	  In	  the	  developing	  neocortex,	  neurons	  can	  derive	  from	  Pax6+	  NPCs	  either	  directly,	  in	  a	  process	   known	   as	   direct	   neurogenesis,	   or	   indirectly,	   through	   an	   intermediate	   cell	  state	   known	   that	   is	   characterized	   by	   the	   presence	   of	   the	   Tbr2	   T-­‐box	   transcription	  factor:	  such	  cells	  are	  known	  as	  intermediate	  progenitors	  or	  transit-­‐amplifying	  cells.	  In	  this	   second	   case,	   Pax6+	  NPCs	   first	   differentiate	   into	   Tbr2+	   cells,	  which	   can	   in	   turn	  self-­‐replicate	   by	   symmetric	   division	   or	   generate	   neurons	   via	   both	   asymmetric	   and	  symmetric	   divisions.	   Given	   the	   observed	   imbalance	   between	   the	   stem	   and	   the	  differentiated	  compartment	  of	  the	  Jmjd3	  KO	  embryonic	  brain,	  we	  reasoned	  that	  also	  the	   intermediate	   compartment	   could	   be	   affected	   by	   the	   loss	   of	   Jmjd3.	   However,	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immunofluorescence	   analysis	   revealed	   that	   the	   number	   of	   Tbr2+	   intermediate	  progenitors	   is	   comparable	   in	   WT	   and	   KO	   brains	   at	   all	   the	   observed	   stages	   of	  development	   (E13.5,	   E16.5,	   E18.5,	   fig.	   12A):	   this	   result	   could	   imply	   that	   the	   loss	   of	  Jmjd3	  preferentially	  impairs	  the	  direct	  route	  of	  neurogenesis.	  
	  
Figure	   12.	   The	   Tbr2+	   population	   of	   intermediate	   progenitors	   is	   not	   affected	   by	   the	   loss	   of	  
Jmjd3.	  Representative	  immunofluorescence	  stainings	  for	  Tbr2	  in	  coronal	  sections	  of	  WT	  or	  KO	  brains	  at	   days	   E13.5,	   E16.5,	   E18.5.	   Graphs	   show	   total	   numbers	   of	   positive	   cells	   in	   a	  window	   spanning	   the	  entire	  cortex	  and	  50	  um	  wide.	  Graphs	  show	  .mean	  ±SD	  of	  three	  biological	  replicates.	  (ns	  =	  P>0.05,	  *	  =	  P≤0.05,	  **	  =	  P≤0.01,	  ***	  =	  P≤0.001)	  
To	  summarize	  these	   findings,	  we	  showed	  that	   lack	  of	   Jmjd3	   in	  the	  developing	  brain	  causes	  an	  expansion	  of	  the	  cortical	  stem	  population	  at	  the	  expense	  of	  the	  production	  of	   mature	   neurons,	   and	   that	   this	   defects	   start	   to	   be	   apparent	   at	   day	   E16.5.	   We	  hypothesize	   that	   the	   phenotype	   starts	   to	   be	   apparent	   only	   late	   in	   development	  because	   the	   increase	   in	   the	   NPC	   population	   needs	   to	   accumulate	   over	   time	   before	  becoming	  detectable	  and	  statistically	  relevant.	  This	  hypothesis	  could	  also	  provide	  an	  alternative	   explanation	   to	   the	   observation	   that	   the	   Tbr2+	   intermediate	   precursors	  are	  not	  reduced	  in	  Jmjd3	  KO	  brains.	  Indeed,	  since	  the	  Tbr2-­‐positive	  is	  only	  a	  transient	  rather	  than	  a	  terminal	  compartment	  and	  thus	  does	  no	  allow	  to	  accumulate	  abundance	  difference	  over	  time,	  and	  since	  we	  assume	  that,	  when	  analyzed	  in	  a	  short	  time	  frame,	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the	   neuronal	   output	   of	   Jmjd3	   KO	   NPCs	   is	   not	   significantly	   lower	   than	   their	   WT	  counterpart,	   the	   very	   nature	   of	   the	   Tbr2+	   compartment	  would	   not	   allow	   scoring	   a	  statistically	  significant	  difference.	  	  
3.4	  The	  demethylase	  activity	  of	  Jmjd3	  is	  necessary	  for	  proper	  development	  of	  the	  mouse	  
neocortex	  Recent	  reports,	  which	  show	  that	  Jmjd3	  is	  able	  to	  regulate	  expression	  of	  target	  genes	  in	   a	   demethylation-­‐independent	   manner	   (Chen	   et	   al.,	   2012;	   De	   Santa	   et	   al.,	   2009;	  Miller	   et	   al.,	   2010),	   prompted	   us	   to	   investigate	   the	   contribution	   of	   the	   catalytic	  activity	  of	  Jmjd3	  to	  the	  phenotype.	  Moreover,	  since	  our	  lab	  previously	  demonstrated	  that	  the	  enzymatic	  activity	  of	  Jmjd3	  is	  required	  to	  rescue	  the	  correct	  formation	  of	  the	  pre-­‐Bötzinger	  complex	  in	  the	  brainstem	  of	  XB814	  mice,	  we	  wished	  to	  clarify	  whether	  the	  cortical	  phenotype	  of	  enlarged	  VZ	  and	  reduced	  cortical	  plate	  was	  dependent	  on	  the	  enzymatic	  activity	  of	  Jmjd3	  (Burgold	  et	  al.,	  2012).	  To	  do	  so,	  we	  took	  advantage	  of	  our	  unique	  cohort	  of	  mouse	  strains	  and	  crossed	  them	  to	  XB814	  mice	  to	  re-­‐express	  WT	  or	  mutant	  Jmjd3	  in	  KO	  embryos	  (fig.	  13A-­‐B).	  
	  
Figure	   13.	   Mouse	   strains	   used	   for	   rescue	   experiments.	   The	   R26.Jmjd3	   and	   BACmut	   strains	   are	  described	  in	  the	  methods	  section	  (§2.6)	  and	  have	  been	  previously	  published	  in	  Burgold	  et	  al.,	  2012.	  When	   crossed	  with	   a	  mouse	   strain	   expressing	   a	  WT	   Jmjd3	   cDNA	   from	   the	   Rosa26	  locus,	  Jmjd3	  KO	  embryos	  displayed	  numbers	  of	  Pax6+	  NPCs	  and	  Tbr1+,	  Ctip2+	  post-­‐mitotic	  neurons	  comparable	  to	  their	  WT	  littermates.	  We	  then	  crossed	  Jmjd3	  KO	  mice	  with	  a	  strain	  harboring	  a	  bacterial	  artificial	  chromosome	  (BAC)	  containing	  the	  whole	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Jmjd3	  genomic	  region,	  in	  which	  Jmjd3	  has	  been	  modified	  with	  a	  point	  mutation	  that	  renders	   it	   catalytically	   inactive	   (His1388Ala)	   (Burgold	   et	   al.,	   2012).	   As	   shown	   in	  figure	   14A-­‐C,	   mutant	   Jmjd3	   fails	   to	   rescue	   the	   phenotype	   as	   the	   numbers	   of	   both	  NPCs	  and	  differentiated	  neurons	  remain	  similar	  to	  those	  of	  Jmjd3	  KO	  embryos.	  Taken	  together,	  these	  data	  demonstrate	  that	  the	  demethylase	  activity	  of	  Jmjd3	  is	  necessary	  for	  the	  normal	  embryonic	  development	  of	  the	  mouse	  neocortex.	  	  
	  
Figure	  14.	  The	  demethylase	  activity	  of	   Jmjd3	   is	  necessary	   for	   the	   correct	  development	  of	   the	  
mouse	  neocortex.	  R26.Jmjd3:	  mouse	  strain	  harboring	  an	  allele	  overexpressing	  the	  WT	  Jmjd3	  mouse	  cDNA	  from	  the	  Rosa26	  locus.	  BACmut:	  mouse	  strain	  harboring	  a	  bacterial	  artificial	  chromosome	  (BAC)	  containing	  the	  whole	  Jmjd3	  genomic	  region,	  in	  which	  Jmjd3	  has	  been	  modified	  with	  a	  point	  mutation	  that	   renders	   it	   catalytically	   inactive	   (His1388Ala).	   (A)	  Representative	   immunofluorescence	   stainings	  and	  graph	  for	  Pax6	   in	  coronal	  sections	  of	  WT	  or	  KO	  brains	  at	  day	  E18.5.	  Graphs	  show	  percentage	  of	  positive	  cells	  over	  DAPI,	  in	  a	  window	  of	  constant	  width	  (100um)	  and	  height	  set	  based	  on	  the	  thickness	  of	   VZ	   in	   KO	   brains.	   Graphs	   show	   mean	   ±SD	   of	   three	   biological	   replicates.	   (B)	   Representative	  immunofluorescence	  stainings	  and	  graph	  for	  Tbr1,	  Ctip2,	  Brn2	  in	  coronal	  sections	  of	  WT	  or	  KO	  brains	  at	  day	  E18.5.	  Graphs	  show	  total	  numbers	  of	  positive	  cells	  in	  a	  window	  spanning	  the	  entire	  cortex	  and	  50	  um	  wide.	  Graphs	  show	  mean	  ±SD	  of	  three	  biological	  replicates.	  (C)	  Representative	  HE	  stainings	  of	  E18.5	  WT	  or	  KO	  brains.	  Black	  arrowheads	  indicate	  the	  LGE.	  	  (A-­‐C)	  ns	  =	  P>0.05,	  *	  =	  P≤0.05,	  **	  =	  P≤0.01,	  ***	  =	  P≤0.001.	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3.5	  In	  vivo	  characterization	  of	  the	  Jmjd3	  KO	  NPC	  population	  Since	  the	  Pax6+	  NPCs	  are	  the	  founding	  population	  of	  the	  mouse	  neocortex,	  it	  is	  safe	  to	  assume	  that	  alterations	  in	  their	  behavior	  might	  lead	  to	  the	  defects	  that	  we	  observed	  in	  the	  post-­‐mitotic	  neurons	  of	  Jmjd3	  KO	  brains,	  which	  are	  generated	  by	  Pax6+	  NPCs	  via	   the	   direct	   or	   indirect	   route	   of	   neurogenesis.	   Based	   on	   this,	   in	   order	   to	   better	  understand	  the	  phenotype	  observed	  in	  Jmjd3	  KO	  brains,	  we	  decided	  to	  characterize	  in	  depth	  the	  Pax6+	  VZ	  population.	  	  
3.5.1	   Jmjd3	  KO	  NPCs	   proliferate	   actively	   and	  have	   a	   higher	   rate	   of	   cell	   cycle	   re-­‐entry	  
after	  completing	  mitosis	  We	   reasoned	   that	   the	   expansion	   of	   the	   VZ	   in	   Jmjd3	   KO	   brains	  might	   be	   related	   to	  alterations	  in	  the	  proliferation	  rate	  of	  NPCs,	  and	  we	  thus	  sought	  to	  investigate	  in	  vivo	  the	  cell	  cycle	  behavior	  of	  the	  expanded	  NPC	  population.	  To	   assess	   the	   proliferation	   rate	   of	   VZ	   NPCs,	   we	   pulse-­‐labeled	   embryos	   with	   the	  thymidine	   analogue	  EdU	   and	  detected	   its	   distribution	   24	   hours	   later	   together	  with	  the	  cell	  proliferation	  marker	  Ki67.	  The	  ratio	  of	  cell	  cycle	  exit	  can	  be	  calculated	  as	  the	  number	   of	   EdU+/Ki67-­‐	   postmitotic	   cells	   among	   the	   total	   EdU+	   cells.	   As	   shown	   in	  figure	   15A-­‐B,	   the	   exiting	   fraction	   is	   lower	   in	   Jmjd3	  KO	   embryonic	   brains,	   implying	  that	   lack	   of	   Jmjd3	   negatively	   affects	   the	   ability	   of	   NPCs	   to	   exit	   the	   cell	   cycle	   after	  mitosis.	  
	   63	  
	  
Figure	   15.	   Loss	   of	   Jmjd3	   enhances	   cell	   cycle	   reentry	   in	   VZ	   NPCs.	   (A)	   Representative	  immunofluorescence	  stainings	  for	  EdU	  and	  Ki67	  in	  coronal	  sections	  of	  WT	  or	  KO	  brains	  at	  days	  E16.5	  and	  E18.5.	  Graphs	  show	  ratios	  of	  EdU+Ki67+/	  total	  EdU+	  (retention)	  or	  Edu+Ki67-­‐/	  total	  EdU+	  (exit)	  counted	   in	  windows	   of	   constant	  width	   (100um)	   and	   height	   set	   based	   on	   the	   thickness	   of	   VZ	   in	   KO	  brains.	  Graphs	  show	  mean	  ±SD	  of	  five	  biological	  replicates.	  	  
3.5.2	  Jmjd3	  KO	  NPCs	  do	  not	  display	  aberrantly-­‐localized	  mitoses	  In	  the	  developing	  neocortex,	  the	  nuclei	  of	  the	  NPCs	  in	  the	  VZ	  undergo	  a	  characteristic	  periodic	   movement	   between	   the	   ventricular	   surface	   and	   the	   VZ-­‐SVZ	   boundary,	   in	  phase	   with	   cell	   cycle	   progression,	   known	   as	   interkinetic	   nuclear	   migration	   (INM)	  (Kriegstein	   and	   Álvarez-­‐Buylla,	   2009).	   Specifically,	   DNA	   replication	   occurs	   towards	  the	  VZ-­‐SVZ	  boundary,	  whereas	   phospho-­‐histone	  H3	   (pH3)	   –positive	  mitotic	   figures	  are	  restricted	  to	  the	  ventricular	  surface	  in	  physiologic	  conditions.	  A	  mechanism	  of	  overcrowd-­‐induced	  mitosis	  delamination	  has	  been	  proposed	  almost	  50	   years	   ago	   (Smart,	   1965)	   and	   recently	   demonstrated	   in	   drosophila	   and	   mouse	  (Marinari	  et	  al.,	  2012;	  Okamoto	  et	  al.,	  2013).	  According	  to	  this	  mechanism,	  when	  cell	  abundance	   at	   the	   ventricular	   surface	   rises	   to	   an	   intolerable	   level,	   some	   NPCs	  may	  leave	  the	  ventricular,	  apical	  surface	  to	  undergo	  mitosis	  at	  a	  more	  basal	  position.	  We	  reasoned	  that	  the	  cellular	  overabundance	  in	  the	  VZ	  of	  brains	  lacking	  Jmjd3	  might	  thus	   in	   turn	   cause	   defects	   in	   the	   localization	   of	   mitoses	   and	   in	   the	   neural	  differentiation	  process.	  We	  determined	  the	  ratio	  of	  apical	  versus	  non-­‐apical	  mitoses	  by	  pH3	  staining,	  and	  found	  that	  this	  ratio	  is	  similar	  in	  WT	  and	  Jmjd3	  KO	  mice,	  at	  both	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early	   and	   late	   stages	   of	   brain	   development,	   suggesting	   that	   the	   degree	   of	   VZ	  expansion	  in	  KO	  mice	  is	  not	  high	  enough	  to	  influence	  INM	  (fig.	  16A).	  
	  
Figure	   16.	   Loss	   of	   Jmjd3	   does	   not	   affect	   the	   localization	   of	   NPC	   mitoses.	   (A)	   Representative	  immunofluorescence	  stainings	  for	  Pax6	  and	  pH3	  in	  coronal	  sections	  of	  WT	  or	  KO	  brains	  at	  days	  E13.5,	  E16.5	  and	  E18.5.	  Graphs	  show	  percentages	  of	  apical	  and	  non-­‐apical	  mitoses	  over	  the	  total	  number	  of	  pH3+	  cells,	  counted	  in	  a	  whole	  section	  of	  a	  single	  hemisphere.	  	  
3.5.3	  The	  timing	  of	  neuronal	  subtype	  production	  is	  not	  altered	  by	  loss	  of	  Jmjd3	  During	   the	   progression	   of	   neocortical	   development,	   NPCs	   sequentially	   generate	  different	   neuronal	   subtypes,	   which	   migrate	   radially	   and	   constitute	   the	   different	  layers	  of	  the	  mature	  cortex,	  with	  the	  late-­‐born	  neurons	  contributing	  to	  the	  outermost	  layer	   (Greig	   et	   al.,	   2013).	   It	   has	   been	   previously	   shown	   that	   KO	   of	   the	   H3K27	  demetyhlase	   EzH2	   affects	   the	   timing	   of	   neuronal	   production	   due	   to	   its	   function	   in	  repressing	  target	  genes	  that	  regulate	  neurogenesis	  (Hirabayashi	  et	  al.,	  2009;	  Pereira	  et	  al.,	  2010),	  and	  as	  outlined	  in	  the	  introduction,	  fine-­‐tuning	  of	  H3K27	  methylation	  is	  required	  for	  the	  proper	  sequence	  of	  neuron	  and	  astrocyte	  production	  (Testa,	  2011).	  We	  reasoned	  that	  the	  alterations	  that	  we	  observed	  in	  the	  numbers	  of	  cortical	  neurons	  in	  Jmjd3	  KO	  mice	  might	  be	  as	  well	  linked	  to	  changes	  in	  the	  timing	  of	  neuronal	  subtype	  production.	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To	   assess	   whether	   the	   timing	   of	   neuronal	   production	   is	   altered,	   we	   performed	   a	  neuronal	   birthdating	   experiment	   by	   injecting	   E13.5	   pregnant	   mice	   with	   EdU,	   and	  collecting	   embryos	   five	   days	   later	   (E18.5)	   to	   check	   the	   distribution	   of	   EdU-­‐labeled	  post-­‐mitotic	  neurons	  (fig.	  17A).	  EdU	  is	  incorporated	  in	  actively-­‐dividing	  VZ	  stem	  cells	  at	  the	  moment	  of	  administration,	  and	  is	  passed	  to	  the	  daughter	  cells	  upon	  mitosis.	  By	  studying	  the	  co-­‐localization	  of	  EdU	  and	  layer-­‐specific	  nuclear	  markers	  in	  the	  cortical	  plate	  it	  is	  possible	  to	  understand	  which	  neuronal	  subtype	  was	  being	  generated	  at	  the	  time	  of	  EdU	  administration.	  Co-­‐staining	   of	   EdU	  with	  Tbr1	   and	  Ctip2	   showed	   that	   both	  WT	   and	   Jmjd3	  KO	  NPCs	  produce	  mainly	  Ctip2+	  neurons	  at	  day	  E13.5,	  pointing	  out	  that	  the	  loss	  of	  Jmjd3	  does	  not	  impact	  on	  the	  timing	  of	  neuronal	  production	  (fig	  17B-­‐C).	  
	  
Figure	   17.	   Loss	   of	   Jmjd3	  does	   not	   affect	   the	   timing	   of	   neuronal	   production.	   (A)	  Pregnant	  mice	  were	   injected	  with	  EdU	  (50mg/kg	  of	   total	  weight)	   in	  PBS	  at	  day	  E13.5.	  Five	  days	   later	  (E18.5),	  mice	  were	  sacrificed	  and	  embryos	  collected.	  (B)	  Representative	  immunofluorescence	  stainings	  for	  Ctip2	  and	  EdU	  in	  coronal	  sections	  of	  WT	  or	  KO	  brains	  at	  day	  E18.5.	  Tbr1	  staining	  was	  also	  performed	  to	  define	  cell	   layers	   but	   is	   not	   shown.	   (C)	   Graph	   showing	   distribution	   of	   EdU+	   cells	   in	   three	   neuronal	   layers	  defined	  by	  Tbr1	  and	  Ctip2	  staining.	  Mean	  ±SD	  of	  5	  WT	  and	  3	  KO	  biological	  replicates	   is	  shown.	  ns	  =	  P>0.05,	  *	  =	  P≤0.05,	  **	  =	  P≤0.01,	  ***	  =	  P≤0.001.	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  Taken	   together,	   these	   data	   suggest	   that,	   in	   absence	   of	   Jmjd3,	   the	   modality	   of	   cell	  division	   of	   VZ	   NPCs	   is	   skewed	   towards	   self-­‐renewal	   rather	   than	   differentiation.	  Interestingly,	   contrary	   to	   what	   has	   been	   shown	   for	   the	   Ezh2	   methyl-­‐transferase	  (Hirabayashi	  et	  al.,	  2009;	  Pereira	  et	  al.,	  2010),	  KO	  of	  the	  Jmjd3	  demethylase	  does	  not	  alter	  the	  timing	  of	  neuronal	  production.	  This	  suggests	  that	  the	  functions	  of	  Jmjd3	  in	  brain	  development	  go	  beyond	  counteracting	  the	  action	  of	  Ezh2	  on	  H3K27,	  and	  hints	  at	   a	   possibly	   different	   mechanism	   of	   action	   of	   these	   two	   proteins	   despite	   their	  opposing	  role	  in	  regulating	  the	  dynamics	  of	  H3K27	  methylation.	  	  	  
3.6	  In	  vitro	  characterization	  of	  Jmjd3	  KO	  brain-­‐derived	  NPCs	  To	   investigate	   the	  consequences	  of	   Jmjd3	  ablation	  on	  NPCs	  at	  single-­‐cell	  resolution,	  we	   resorted	   to	   in	   vitro	   cultures	   of	   primary	   embryonic	   NPCs.	   To	   isolate	   NPCs,	   we	  dissected,	   disaggregated	   and	   put	   in	   culture	   E13.5	   cortices,	   and	   then	   selectively	  expanded	   nestin-­‐positive	   NPCs	   by	   daily	   addition	   of	   the	  mitogen	   bFGF.	   It	   has	   been	  previously	  demonstrated	  that	  cells	  cultured	  in	  these	  conditions	  can	  be	  expanded	  for	  several	  passages	  while	  keeping	  a	  self-­‐renewing	  behavior,	  allowing	  to	  study	  their	  cell	  cycle	  dynamics	  (Ravin	  et	  al.,	  2008).	  Also,	  when	  pushed	  to	  differentiate	  by	  change	  of	  culture	   conditions	   (see	  materials	   and	  methods	   §2.1.2	   and	   fig.	   18C	   for	  details),	   they	  are	  able	  to	  generate	  neurons	  and	  glia	  through	  complex	   lineages	  that	  can	  be	  tracked	  via	  high-­‐resolution	  time-­‐lapse	  video-­‐microscopy.	  This	  analysis	  allows	  to	  track	  a	  high	  number	  of	  neural	  stem	  cells	  for	  days	  in	  culture	  and	  to	  gain	  information	  at	  the	  single	  cell	  level	  on	  different	  aspects	  of	  their	  behavior,	  such	  as	  their	  differentiation	  potential	  and	  cell	  cycle	  time.	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3.6.1	  In	  vitro-­‐cultured	  Jmjd3	  KO	  VZ	  NPCs	  can	  differentiate	  in	  the	  three	  neural	  lineages	  In	   order	   to	   parallel	   the	   in	   vivo	   observation	   of	   reduced	   neuronal	   output,	   we	   first	  wanted	  to	  assess	  the	  differentiation	  potential	  of	  Jmjd3	  KO	  NPCs.	  To	  do	  so,	  we	  adopted	  a	  previously	  described	  differentiation	  protocol	  (Ravin	  et	  al.,	  2008)	  that	  allows	  cortical	  NPCs	  to	  generate	  the	  three	  neural	  lineages:	  Tuj1+	  neurons,	  O4+	  oligodendrocytes	  and	  GFAP+	   astrocytes.	   As	   assessed	   by	   qRT-­‐PCR	   (Fig.	   18D),	   Jmjd3	   expression	   is	  upregulated	  during	  neural	  differentiation	  and	  peaks	  after	  2	  days	  of	  bFGF	  withdrawal,	  whereas	  the	  expression	  level	  remains	  stably	  low	  in	  KO	  samples.	  However,	  at	  the	  end	  of	   the	   differentiation	   process,	   both	   WT	   and	   Jmjd3	   KO	   samples	   displayed	   similar	  proportions	  of	  the	  three	  cell	  types	  (Fig.	  18A-­‐B).	  This	  suggests	  that	  loss	  of	  Jmjd3	  does	  not	   impact	   the	   intrinsic	   capability	  of	  NPCs	   to	   start	   a	  differentiation	  program:	   these	  data	   are	   in	   agreement	  with	   the	  observation	   that,	   albeit	   at	   lower	   efficiency,	  NPCs	   in	  
vivo	  are	  indeed	  able	  to	  differentiate	  into	  neurons.	  However,	  it	  could	  be	  expected	  that	  Jmjd3	  KO	  NPCs	  would	  display	  also	  in	  vitro	  a	  reduced	  capability	  to	  generate	  neurons.	  This	   apparent	   discrepancy	  might	   be	   caused	   by	   the	   strict	   culture	   conditions,	   which	  entail	   the	   presence	   of	   a	   high	   concentration	   of	   bFGF	   until	   its	   total	   withdrawal	   and	  substitution	   with	   differentiating	   factors.	   These	   culture	   conditions	   might	   be	  constraining	  enough	  on	  the	  NPC	  population	  to	  shroud	  subtle	  mechanisms	  that	  on	  the	  other	  hand	  allow	  for	  a	  fine-­‐tuning	  of	  the	  differentiation	  process	  in	  vivo.
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Figure	  18.	   In	   vitro-­‐cultured	   Jmjd3	  KO	  VZ	   fail	   to	  upregulate	   Jmjd3	  but	   can	  differentiate	   in	   the	  
three	   neural	   lineages.	   (A-­‐B)	   Representative	   immunofluorescence	   stainings	   for	   Nestin	   (NPC),	   Tuj1	  (neurons),	  O4	  (oligodendrocytes),	  GFAP	  (astrocytes),	  DAPI,	  of	  undifferentiated	  (d0)	  and	  differentiated	  (d4)	  WT	  and	  KO	  NPCs.	   (C)	  Differentiation	  protocol	  of	   cortical	  NPCs,	  which	  entails	  NPC	  expansion	   in	  medium	  with	  bFGF,	  2	  days	  of	  bFGF	  withdrawal,	  2	  days	  of	  differentiation	  in	  Neurobasal	  medium	  with	  B27	  supplement,	  neurotrophin-­‐3	  and	  BDNF.	  (D)	  The	  graph	  shows	  qRT-­‐PCR	  data	  of	  Jmjd3	  expression	  in	  differentiating	  NPCs,	  days	  of	  differentiation	  correspond	  to	  figure	  4	  C.	  Data	  are	  plotted	  as	  mean	  ±SD	  of	  three	  independent	  biological	  replicates.	  	  
3.6.2	  Jmjd3	  KO	  NPCs	  show	  a	  lower	  proliferation	  rate	  upon	  serial	  passaging	  We	  then	  sought	  to	  investigate	  the	  proliferative	  capacity	  of	  Jmjd3	  KO	  NPCs.	  To	  do	  so,	  we	  plated	  1x10^6	  WT	  or	  KO	  NPCs	  at	  passage	  1	  after	  culture	  establishment,	  kept	  them	  in	  proliferative	  conditions	  by	  daily	  bFGF	  addition,	  and	  serially	  replated	  1x10^6	  cells	  after	   three	   days	   of	   culture,	   until	   passage	   5	   (fig.	   19A).	   The	   resulting	   growth	   curves,	  performed	  in	  biological	  triplicates,	  revealed	  that	  Jmjd3	  KO	  cells	  proliferate	  less	  than	  their	  WT	  counterpart	  (fig	  19B).	  The	  lower	  cell	  numbers	  observed	  in	  KO	  NPCs	  at	  the	  end	  of	  the	  growth	  curve	  might	  be	  due	  to	  higher	  cell	  death,	  to	  the	  presence	  of	  cells	  that	  do	  not	  divide,	  or	  to	  a	  general	  lengthening	  of	  the	  cell	  cycle.	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Figure	  19.	  Loss	  of	  Jmjd3	  causes	  reduced	  proliferation	  of	  in	  vitro-­‐cultured	  NPCs	  derived	  from	  the	  
embryonic	   brain.	   (A)	   Schematics	   of	   the	   protocol	   used	   to	   expand	   NPCs	   in	   order	   to	   obtain	   growth	  curves	   and	   cell	   cycle	   data.	   1x10^6	   WT	   or	   KO	   NPCs	   were	   plated	   at	   passage	   1	   after	   culture	  establishment,	  kept	  in	  proliferative	  conditions	  by	  daily	  bFGF	  addition,	  and	  1x10^6	  cells	  were	  serially	  replated	  after	  three	  days	  of	  culture,	  until	  passage	  5.	  NPCs	  were	  exposed	  to	  30’	  of	  EdU	  pulse,	  followed	  by	  EdU	  detection,	  PI	  staining	  and	  FACS	  analysis.	  Since	   in	  vitro	  cultured	  NPCs	  stop	  proliferating	  when	  they	  reach	  high	  confluence	  levels,	  the	  cells	  were	  pulsed	  with	  EdU	  48	  hours	  after	  replating,	  when	  they	  are	   still	   in	   exponential	   growth	  phase.	   (B)	  Log	   scale	  graph	   showing	   cumulative	  growth	  curves	  of	  WT	  and	  KO	  NPCs,	  kept	  in	  proliferative	  conditions	  by	  the	  method	  in	  Fig.	  4	  E.	  	  
3.6.3	  In	  vitro-­‐cultured	  Jmjd3	  KO	  VZ	  NPCs	  have	  a	  longer	  cell	  cycle	  To	  precisely	  pinpoint	  the	  cause	  of	  the	   lower	  proliferation	  rate	  observed	  upon	  serial	  passaging,	  we	   subjected	   cultures	   in	   proliferative	   conditions	   of	  WT	   and	  KO	  NPCs	   to	  time-­‐lapse	   video-­‐microscopy:	   such	   high-­‐resolution	   analysis	   allowed	   us	   to	   track	   the	  progeny	   of	   single	   NPCs	   and	   assess	   their	   proliferative	   behavior.	   By	   measuring	   the	  interval	   between	   subsequent	   mitoses	   in	   a	   cell	   progeny,	   we	   observed	   that	   in	   the	  absence	  of	  Jmjd3,	  NPCs	  have	  a	  much	  longer	  cell	  cycle	  than	  their	  WT	  counterpart	  (Fig.	  19A-­‐C).	  This	  feature	  is	  even	  more	  evident	  when	  cell	  cycle	  times	  are	  stratified	  by	  cell	  generation,	  with	  cells	  belonging	  to	  the	  first	  generation	  (that	  is,	  cells	  deriving	  from	  the	  first	   mitosis	   to	   be	   scored)	   having	   the	   highest	   difference	   (KO	   18.3±5.3	   hrs,	   WT	  13.6±2.2	  hrs).	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Figure	   20.	   Loss	   of	   Jmjd3	   causes	   a	   lengthening	   of	   the	   total	   cell	   cycle	   time	   in	   in	  vitro-­‐cultured	  
NPCs	   (A)	   Representative	   lineage	   dendrograms	   of	   WT	   and	   KO	   NPCs,	   imaged	   by	   time-­‐lapse	  videomicroscopy	  while	  kept	  in	  differentiating	  conditions.	  The	  interval	  between	  two	  nodes	  (mitoses)	  is	  used	  to	  determine	  the	  cell	  cycle	  time.	  Time	  in	  minutes	  is	  shown	  on	  the	  left	  Y	  axis.	  (B)	  Aggregated	  cell	  cycle	   times	  of	  WT	  and	  KO	  NPCs,	   stratified	  by	  cell	   generation.	  The	  cell	   cycle	   length	  was	  measured	  as	  difference	  in	  time	  (ΔT)	  of	  two	  subsequent	  mitoses	  occurring	  in	  the	  time	  frame	  of	  48	  hours.	  (C)	  Mean	  ±SD	  of	  the	  cell	  cycle	  times	  for	  WT	  and	  KO	  samples	  is	  shown,	  aggregated	  by	  cell	  generation.	  ns	  =	  P>0.05,	  *	  =	  P≤0.05,	  **	  =	  P≤0.01,	  ***	  =	  P≤0.001.	  
	  	  
3.6.4	   Loss	   of	   Jmjd3	   causes	   a	   general	   lengthening	   of	   the	   cell	   cycle	   in	   in	   vitro-­‐cultured,	  
brain-­‐derived	  NPCs	  Some	   recent	   reports	   (Arai	   et	   al.,	   2011;	   Lange	   et	   al.,	   2009)	   demonstrated	   that	   the	  length	   of	   specific	   cell	   phases	   is	   associated	  with	   the	   choice	   between	   symmetric	   and	  asymmetric	  cell	  division	  in	  both	  apical	  and	  basal	  cortical	  progenitors.	  In	  particular,	  in	  apical	   progenitors	   (Pax6+	  NPCs),	   cells	   that	  will	   perform	  a	   symmetric	   self-­‐renewing	  division	  have	  a	  longer	  S	  phase	  (Arai	  et	  al.,	  2011).	  Based	  on	  these	  evidences,	  and	  since	  we	   observed	   that	   Jmjd3	   KO	   NPCs	   have	   both	   a	   preference	   for	   self-­‐renewal	   and	   a	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overall	   longer	   cell	   cycle,	   we	   wondered	   whether	   lack	   of	   Jmjd3	   would	   selectively	  impact	  the	  length	  of	  a	  specific	  phase	  of	  the	  cell	  cycle.	  To	  do	  so,	  we	  exposed	  NPCs	  to	  30’	  of	  EdU	  pulse,	  followed	  by	  EdU	  detection,	  PI	  staining	  and	   FACS	   analysis.	   Since	   in	  vitro	  cultured	  NPCs	   stop	   proliferating	  when	   they	   reach	  high	  confluence,	  the	  cells	  were	  pulsed	  with	  EdU	  48	  hours	  after	  replating,	  when	  they	  are	   still	   in	   exponential	   growth	   phase	   (fig.	   20A).	   As	   indicated	   in	   figure	   21A-­‐B,	   the	  relative	   percentages	   of	   cells	   in	   G1,	   S	   and	   G2	   phases	   in	   Jmjd3	   KO	   NPCs	   were	  comparable	   to	  WT	  NPCs,	   suggesting	   that	   the	  overall	   longer	   cell	   cycle	  uncovered	  by	  the	  time-­‐lapse	  video-­‐microscopy	  analysis	  is	  due	  to	  a	  general	  lengthening	  of	  all	  the	  cell	  cycle	   phases,	   thus	   including	   S-­‐phase.	   Thus,	   despite	   the	   lack	   of	   a	   proportional	  lengthening	   of	   S-­‐phase	   at	   the	   expense	   of	   the	   other	   phases,	   these	   results	   show	   that	  Jmjd3	  KO	  NPCs	  do	  anyway	  have	  a	  longer	  S-­‐phase	  than	  their	  WT	  counterpart,	  which	  in	  turn	  can	  explain	  their	  bias	  towards	  self-­‐renewing	  divisions.	  
	  
Figure	  21.	  Loss	  of	  Jmjd3	  causes	  a	  general	  lengthening	  of	  the	  all	  the	  cell	  cycle	  phases	  in	  in	  vitro-­‐
cultured	  NPCs.	  (A-­‐B)	  Representative	  FACS	  plot	  and	  graphs	  showing	  percentages	  of	  WT	  and	  KO	  NPCs	  in	   G0/G1,	   S	   and	   G2/M	   phases,	   as	   determined	   by	   PI/	   EdU	   detection.	   The	   graphs	   show	  mean	   ±SD	   of	  three	  independent	  biological	  replicates.	  
	   72	  
However,	  a	  careful	  evaluation	  of	  the	  cell	  cycle	  parameters	  in	  vivo	  is	  necessary	  before	  the	   in	   vitro	  observation	   can	   be	   linked	   to	   the	   selective	   expansion	   of	   NPCs	   that	   we	  observe	  in	  the	  VZ	  of	  Jmjd3	  KO	  embryonic	  brains.	  To	  address	  this	  point,	  we	  resorted	  to	  
in	  vivo	  cell	  cycle	  parameters	  analysis	  (§3.7),	  as	  described	  in	  methods	  (§2.5.2).	  	  
3.6.5	  Cyclins	  and	  crucial	  cell	  cycle	  regulators	  are	  not	  affected	  at	  the	  protein	  level	  in	  in	  vitro-­‐cultured	  NPCs	  by	  the	  loss	  of	  Jmjd3	  As	  shown	  above,	  our	  FACS	  analysis	  on	  in	  vitro-­‐cultured	  NPCs	  did	  not	  reveal	  neither	  a	  lengthening	   of	   a	   specific	   cell	   cycle	   phase	   nor	   a	   block	   at	   any	   cell	   cycle	   checkpoint.	  However,	   subtle	   defects	   in	   cell	   cycle	   progressions	  might	   escape	   FACS	   analysis:	   we	  thus	  decided	   to	   assess	   the	   abundance	  of	   critical	   cell	   cycle	   regulators	   at	   the	  protein	  level	  in	  Jmjd3	  KO	  in	  vitro-­‐cultured	  NPCs.	  Cyclins	   regulate	   the	   progression	   of	   the	   eukaryotic	   cell	   cycle	   by	   interacting	   with	  cyclin-­‐dependent	   kinases	   (CdKs)	   and	   alterations	   in	   their	   levels	   are	   associated	   to	  defects	   in	   the	   unwinding	   of	   the	   cell	   cycle.	  We	   thus	   probed	   the	   expression	   level	   of	  cyclins	  associated	   to	  different	  phases	  of	   the	  cell	   cycle:	  cyclin	  D1,	   linked	   to	   the	  G1/S	  transition,	   cyclin	   A,	   which	   is	   present	   during	   S-­‐phase	   progression	   and	   G2/M-­‐phase,	  and	  cyclin	  B1,	  which	   is	  necessary	   for	   the	  completion	  of	  mitosis.	  As	   shown	   in	   figure	  22A,	   and	   consistently	   with	   the	   FACS	   results,	   western	   blot	   reveals	   that	   the	   protein	  level	   of	   these	   cyclins	   is	   not	   altered	   in	   Jmjd3	   KO	   NPCs,	   strengthening	   our	   previous	  observation	  that	  the	   increase	   in	  cell	  cycle	   length	  is	  not	  specific	  of	  a	  given	  phase	  but	  rather	  a	  distributed	  phenomenon.	  p16-­‐Ink4a	  and	  p19-­‐Arf	  are	   two	  proteins	   that	  are	  encoded	  by	   the	  Cdkn2a	   locus	  and	  play	  a	  crucial	  role	   in	  cell	  cycle	  regulation	  by	   inhibiting	  the	  G1/S	  phase	  transition.	   It	  has	  been	  reported	  (Agger	  et	  al.,	  2009)	  that	  Jmjd3	  can	  activate	  the	  Cdkn2a	  locus,	  and	  that	   loss	   of	   Jmjd3	   causes	   an	   acceleration	   of	   the	   cell	   cycle	   progression	   in	  MEFs	   via	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reduced	  expression	  of	  p16	  and	  p19	  and	   faster	  G1/S	   transition.	  This	   effect	   of	   Jmjd3	  loss	  in	  MEFs	  is	  diametrically	  opposed	  to	  the	  one	  we	  observe	  in	  our	  model	  of	  in	  vitro-­‐cultured	  brain-­‐derived	  NPCs.	  This	  apparent	  discrepancy	  is	  most	  likely	  due	  to	  the	  fact	  that	  p16	  and	  p19	  are	  not	  present	  in	  the	  developing	  telencephalon	  VZ,	  as	  reported	  in	  (Bruggeman	  et	   al.,	   2007;	  Molofsky	  et	   al.,	   2005;	  Nishino	  et	   al.,	   2008),	   and	   thus	   their	  expression	  cannot	  be	  further	  downregulated	  by	  the	  lack	  of	  Jmjd3.	  We	  anyway	  wished	  to	   assess	   the	   expression	   level	   of	   p16-­‐Ink4a	   and	  p19-­‐Arf	   in	   the	  E13.5	  brain-­‐derived	  NPCs:	  as	  shown	  in	  figure	  22B,	  western	  blot	  analysis	  reveals	  that	  both	  proteins	  are	  not	  expressed	  in	  WT	  as	  well	  as	  in	  Jmjd3	  KO	  NPC	  protein	  extract,	  supporting	  our	  idea	  of	  a	  Cdkn2a-­‐independent	  function	  of	  Jmjd3	  in	  regulating	  cell	  cycle	  progression.	  
	  
Figure	  22.	  Western	  blot	  analysis	  shows	  that	  the	  level	  of	  cyclins	  and	  crucial	  cell	  cycle	  regulators	  
are	  not	   altered	   in	   Jmjd3	  KO	  brains.	   (A)	  Western	  blot	   for	  Cyclin	  A,	  Cyclin	  B1,	  Cyclin	  D1	  on	  protein	  lysates	  prepared	   from	  E13.5	  WT	  or	   Jmjd3	  KO	  brains	  using	  RIPA	  buffer.	  Vinculin	   is	  used	  as	  a	   loading	  control.	   (A)	  Western	  blot	   for	  p16-­‐Ink4a	   and	  p19-­‐Arf	   on	  protein	   lysates	  prepared	   from	  E13.5	  WT	  or	  Jmjd3	  KO	  brains	  using	  RIPA	  buffer.	  Vinculin	  is	  used	  as	  a	  loading	  control.	  
	  
3.6.6	   Synchronization	   and	   release	   of	   WT	   and	   KO	   NPCs	   shows	   similar	   S-­‐phase	  
progression	  In	  order	  to	  strengthen	  our	  understanding	  of	  the	  kinetics	  of	  S-­‐phase	  in	  Jmjd3	  KO	  NPCs,	  we	  chose	  to	  analyze	  the	  cell	  cycle	  progression	  in	  synchronized	  NPC	  populations	  after	  double	   thymidine	   block	   and	   release.	   Briefly,	   by	   providing	   high	   concentrations	   of	  thymidine,	  cultured	  cells	  can	  be	  blocked	  at	  the	  G1/S	  boundary	  and	  then	  released	  by	  the	  addition	  of	  normal	  growth	  medium:	  two	  such	  blocks	  performed	  in	  sequence	  allow	  to	   obtain	   a	   higher	   level	   of	   synchronization.	  However,	   the	   efficacy	   of	   this	  method	   is	  very	   dependent	   on	   the	   cell	   type	   being	   analyzed:	   it	   is	   indeed	   possible	   that	   some	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particular	  cell	  types	  might	  be	  less	  responsive	  to	  the	  block	  and	  not	  get	  synchronized,	  other	  might	   exhibit	   cell	   death	   due	   to	   thymidine	   toxicity,	   and	   other	   could	   fail	   to	   be	  released	  upon	  thymidine	  withdrawal.	  PI	   staining	   and	   FACS	   analysis	   of	   WT	   and	   KO	   NPCs	   after	   double	   thymidine	   block	  revealed	   that	  95%	  of	   the	  cells	   could	  be	  synchronized,	  but	  50%	  of	   the	  NPCs	  of	  both	  genotypes	  failed	  to	  be	  released	  upon	  thymidine	  withdrawal,	  as	  it	  is	  shown	  by	  the	  G1	  peak	  present	  in	  all	  plots	  in	  figure	  23A	  and	  highlighted	  in	  figure	  23B.	  The	  other	  50%	  of	  cells,	   which	   are	   indistinguishable	   by	   physical	   parameters	   from	   the	   stalled	  subpopulation	   (fig.	   23C),	   proceeded	   through	   cell	   cycle	  with	   similar	   kinetics	   in	  both	  conditions,	  fully	  completing	  S-­‐phase	  by	  5	  hours	  after	  the	  release.	  
	  
Figure	   23.	   WT	   and	   Jmjd3	   KO	   brain-­‐derived	   NPCs	   show	   similar	   cell	   cycle	   progression	   upon	  
release	  after	  double	   thymidine	  block.	  (A)	  FACS	  plots	  showing	  PI	  (FL3-­‐A)	  staining	  of	  WT	  (blue)	  or	  Jmjd3	  KO	  (red)	  in	  vitro-­‐cultured	  NPCs.	  0h	  indicates	  a	  sample	  analyzed	  without	  thymidine	  removal,	  1-­‐6h	   show	   progressive	   entry	   in	   S	   phase	   upon	   release.	   (B)	   Highlighted	   graph	   (5h).	   (C)	   FACS	   plot	   for	  physical	  parameters	  (FSC-­‐H,	  SSC-­‐H)	  of	  the	  5h	  time	  point.	  
	   75	  
Taken	   together,	   these	   results	   show	   that	   the	   cell	   cycle	   progression	   of	   brain-­‐derived	  NPCs	  is	  hampered	  by	  the	  thymidine	  treatment.	  For	  this	  reason,	  and	  since	  this	  lack	  of	  difference	  in	  S-­‐phase	  length	  between	  WT	  and	  KO	  NPCs	  is	  also	  in	  stark	  contrast	  with	  the	   results	   shown	   previously	   on	   in	   vitro-­‐cultured	   NPCs	   and	   also	   with	   the	   in	   vivo	  evidences	   that	   are	   shown	   in	   the	   following	   paragraphs,	   we	   consider	   this	   particular	  experimental	  system	  as	  not	  suitable	  to	  investigate	  differences	  in	  the	  cell	  cycle	  kinetics	  of	  this	  particular	  cell	  type.	  	  
3.7	  VZ	  NPCs	  in	  the	  Jmjd3	  KO	  developing	  brain	  display	  a	  generalized	  lengthening	  of	  the	  
cell	  cycle,	  dependent	  on	  the	  loss	  of	  the	  catalytic	  activity	  of	  Jmjd3	  In	  order	  to	  complement	  the	  observation	  that	  in	  vitro-­‐cultured	  NPCs	  show	  a	  longer	  cell	  cycle	  upon	  Jmjd3	  loss,	  we	  decided	  to	  assess	  the	  cell	  cycle	  parameters	  of	  VZ	  NPCs	  in	  the	   developing	   embryonic	   brain	   in	   vivo.	   Historically,	   cumulative	   BrdU	   labeling	   has	  been	  the	  method	  of	  choice	  to	  perform	  such	  analysis.	  This	  method	  entails	  sequential	  intraperitoneal	   administration	   of	   BrdU	   to	   the	   pregnant	  mouse	   at	   fixed	   intervals	   of	  time,	  tipically	  1.5	  hrs,	  and	  analysis	  of	  the	  BrdU	  incorporation	  levels	  in	  the	  VZ	  cells	  of	  the	   embryonic	   brains:	   a	   BrdU	   saturation	   curve	   can	   then	   be	   plotted	   that	   yields	   the	  desired	   cell	   cycle	   parameters	   (Nowakowski	   et	   al.,	   1989).	   However,	   this	   method	  entails	  the	  use	  of	  a	  high	  number	  of	  animals,	  since	  for	  each	  time	  point	  (tipically	  6-­‐8	  per	  experiment)	  several	  mice	  need	  to	  be	  sacrificed	  in	  order	  to	  obtain	  enough	  embryos	  to	  perform	  a	  meaningful	  statistical	  analysis.	  Recently,	  more	   advanced	  methods	   that	  make	   use	   of	   different	   thymidine	   analogues	  while	   allowing	   a	   dramatic	   reduction	   of	   the	   number	   of	   animals	   needed	   have	   been	  developed	   (Martynoga	  et	   al.,	   2005).	  We	   took	  advantage	  of	   one	   such	  method	   that	   is	  based	  on	  the	  sequential	  administration	  of	  BrdU	  and	  IdU	  to	  the	  same	  pregnant	  mouse.	  As	  described	   in	  detail	   in	  methods	   (§2.5.2),	   the	  differential	   incorporation	  of	   the	   two	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analogs	  can	  be	  used	  to	  mathematically	  reconstruct	  the	  S	  phase	  length	  and,	  based	  on	  the	   warranted	   assumption	   that	   the	   100%	   of	   the	   VZ	   population	   is	   actively	  proliferating,	  the	  total	  cell	  cycle	  length.	  We	   sequentially	   administered	   E13.5	   pregnant	   mice	   with	   IdU	   and	   BrdU,	   and	   by	  analyzing	  their	  incorporation	  in	  Jmjd3	  WT	  or	  KO	  embryonic	  brains,	  we	  found	  that	  the	  length	  of	  both	  S	  phase	  and	  total	  cell	  cycle	  is	  proportionately	  increased	  in	  the	  absence	  of	  Jmjd3	  in	  VZ	  NPCs.	  Importantly,	  we	  were	  able	  to	  rescue	  the	  phenotype	  by	  crossing	  XB814	  mice	  with	  a	  strain	  expressing	  a	  wild	  type	  Jmjd3	  cDNA	  from	  the	  Rosa26	  locus,	  paralleling	  the	  observation	  that	  the	  enzymatic	  activity	  of	  Jmjd3	  is	  necessary	  to	  rescue	  the	  expansion	  of	  Pax6+	  cells	  in	  the	  VZ	  (fig	  24A-­‐B).	  
	  
Figure	   24.	   Loss	   of	   Jmjd3	   causes	   lengthening	   of	   S	   phase	   and	   total	   cell	   cycle	   in	   vivo.	   (A)	  Representative	   immunofluorescences	  of	   IdU	   (green),	  BrdU	   (red),	  DAPI	   (blue)	  of	  E13.5	  VZ	   in	   cortical	  sections	   from	   WT,	   Jmjd3	   KO	   or	   Jmjd3	   KO/R26.Jmjd3	   (rescued)	   mice.	   White	   arrowheads	   indicate	  IdU+/BrdU-­‐	  nuclei,	  which	  have	   exited	   the	   S	  phase	  between	   the	   administration	  of	   IdU	  and	  BrdU.	   (B)	  Graph	   showing	   individual	   Ts	   and	  Tc	   for	   all	   the	   analyzed	   embryos.	   Images	   from	  at	   least	   four	   distinct	  sections	  were	   acquired	   for	   each	   embryo,	   and	  were	   averaged	   before	   plotting	   and	   analysis.	   Each	   dot	  represents	  a	  single	  embryo.	  Mean	  ±SD	  for	  each	  genotype	  is	  also	  included	  in	  the	  graph.	  
In	   order	   to	   assess	   whether	   the	   in	   vitro	   NPC	   experimental	   system	   faithfully	  recapitulates	  the	  in	  vivo	  finding,	  we	  compared	  the	  total	  and	  relative	  length	  of	  the	  total	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cell	   cycle	  and	  of	   the	  S	  phase	   that	  we	  obtained	   from	  E13.5-­‐derived,	   in	  vitro	  cultured	  NPCs	   and	   from	   the	   E13.5	   in	   vivo	   experiments.	   As	   shown	   in	   figure	   25A,	   the	   overall	  ratio	  between	  S-­‐phase	  and	  total	  cell	  cycle	  is	  conserved	  in	  the	  two	  conditions,	  and	  the	  lengthening	  deriving	  from	  the	  loss	  of	  Jmjd3	  is	  similar	  in	  both	  systems.	  This	  confirms	  that	  our	  in	  vitro	  model	  offers	  a	  suitable	  recapitulation	  of	  the	  VZ	  NPC	  features	  to	  study	  alterations	  of	  the	  cell	  cycle	  dynamics.	  
	  
Figure	  25.	  The	  ratio	  between	  S	  phase	  and	  total	  cell	  cycle	  length	  is	  conserved	  among	  in	  vitro	  and	  
in	   vivo	   conditions	   and	   between	   WT	   and	   Jmjd3	   KO	   mice.	   The	   length	   of	   S	   phase	   is	   shown	   as	   a	  percentage	  of	  the	  total	  cell	  cycle	  length.	  The	  ratio	  for	  the	  in	  vitro	  experiments	  is	  extrapolated	  from	  the	  data	  presented	  in	  figure	  15,	  whereas	  the	  ratio	  for	  the	  in	  vivo	  experiments	  is	  extrapolated	  from	  the	  data	  presented	  in	  figure	  18.	  
We	  also	  noted	  that	  both	  S	  phase	  and	  total	  cell	  cycle	  length	  show	  a	  slight	  increase	  in	  the	  in	  vitro	  condition	  over	  the	  in	  vivo,	  an	  observation	  that	  probably	  reflects	  the	  time	  that	  the	  cells	  were	  kept	  in	  culture.	  It	  has	  indeed	  been	  reported	  that	  the	  NPC	  cell	  cycle	  becomes	  longer	  as	  embryonic	  corticogenesis	  proceeds	  and	  that	  this	  phenomenon	  can	  be	   mirrored	   in	   vitro,	   by	   serial	   passaging	   of	   NPCs	   sourced	   from	   cortical	   tissue	  (Hirabayashi	  et	  al.,	  2009).	  The	   fact	   that	   the	   lengthening	   of	   the	   cell	   cycle	   is	   already	   detectable	   at	   E13.5	   is	   of	  particular	   interest.	   Indeed,	   we	   previously	   demonstrated	   that	   the	   phenotype	   of	   VZ	  expansion	   is	   absent	   at	   day	   E13.5	   and	   only	   visible	   starting	   at	   day	   E16.5,	   and	  hypothesized	   that	   this	  might	   be	   due	   to	   the	   fact	   that	   the	   VZ	   expansion	   needs	   to	   be	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accumulated	   over	   time	   in	   order	   to	   be	   statistically	   detectable.	   The	   fact	   that	   the	   cell	  cycle	  lengthening,	  which	  might	  be	  causing	  the	  VZ	  expansion,	  is	  indeed	  present	  before	  the	  appearance	  of	   the	  VZ	  expansion	   supports	  our	   initial	  hypothesis,	  despite	  we	  are	  not	  able	  to	  provide	  a	  formal	  causative	  link	  between	  the	  two	  phenomena	  at	  this	  point.	  	  
3.8	  Generation	  of	  a	  conditional	  Jmjd3	  KO	  strain	  In	   order	   to	  better	  understand	   the	   function	  of	   Jmjd3	   in	  vivo,	  we	  developed	   a	  mouse	  carrying	   a	   conditional	   (floxed)	   Jmjd3	   allele	   (Jmjd3.fl).	   In	   this	  mouse	   line,	   loxP	   sites	  flank	  exons	  2-­‐4,	  which	  contain	  the	  first	  ATG	  of	  the	  Jmjd3	  gene	  (fig.	  26A)	  (see	  methods	  §2.6.6	   for	   details).	   This	   mouse	   was	   obtained	   using	   the	   ‘knockout-­‐first’	   targeting	  strategy	  (Testa	  et	  al.,	  2004a),	  that	  has	  been	  adopted	  by	  the	  EUCOMM	  consortium	  for	  the	   high-­‐throughput	   generation	   of	   versatile	   conditional	   knockout	   mouse	   strains.	  Thanks	  to	  the	  presence	  of	  FRT	  sites	  surrounding	  a	  LacZ-­‐neo	  selection	  cassette	  placed	  in	  an	  intronic	  region,	  followed	  by	  loxP	  sites	  flanking	  an	  exon,	  it	  is	  possible	  to	  flexibly	  generate	   constitutive	   or	   conditional	   mice	   that	   can	   then	   be	   bred	   with	   Cre-­‐deleter	  strains	  that	  allow	  for	  time-­‐	  or	  space-­‐specific	  deletion	  of	  the	  gene	  of	  interest.	  We	  first	  crossed	  the	  Jmjd3-­‐KOfirst	  mice	  with	  an	  Flp	  deleter	  to	  get	  rid	  of	  the	  LacZ-­‐neo	  selection	   cassette	   and	   thus	   obtained	   Jmjd3.fl	   mice.	   When	   crossed	   with	   the	  constitutive	   deleter	   strain	   PGK-­‐Cre,	   homozygous	   mice	   die	   at	   birth,	   mirroring	   the	  perinatal	   lethality	   phenotype	   of	   the	   constitutive	   KO	   XB814	   strain.	   To	   confirm	   the	  abrogation	  of	  protein	  expression	   in	  vivo,	  we	  analyzed	   the	   level	  of	   Jmdj3	  by	  western	  blot	  on	  protein	  lysates	  taken	  from	  Jmjd3.fl/PGK.Cre	  embryos	  at	  developmental	  days	  E13.5	   and	   E16.5,	   confirming	   that	   the	   protein	   is	   absent	   throughout	   neural	  development	  (fig.	  26B).	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Figure	  26.	  The	  Jmjd3	  conditional	  KO	  allele.	  (A)	  Structure	  of	  the	  allele	  after	  Flp	  recombination,	  and	  prior	   to	   Cre	   recombination.	   (B)	   Western	   blot	   showing	   reduced	   levels	   of	   Jmjd3	   protein	   in	  Jmjd3.fl/PGK.Cre	   embryonic	   telencephali,	   at	   days	   E13.5	   and	   E16.5.	   Jmjd3	   is	   detected	   using	   our	   in	  house-­‐developed	  MAb	  (black	  arrow),	  Vinclin	  is	  used	  as	  a	  loading	  control.	  	  
3.8.1	   Constitutive	   deletion	   of	   Jmjd3.fl	   upon	   crossing	  with	   PGK.Cre	   strain	   recapitulates	  
the	  cortical	  phenotype	  of	  XB814	  mice	  but	  to	  a	  slightly	  lesser	  degree	  of	  severity	  After	   confirming	   that	   constitutive	  deletion	   in	  our	   Jmjd3.fl	   conditional	  mouse	   strain,	  by	   crossing	   it	   with	   the	   PGK.Cre	   deleter	   strain,	   recapitulates	   the	   phenotype	   of	  perinatal	  death	  of	  the	  XB814	  constitutive	  Jmjd3	  KO,	  we	  proceeded	  to	  assess	  whether	  the	   cortical	   phenotype	   of	   NPC	   expansion	   was	   reproduced	   as	   well.	   To	   do	   so,	   we	  analyzed	   the	   numbers	   of	   Pax6+	   NPCs	   at	   days	   E16.5	   and	   E18.5	   of	   development	   in	  cortical	   sections	  of	  WT	  and	  KO	  brains.	   Surprisingly	  we	  were	  not	   able	   to	  detect	   any	  increase	   in	   the	   Pax6+	   NPC	   compartment	   at	   day	   E16.5	   at	   any	   level	   along	   the	  rostrocaudal	  axis	  (fig.	  27A).	  E18.5	  Jmjd3	  brains,	  however,	  displayed	  as	  expected	  the	  expansion	  of	  the	  Pax6+	  NPC	  compartment,	  albeit	  at	  a	  lower	  level	  than	  what	  we	  could	  observe	  at	  the	  same	  day	  of	  development	  in	  the	  XB814	  mouse	  model	  (fig.	  27B).	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Figure	   27.	   Jmjd3.fl/PGK.Cre	   embryos	   show	   a	   milder	   phenotype	   than	   XB814	   embryos.	   (A-­‐B)	  Graphs	  show	  total	  numbers	  of	  positive	  cells	  in	  a	  window	  spanning	  the	  entire	  cortex	  and	  50	  um	  wide.	  Graphs	   show	  mean	   ±SD	   of	   three	   biological	   replicates.	   (ns	   =	   P>0.05,	   *	   =	   P≤0.05,	   **	   =	   P≤0.01,	   ***	   =	  P≤0.001)	  	  We	  believe	  that	  this	  discrepancy	  is	  due	  to	  a	  different	  genetic	  background	  in	  the	  two	  mouse	  strains	  XB814	  and	  Jmjd3.fl.	  The	   initial	  XB814	  gene	  trapping	  was	  done	   in	   the	  e14tg2a	   cell	   line	   (129/Ola	   background)	   and	   has	   been	   completely	   backcrossed	   in	  C57BL/6	  background;	  on	  the	  other	  hand,	  the	  Jmjd3.fl	  mice	  were	  also	  initially	  129/Ola	  but	   had	   not	   been	   completely	   backcrossed	   in	   C57/BL6	   at	   the	   time	   that	   the	  experiments	  were	  done.	   It	   is	   indeed	  known	  that	  a	  different	  genetic	  background	  can	  influence	  phenotype	  variability	  in	  mouse	  models	  (Montagutelli,	  2000;	  Nadeau,	  2005;	  Tanabe	  et	  al.,	  2012).	  Taken	  together,	  these	  evidences	  suggest	  that	  lack	  of	  Jmjd3	  is	  able	  to	  cause	  expansion	  of	  the	  NPC	  compartment	  regardless	  of	  the	  different	  genetic	  background	  of	  the	  mouse	  strains	  we	  used.	  However,	  the	  fact	  that	  the	  phenotype	  is	  significantly	  stronger	  in	  the	  XB814	  constitutive	  KO	  suggests	  that	  better	  mechanistic	   insights	  might	  be	  gained	  by	  focusing	  our	  study	  on	  this	  particular	  strain.	  	  	  
	   81	  
3.9	   Transcriptomic	   analysis	   shows	   differences	   between	   WT	   and	   Jmjd3	   KO	   mRNA	  
extracted	  from	  in	  vitro-­‐cultured	  NPCs	  It	  has	  been	  extensively	  demonstrated	   that	   the	  demethylase	  activity	  of	   Jmjd3,	  which	  we	  showed	  to	  be	  responsible	  for	  the	   in	  vivo	  phenotype	  and	  for	  the	  in	  vitro	  cell	  cycle	  lengthening,	   is	   mainly	   directed	   at	   regulating	   the	   dynamics	   of	   H3K27	   methylation,	  eventually	   impacting	   on	   gene	   expression	   levels	   (Agger	   et	   al.,	   2007;	   Burgold	   et	   al.,	  2008;	  Burgold	  et	  al.,	  2012;	  De	  Santa	  et	  al.,	  2009;	  De	  Santa	  et	  al.,	  2007),	  even	  though	  the	  gene	  expression	  deregulation	  is	  usually	  restricted	  to	  small	  subsets	  of	  genes	  that	  are	  context-­‐specific.	  In	  order	  to	  investigate	  the	  mechanisms	  that	  underlie	  the	  NPC	  cell	  cycle	  lengthening	  and	  VZ	  population	  expansion	  in	  the	  absence	  of	  Jmjd3,	  we	  resorted	  to	  transcriptomic	  analysis.	  To	   do	   so,	   we	   extracted	   mRNA	   from	   WT	   and	   Jmjd3	   KO	   in	   vitro-­‐cultured	   NPCs,	   4	  samples	  from	  each	  condition	  (fig.	  28A),	  and	  subjected	  it	   to	  Illumina	  sequencing.	  We	  chose	  RNAseq	  over	  microarray	  technology	  since	  RNAseq	  allows	  for	  the	  discovery	  of	  uncharacterized	   transcripts,	  and	  we	  wished	   to	  keep	  an	  explorative	  approach	   in	  our	  transcriptional	   analysis	   rather	   than	   focusing	   on	   the	   limited	   number	   of	   targets	   that	  microarray	   technology	   allows.	   RNAseq	   has	   also	   the	   advantage	   of	   delivering	   a	   low	  background	   signal	   while	   allowing	   for	   the	   quantification	   of	   transcripts	   over	   a	   high	  dynamic	  range,	  thus	  facilitating	  the	  discovery	  of	  subtle	  differences	  in	  gene	  expression	  between	  conditions.	  We	  decided	  to	  prepare	  “stranded”	  libraries,	  which	  retain	  strand-­‐of-­‐origin	  information	  with	  high	  accuracy	  and	  avoid	  confusion	  during	  sequence	  analysis	  and	  data	  alignment	  deriving	  from	  the	  presence	  of	  both	  direct	  and	  reverse	  reads.	  We	  obtained	  an	  average	  of	  55	  million	  reads	  from	  each	  of	   the	  4	  WT	  and	  4	  Jmjd3	  KO	  samples	   (fig.	   28A),	   and	   aligned	   them	   to	   the	   mouse	   transcriptome	   (mm9)	   using	  TopHat,	   as	  detailed	   in	  methods	  §2.3.1.	  We	   then	  quantified	   the	   reads	   and	  estimated	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differential	  gene	  expression	  using	  Cufflinks.	  Thanks	  to	  this	  approach,	  we	  were	  able	  to	  identify	  117	  genes	  that	  are	  differentially	  expressed	  between	  WT	  and	  KO	  samples,	  as	  shown	  in	  figure	  28B.	  
	  
Figure	   28.	   Transcriptomic	   analysis	   of	   WT	   or	   Jmjd3	   KO	   in	   vitro-­‐cultured	   NPCs	   identifies	   117	  
differentially	   expressed	   genes	   (DEG).	   (A)	   4	  WT	   and	   4	   KO	   samples	  were	   analyzed,	   the	   histogram	  shows	   the	   total	   number	   of	   reads	   obtained	   for	   each	   sample.	   70	   million	   reads	   (dashed	   lines)	   were	  expected	  based	  on	  flow	  cell	  loading.	  (B)	  Scatterplot	  showing	  the	  averaged	  expression	  level	  of	  all	  read	  mapped	  to	  a	  RefSeq	  annotated	  gene.	  Red	  dots	  represent	  DEGs.	  	  
3.9.1	  Bioinformatics	  analysis	  highlights	  enrichment	  of	  DEGs	  among	  pathways	  relevant	  
to	  the	  phenotype	  of	  NPC	  expansion	  and	  cell	  cycle	  lengthening	  We	   then	   took	   advantage	   of	   the	   IPA	   software	  package	   to	   understand	  whether	   there	  was	  an	  enrichment	  of	  the	  differentially	  expressed	  genes	  among	  particular	  pathways	  or	   gene	   functions,	   and	   we	   found	   several	   interesting	   candidate	   pathways	   that	   are	  relevant	   to	   the	   phenotype	   of	   NPC	   expansion	   (fig.	   29A-­‐B):	   TR-­‐RXR	   (retinoic	   acid	  receptor)	  activation,	  Wnt/B-­‐catenin,	  Glycolysis,	  Axon	  Guidance,	  ES	  pluripotency	  and	  Notch	   signaling.	   It	   is	   of	   particular	   interest	   that	   we	   found	   upregulation	   in	   genes	  belonging	   to	   the	   Wnt/B-­‐catenin	   and	   the	   Notch	   pathways,	   which	   are	   involved	   in	  defining	  the	  symmetry	  of	  NPC	  cell	  division	  in	  the	  VZ.	  It	  has	  indeed	  been	  shown	  that	  high	  levels	  of	  Notch	  signaling	  inhibit	  neural	  differentiation	  (Lui	  et	  al.,	  2011)	  and	  Wnt	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signaling	  has	  also	  been	  shown	  to	   increase	   the	  self-­‐renewal	  potential	  of	  neural	  stem	  cells	  (Kalani	  et	  al.,	  2008;	  Pei	  et	  al.,	  2012;	  Piccin	  and	  Morshead,	  2011).	  Thus,	  we	  hypothesize	   that	   the	   in	  vivo	   expansion	  of	   the	  NPC	  population	  observed	   in	  Jmjd3	  KO	  embryonic	  cortices	  might	  be	  linked	  to	  the	  alterations	  in	  the	  expression	  level	  of	   genes	  belonging	   to	   these	   two	  pathways,	  which	   causes	   the	  NPCs	   to	  preferentially	  undergo	  self-­‐renewal	  rather	  than	  neural	  differentiation.	  We	  also	  found	  an	  enrichment	  of	   downregulated	   genes	   in	   the	   “Axon	   Guidance”	   pathway,	   whose	   upregulation	   is	  usually	  associated	  with	   the	  process	  of	  neurogenic	  differentiation.	  We	  reasoned	   that	  the	  fact	  that	  genes	  involved	  in	  the	  definition	  of	  neuronal	  identity	  are	  less	  expressed	  in	  absence	  of	   Jmjd3	  already	   in	   the	  NPC	  state	  might	  reflect	  a	   reduced	  proneness	  of	   the	  Jmjd3	   KO	   NPCs	   to	   differentiate	   into	   neurons.	   This	   speculation	   parallels	   the	   in	   vivo	  observation	  that	  the	  neuronal	  production	  is	  reduced	  in	  the	  absence	  of	  Jmjd3	  during	  the	  early	  stages	  of	  corticogenesis.	  
	  
Figure	  29.	  Ingenuity	  Pathway	  Analysis	  highlights	  enrichment	  of	  DEGs	  among	  pathways	  relevant	  
to	   the	  phenotype	  of	  NPC	  expansion	  and	  cell	  cycle	   lengthening.	  (A)	  Histogram	  showing	  pathways	  selected	   among	   the	  most	   enriched	   ones,	   -­‐log(p-­‐value)	   is	   indicated.	   (B)	   Genes	   belonging	   to	   the	  most	  enriched	   pathways	   are	   shown	   for	   each	   pathway,	   together	  with	   the	   degree	   of	   upregulation	   (red)	   or	  downregulation	  (green).	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Surprisingly,	   despite	   the	   abundance	   of	   in	  vivo	   and	   in	  vitro	   evidences	   corroborating	  the	  observation	  that	   lack	  of	   Jmjd3	  causes	  a	  general	   lengthening	  of	   the	  cell	  cycle,	  we	  were	  not	  able	  to	  detect	  an	  enrichment	  of	  DEGs	  in	  pathways	  relevant	  to	  the	  cell	  cycle	  progression.	  However,	  we	  found	  an	  upregulation	   in	  genes	   involved	   in	  the	  glycolysis	  pathway,	   together	   with	   a	   pronounced	   downregulation	   of	   Atp5g1	   (-­‐1.44	   Log2FC),	   a	  gene	   encoding	   for	   a	   subunit	   of	   the	  mitochondrial	   ATP	   synthase	   machinery.	   Taken	  together,	   these	   data	  might	   suggest	   that	   there	   is	   a	   reduction	   in	   the	   phosphorylative	  oxidation	   capacity	   of	   Jmjd3	   KO	   cells	   followed	   by	   an	   upregulation	   of	   the	   anaerobic	  glycolysis	   pathway.	   In	   turn,	   this	   general	   metabolic	   alteration	   might	   be	   causatively	  linked	  to	  the	  general	  lengthening	  of	  the	  cell	  cycle	  that	  we	  observed	  in	  vivo	  and	  in	  vitro	  in	  the	  absence	  of	  Jmjd3.	  
	  
3.9.2	   Integration	   of	   RNAseq	   data	   with	   publicly	   available	   Jmjd3	   and	   H3K27	   ChIPseq	  
profiles	  identifies	  a	  subset	  of	  putative	  direct	  Jmjd3	  targets	  RNAseq	  analysis	  has	  helped	  us	  in	  defining	  the	  molecular	  consequences	  of	  the	  loss	  of	  Jmjd3,	   and	   in	   generating	  mechanistic	   hypotheses	  on	  how	   they	  underlie	   the	   cortical	  phenotype	  that	  I	  described	  in	  the	  previous	  paragraphs.	  However,	  the	  direct	  targets	  of	  Jmjd3	  are	  most	  likely	  only	  a	  subset	  of	  all	  the	  genes	  that	  show	  differential	  expression,	  while	   the	   others	   represent	   secondary	   targets.	   In	   order	   to	   precisely	   pinpoint	   the	  mechanism	  of	  action	  of	  Jmjd3	  in	  our	  system	  and	  to	  discern	  the	  direct	  targets	  of	  Jmjd3,	  we	   complemented	   our	   RNAseq	   analysis	   with	   publicly	   available	   datasets	   of	   Jmjd3	  binding	   (Estarás	   et	   al.,	   2012)	   and	   H3K27me3	   distribution	   (Burney	   et	   al.,	   2013),	  obtained	  from	  WT	  mouse	  NPCs.	  We	  reasoned	  that	  a	  gene,	  in	  order	  to	  be	  considered	  a	  direct	  target	  of	  Jmjd3,	  should	  display:	  a)	  reduced	  mRNA	  expression	  in	  Jmjd3	  KO	  NPCs,	  b)	  Jmjd3	  binding	  in	  WT	  NPCs,	  c)	  no	  or	  reduced	  H3K27me3	  levels	  in	  WT	  NPCs.	  Based	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on	  these	  criteria,	  we	  were	  able	  to	  identify	  a	  subset	  of	  13	  genes	  which	  might	  be	  direct	  targets	  of	  Jmjd3	  in	  NPCs	  (fig.	  30).	  
	  
Figure	   30.	   Identification	   of	   putative	   Jmjd3	   targets.	   Venn	   diagram	   showing	   the	   subset	   of	   genes,	  among	   those	   found	   downregulated	   in	   Jmdj3	   KO	   NPCs	   (red),	   that	   were	   found	   bound	   by	   Jmjd3	   in	   a	  published	  study	  (green)	  (REF).	  Genes	  that	  displayed	  high	  levels	  of	  H3K27	  (ref)	  are	  shown	  in	  blue,	  and	  do	  not	  overlap	  with	  the	  possible	  targets	  of	  Jmjd3.	  
3.9.3	   Transcriptomic	   analysis	   of	   E16.5	   cortical	   tissue	   reveals	   minor	   overlap	   with	   in	  
vitro-­‐cultured	  NPCs	  We	   next	   wanted	   to	   assess	   the	   transcriptional	   effects	   of	   loss	   of	   Jmjd3	   on	   the	  developing	  neocortex.	  To	  do	  so,	  we	  extracted	  mRNA	  from	  whole	  forebrains	  of	  WT	  and	  Jmjd3	   KO	   E16.5	   embryos,	   and	   subjected	   them	   to	   RNA	   sequencing.	   We	   decided	   to	  extract	  mRNA	   from	  whole	   forebrains	   in	  order	   to	  obtain	  high	  yields	  of	  material	   in	  a	  streamlined	   manner,	   and	   to	   avoid	   more	   selective	   techniques	   like	   laser-­‐capture	  microdissection	   and	   FACS	   sorting,	   which	   can	   worsen	   RNA	   quality	   and	   yield.	   After	  bioinformatics	  analysis	  we	  were	  able	  to	  detect	  differential	  expression	  for	  19	  genes,	  4	  of	   which	   are	   shared	   between	   the	   in	   vivo	   and	   the	   in	   vitro	   samples	   (Lars2,	   Rsad1,	  Atp5g1,	  and	  Jmjd3).	  Two	   of	   these	   targets,	   Lars2	   and	   Rsad1,	   are	   poorly	   characterized	   nuclear-­‐encoded,	  mitochondrial	   proteins	   with	   a	   role	   in	   aminoacylation	   of	   mitochondrial	   tRNALeu	   (Li	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and	  Guan,	  2010)	  and	  an	  uncharacterized	  role,	  respectively.	  As	  stated	  above,	  Atp5g1	  encodes	   for	   a	   subunit	   of	   the	   mitochondrial	   ATP	   synthase	   machinery:	   the	   fact	   that	  mitochondrial	  genes	  are	  significantly	  enriched	  among	  the	  common	  DEGs	  found	  in	  in	  
vitro	   and	   in	   vivo	   samples	   reinforces	   our	   previous	   hypothesis	   that	   a	   general	  disregulation	   of	   mitochondrial	   function	   might	   be	   linked	   to	   the	   observed	   general	  lengthening	  of	  the	  cell	  cycle	  in	  Jmjd3	  KO	  NPCs.	  This	  degree	  of	  correlation	  could	  be	  explained	  by	  the	  relative	  low	  abundance	  of	  NPCs	  with	  respect	  to	  the	  whole	  telencephalon	  at	  day	  E16.5,	  which	  might	  cause	  differences	  in	  gene	  expression	  levels	  to	  be	  diluted	  to	  the	  point	  of	  becoming	  undetectable.	  In	  order	  to	   address	   this	   issue,	   we	   are	   trying	   to	   isolate	   NPCs	   from	   embryonic	   brains	   using	  fluorescent	   antibodies	   against	   Pax6	   coupled	   to	   FACS	   sorting.	   This	   method	   has	   the	  drawback	  that	  cells	  need	  to	  be	  fixed	  and	  permeabilized	  for	  the	  antibody	  to	  access	  the	  antigen	   in	   the	  nucleus,	   causing	   reduction	   in	   yield	   and	  quality	   of	   the	   resulting	  RNA.	  Nonetheless,	  we	  were	  able	  to	  set	  up	  an	  intracellular	  staining	  protocol	  to	  consistently	  isolate	   NPCs	   from	   other	   cell	   types,	   and	   to	   obtain	   total	   RNA	   that,	   despite	   its	   low	  integrity	   (RIN	   3±0.42	   as	   measured	   by	   Agilent	   Bioanalyzer),	   can	   be	   used	   to	   create	  RNAseq	  libraries	  using	  an	  adapted	  protocol	  (fig.	  31A-­‐B).	  
	  
Figure	  31.	  FACS-­‐based	  strategy	  to	  isolate	  RNA	  from	  freshly-­‐derived	  cortical	  NPCs.	  (A)	  FACS	  plots	  showing	   specific	   staining	   using	   a	   Pax6-­‐488	   primary	   conjugated	   antibody	   on	   single-­‐cell	   suspension	  derived	   from	   E15.5	   cortical	   tissue.	   (B)	   Histograms	   showing	   the	   RNA	   integrity	   number	   (RIN)	   as	  determined	  by	  the	  Agilent	  Bioanalyzer	  (left)	  and	  the	  total	  yield	  of	  RNA	  in	  μg	  (right)	  for	  each	  step	  of	  the	  protocol.	  Protocol	  steps:	  green	  =	  fresh	  single	  cell	  suspension;	  light	  blue	  =	  after	  methanol	  fixation;	  dark	  blue	  =	  after	  antibody	  staining;	  purple	  =	  after	  a	  long	  incubation	  mimicking	  FACS	  processing.	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As	  a	  more	  suitable	  alternative,	  we	  are	  currently	  testing	  a	  fluorescent	  small	  molecule,	  CDr3	  (Yun	  et	  al.,	  2012),	  which	  is	  able	  to	  selectively	  stain	  live	  NPCs	  without	  the	  need	  for	  fixation	  and	  permeabilization,	  in	  virtue	  of	  its	  ability	  to	  bind	  BLBP,	  a	  protein	  that	  is	  characteristic	  of	  embryonic	  NPCs.	  	  
3.10	  Generation	  of	  a	  mouse	  strain	  harboring	  a	  Jmjd3-­‐Venus	  fusion	  protein	  ChIP	   approaches	   to	   evaluate	   chromatin	   binding	   of	   transcription	   can	   be	   heavily	  influenced	   by	   the	   quality	   of	   the	   antibodies	   used.	   All	   the	   commercial	   anti-­‐Jmjd3	  antibodies	   that	   we	   tested	   perform	   poorly	   in	   IP,	   and	   also	   our	   in	   house-­‐developed	  monoclonal	   antibodies	   did	   not	   yield	   reliable	   results	   when	   tested	   in	   simple	   IP	  applications.	   The	   use	   of	   tagged	   constructs	   to	   transfect	   or	   transduce	   the	   target	   cell	  population	  can	  solve	  the	  need	  for	  an	  antigen-­‐specific	  antibody,	  as	  anti-­‐tag	  antibodies	  are	   optimized	   for	   these	   applications:	   however,	   the	   abundance	   of	   the	   fused	   protein	  cannot	   be	   easily	   controlled	   by	   transduction	   of	   transfection,	   leading	   to	   situations	   of	  over-­‐	   or	   under-­‐abundance	   of	   the	   tagged	   protein	   with	   respect	   to	   its	   wild	   type	  counterpart.	  In	  these	  cases,	  false	  positive	  or	  false	  negatives	  can	  be	  easily	  generated	  in	  high-­‐throughput	   applications	   such	   as	   ChIPseq,	   and	   the	   targets	   need	   anyway	   to	   be	  validated	  using	  an	  anti-­‐antigen	  antibody.	  In	  order	  to	  circumvent	  these	  limitations,	  we	  generated	  a	  mouse	  line	  harboring	  a	  BAC	  containing	  the	  whole	  genomic	  region	  of	  Jmjd3,	  and	  a	  Venus	  fluorescent	  protein	  tag	  at	  the	  C-­‐terminal	  of	  Jmjd3	  (see	  methods	  §2.6.7)	  (fig.	  32A)	  (Choo	  et	  al.,	  2011;	  Ciotta	  et	  al.,	  2011).	  The	  presence	  of	  the	  whole	  genomic	  region	  allows	  for	  a	  physiological	  control	  of	  gene	  expression,	  such	  that	  the	  level	  of	  the	  fused	  protein	  should	  always	  mirror	  that	  of	  the	   wild	   type	   protein.	   The	   Venus	   tag	   represents	   a	   suitable	   substrate	   for	   IP	  applications	   (Ciotta	   et	   al.,	   2011;	   Hofemeister	   et	   al.,	   2011),	   and	   it	   moreover	   allows	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detecting	   the	   distribution	   of	   the	   protein	   in	   fluorescence	   microscopy	   applications,	  both	  live	  through	  direct	  fluorescence	  and	  on	  fixed	  tissues	  by	  indirect	  fluorescence.	  After	   several	   rounds	   of	   nuclear	   microinjection,	   we	   were	   able	   to	   obtain	   a	   single	  founder	   female	  (fig.	  32B),	  which	  has	  recently	  given	  birth	   to	  generation	  F1.	  Once	  the	  colony	   has	   been	   established,	  we	  will	   derive	  NPCs	   from	  E13.5	   telencephali	   and	  will	  perform	  ChIPseq	  analysis	  to	  complement	  the	  RNAseq	  data.	  
	  
Figure	  32.	  Generation	  of	  the	  Jmjd3.Venus	  mouse	  strain.	  (A)	  Diagram	  showing	  the	  structure	  of	  the	  fusion	   protein	   harbored	   in	   the	  modified	   BAC	   that	   was	   used	   to	   generate	   the	  mouse	   strain.	   (B)	   PCR	  showing	   the	   presence	   of	   the	   band	   corresponding	   to	   the	   Venus	   CDS	   (obtained	   with	   the	   primers	  VENfw01,	  VENrv01)	  in	  mouse	  #889.	  Diluted	  purified	  BAC	  is	  used	  as	  a	  positive	  control.	  	  
3.10.1	  Derivation	  of	  NPCs	  from	  mouse	  ES	  cells	  harboring	  a	  human	  Jmjd3-­‐Venus	  fusion	  
protein	  Furthermore,	  we	  obtained	  from	  a	  collaborating	  group	  mouse	  ES	  cells	  that	  have	  been	  engineered	   to	   express	   a	   human	   Jmjd3-­‐Venus	   fusion	   protein	   from	   a	  BAC	   containing	  the	  whole	   locus	   control	   region.	  The	  absence	  of	   a	  murine	  genomic	   context,	  with	   the	  proper	   enhancer	   and	   promoter	   sequences,	   does	   not	   guarantee	   that	   physiologically	  dynamic	   expression	   levels	   are	   reached	   during	   differentiation	   processes,	   but	   the	  mouse	  and	  the	  human	  Jmjd3	  orthologs	  share	  98%	  aminoacid	  identity,	  suggesting	  that	  the	  binding	  preferences	  should	  anyway	  be	  comparable.	  We	   first	   assessed	   the	   cellular	   distribution	   of	   the	   Jmjd3.Venus	   fusion	   protein	   by	  immunofluorescence	   in	  ES	  cell	   cultures.	  As	   shown	   in	   figure,	   Jmjd3.Venus	  displays	  a	  nuclear	   localization	   and	   is	   excluded	   from	   nucleoli.	   Some	   cells	   show	   low	   to	  undetectable	   levels	   of	   fluorescence,	   suggesting	   heterogeneous	   expression	   of	   the	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fusion	  protein	  in	  the	  ES	  cell	  population	  (fig.	  33A).	  Moreover,	  by	  the	  use	  of	  a	  dual	  color	  fluorescence	  western	  blotting	  system	  we	  were	  able	  to	  confirm	  that	  the	  fusion	  protein	  is	  indeed	  reactive	  to	  both	  anti-­‐Jmjd3	  and	  anti-­‐Venus	  antibody	  (fig.	  33B).	  
	  
Figure	   33.	   Detection	   of	   the	   hJmjd3.Venus	   fusion	   protein	   in	   mouse	   ESCs.	   (A)	   Confocal	  immunofluorescence	   image	   showing	   indirect	   detection	   (via	   an	   anti	   C-­‐YFP	   antibody)	   of	   the	  hJmjd3.Venus	  fusion	  protein	  (green).	  DAPI	  (blue)	  and	  Phalloidin-­‐TRITC	  (red)	  are	  used	  as	  nuclear	  and	  cytoplasmic	   counterstain,	   respectively.	   (B)	   Dual-­‐color	   immunofluorescence	   WB	   showing	   co-­‐occurrence	  of	  the	  Jmjd3	  and	  Venus	  signal	  in	  ESC	  lysate.	  The	  two	  images	  are	  shown	  in	  black	  and	  white	  for	  clarity.	  We	  differentiated	  the	  Jmjd3.Venus	  ES	  cells	  into	  Pax6+	  NPCs	  by	  taking	  advantage	  of	  a	  previously	   published	   protocol(Bibel	   et	   al.,	   2007),	   and	  we	   are	   currently	   performing	  ChIP	  using	  an	  anti-­‐Venus	  antibody	  in	  order	  to	  gain	  information	  about	  the	  chromatin	  distribution	  of	  Jmjd3	  in	  NPCs.	  	  
3.11	  Jmjd3	  binds	  to	  the	  Dlx2	  promoter	  in	  an	  in	  vitro	  model	  of	  adult	  neurogenesis	  The	  H3K4	  methyltransferase	  Mixed-­‐lineage	  leukemia	  1	  (Mll1)	  has	  been	  shown	  to	  be	  necessary	   for	   adult	   neurogenesis,	   in	   virtue	   of	   its	   role	   in	   the	   activation	   of	   genes	  necessary	  for	  the	  unwinding	  of	  the	  neurogenic	  program	  (Lim	  et	  al.,	  2009).	  Dlx2	  is	  a	  key	   regulator	   of	   adult	   SVZ	   neurogenesis:	   in	   the	   undifferentiated	   state,	   the	   Dlx2	  promoter	   is	   bivalently	   marked	   by	   both	   H3K4me3	   and	   H3K27me3,	   and	   is	   hence	  transcriptionally	  silent	  but	  poised	  for	  activation.	  Lim	  and	  coworkers	  have	  observed	  in	  in	   vitro-­‐cultured	   SVZ	   RGCs	   that	   Dlx2	   shows	   high	   levels	   of	   H3K4me3	   and	   low	  H3K27me3	   on	   the	   promoter	   region	   upon	   differentiation,	   and	   that	   lack	   of	   Mll1	  prevents	   the	   expression	   of	  Dlx2,	   hampering	   neuronal	   production.	   Interestingly,	   the	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loss	  of	  Mll1	  does	  not	  affect	  the	  levels	  of	  H3K4	  but	  rather	  prevents	  demethylation	  of	  H3K27,	  and	  the	  authors	  hypothesize	  that	  Mll1	  recruits	  a	  H3K27	  demethylase	  during	  the	  differentiation	  process	  to	  allow	  activation	  of	  the	  Dlx2	  locus.	  We	  established	  a	  collaboration	  with	   the	   lab	  of	  Daniel	  Lim	   in	  order	   to	  provide	  proof	  that	  Jmjd3	  is	  selectively	  recruited	  on	  the	  Dlx2	  locus	  upon	  differentiation	  of	  adult	  SVZ	  RGCs,	   and	   to	   demonstrate	   that	   Jmjd3	   is	   indeed	   recruited	   by	   Mll1	   to	   allow	  transcriptional	   activation	   of	   Dlx2.	   Using	   the	   same	   system	   of	   adult	   SVZ	   RGC	  differentiation,	  we	  analyzed	  by	  ChIP-­‐qPCR	  the	  dynamics	  of	  the	  binding	  of	  Jmjd3	  at	  the	  Dlx2	   promoter	   upon	   differentiation,	   and	   compared	   it	   to	   the	   Hoxa2	   and	   Olig2	  promoters	   as	   a	   control:	   we	   found	   that	   Jmjd3	   is	   selectively	   increased	   at	   the	   Dlx2	  promoter	  with	  respect	  to	  the	  controls,	  supporting	  a	  role	   for	   Jmjd3	  in	  the	  process	  of	  adult	  neurogenesis	  (fig.	  34).	  
	  
Figure	   34.	   Jmjd3	   is	   enriched	   at	   the	   Dlx2	   promoter	   in	   an	   in	   vitro	   model	   of	   adult	   SVZ	  
neurogenesis.	  Histograms	  show	  that	  Jmjd3	  is	  enriched	  at	  the	  Dlx2	  promoter	  (Dlx2_60,	  Dlx2_82)	  but	  not	  at	   the	  Olig2	  and	  HoxA2	  promoters.	   IPs	  were	  performed	   in	   triplicates	  per	  each	   time	  point,	   and	  a	  single	  mock	  IP	  is	  used	  as	  a	  control.	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Our	   experiments	   have	   then	   contributed	   to	   a	   paper	   by	   the	   Lim	   lab	   that	   has	   been	  recently	  published	  in	  Cell	  Reports	  (Park	  et	  al.,	  2014).	  	   	  
	   92	  
4	  DISCUSSION	  	  In	  this	  thesis,	  I	  define	  a	  role	  for	  Jmjd3	  in	  regulating	  cell	  cycle	  progression	  and	  the	  rate	  of	   self-­‐renewing	   versus	   differentiating	   divisions	   in	   the	   ventricular	   zone	   neural	  progenitor	  cells	  of	  the	  developing	  mouse	  neocortex.	  Loss	  of	  Jmjd3	  causes	  VZ	  NPCs	  to	  lengthen	   their	   cell	   cycle	   and	   preferentially	   undergo	   self-­‐renewing	   cell	   divisions,	  resulting	   in	   an	   aberrantly	   expanded	   ventricular	   zone	   and	   a	   reduced	   number	   of	  differentiated	  neurons	  in	  the	  cortical	  plate.	  I	  propose	  that	  this	  phenotype	  is	  linked	  to	  the	   supraphysiological	   activation	   of	   the	   Wnt/B-­‐catenin	   and	   Notch	   pathways,	   two	  known	   regulators	   of	   the	   choice	   between	   self-­‐renewal	   and	   differentiation	   in	   the	   VZ	  NPCs	  of	   the	  developing	  brains,	  whose	  hyperactivation	  has	  been	  demonstrated	  to	  be	  associated	  with	  an	  increased	  proliferative	  potential.	  	  Histone-­‐modifying	   proteins,	   including	   histone	   methyltransferases	   and	   histone	  demethylases,	   have	   been	   demonstrated	   to	   play	   a	   role	   in	   cell	   state	   transitions	   and	  developmental	  processes,	   in	  virtue	  of	   their	  ability	   to	  participate	   in	   the	  activation	  or	  repression	  of	   lineage-­‐specific	  genes.	   Jmjd3,	   in	  particular,	  has	  been	  shown	  by	  us	  and	  by	  others	  to	  have	  a	  role	  in	  enabling	  cellular	  differentiation	  along	  the	  neural	   lineage,	  beyond	   other	   roles	   in	   osteoblast	   differentiation,	  macrophage	   activation,	   Hox	   genes	  activation	  and	  transcriptional	  regulation	  of	  the	  Cdkn2a	  locus.	  Based	  on	   these	   lines	  of	   evidence,	   the	   initial	   aim	  of	  our	  work	  was	   to	   investigate	   the	  specific	   role	   of	   Jmjd3	   in	   the	   cell	   state	   transitions	   that	   allow	   the	   stem	   cells	   of	   the	  developing	   neocortex,	   or	   radial	   glial	   cells,	   to	   give	   rise	   to	   the	   different	   subtypes	   of	  neurons.	  By	  taking	  advantage	  of	  the	  XB814	  loss-­‐of-­‐function	  mouse	  strain,	  previously	  published	  by	  our	  lab	  (Burgold	  et	  al.,	  2012),	  we	  were	  able	  to	  score	  abnormalities	  in	  the	  developing	  neocortex	  of	  mouse	  embryos	   lacking	   Jmjd3.	   In	  particular,	  we	  noted	   that	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Jmjd3	  KO	   embryos	   showed	   a	   higher	   number	   of	   VZ	  NPCs	   and	   a	   reduced	   number	   of	  differentiated	   neurons,	   and	   that	   this	   phenotype	   was	   detectable	   only	   at	   late	   time	  points	  in	  development,	  at	  day	  E16.5	  or	  later.	  This	  observation	  can	  easily	  be	  reconciled	  with	  our	   initial	  hypothesis	  that	  Jmjd3	  is	  necessary	  for	  the	  differentiation	  of	  NPCs	  to	  neurons.	   When	   we	   characterized	   specifically	   the	   NPC	   population	   of	   Jmdj3	   KO	  embryos	   in	  vivo	  by	  EdU/Ki67	  staining,	  we	   found	   that	   these	  cells	  are	  more	  prone	   to	  undergo	   self-­‐renewing	   rather	   than	   differentiating	   divisions,	   suggesting	   that	   the	  neural	  differentiation	  program	  is	  indeed	  affected	  by	  the	  loss	  of	  Jmjd3.	  Our	  model	  so	  far	  would	  thus	  entail	  that	  the	  differentiation	  of	  NPCs	  is	  specifically	  hampered	  by	  the	  loss	  of	  Jmjd3,	  but	  the	  stem	  cell	  state	  in	  itself	  should	  not	  be	  affected.	  The	  observation	  of	  in	  vivo	  systems	  allows	  to	  analyze	  biological	  processes	  as	  a	  whole,	  and	  to	  assess	  the	  role	  of	  a	  specific	  factor	  in	  its	  physiological	  environment,	  without	  the	  potential	   artifacts	   that	   derive	   from	   the	   use	   of	   in	  vitro	  models.	   However,	   the	   use	   of	  cellular	  in	  vitro	  models,	  which	  are	  inherently	  reductionist,	  can	  help	  in	  dissecting	  the	  role	  of	  a	   target	   factor	   in	  a	  specific	  cellular	  context	  whose	  boundaries	  would	  appear	  blurred	  when	  analyzed	  in	  vivo.	  To	   characterize	   in	   detail	   the	   NPC	   population,	   we	   resorted	   to	   in	   vitro	   time-­‐lapse	  videomicroscopy.	   This	   technique	   allowed	   us	   to	   analyze	   the	   behavior	   of	   a	   pure	  population	   of	   NPCs	   derived	   from	   the	   E13.5	   embryonic	   brain,	   and	   to	   track	   their	  mitotic	   choices	   at	   the	   single-­‐cell	   level	   over	   a	   period	   of	   several	   days.	  We	  were	   also	  able,	   by	  modulating	   the	   availability	   of	   the	  mitotic	   factor	   bFGF,	   to	   selectively	   grow	  them	   in	   self-­‐renewing	   (high	   bFGF)	   or	   differentiative	   (no	   bFGF)	   conditions,	   and	   to	  assess	  the	  effect	  of	  the	  role	  of	  Jmjd3	  specific	  to	  each	  of	  these	  two	  conditions.	  Intriguingly,	  we	  found	  that	  loss	  of	  Jmdj3	  specifically	  affects	  the	  cell	  cycle	  behavior	  of	  NPCs	   when	   they	   are	   kept	   in	   strict	   proliferative	   conditions.	   Indeed,	   repeated	  experiments	  showed	  Jmjd3	  KO	  NPCs	  have	  a	  significantly	   longer	  cell	  cycle	   time	  than	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their	  WT	  counterpart,	  and	  that	  this	  is	  caused	  by	  a	  generalized	  lengthening	  of	  all	  the	  cell	  cycle	  phases.	  We	  then	  sought	  to	  parallel	  this	  observation	  in	  vivo,	  and	  by	  the	  use	  of	  multiple	   thymidine	   analogues	   to	  mark	   cells	   in	   S-­‐phase	   in	   the	   VZ,	   we	  were	   able	   to	  confirm	  that	  loss	  of	  Jmdj3	  caused	  cell	  cycle	  lengthening	  also	  in	  an	  in	  vivo	  context.	  This	  observation	  moved	   the	   focus	   of	   our	   analysis	   from	   the	   cell	   state	   transition	  between	  NPCs	  and	  neurons,	  to	  the	  maintenance	  of	  the	  neural	  stem	  cell	  state	  itself.	  	  The	  fact	  that	  Jmjd3	  KO	  NPCs	  show	  both	  a	  longer	  cell	  cycle	  together	  and	  an	  increased	  propensity	  to	  undergo	  self-­‐renewal	  is	  of	  particular	  interest.	  It	  has	  indeed	  been	  shown	  that	  self-­‐renewing	  and	  differentiating	  VZ	  NPC	  populations	  show	  differential	  length	  in	  specific	   cell	   cycle	  phases.	  No	  detailed	  mechanistic	  explanations	  have	  been	  provided	  for	   these	   phenomena:	   however,	   the	   “cell-­‐cycle	   length	   hypothesis”	   suggests	   that	   in	  general,	   a	   longer	   cell	   cycle	   is	   associated	   to	   a	   differentiating	   behavior,	   and	   that	   the	  length	  of	  a	  specific	  cell	  cycle	  phase	  might	  influence	  the	  overall	  availability	  and	  hence	  activity	  of	  a	  cell	  fate	  determinant	  that	  is	  typically	  present	  during	  that	  phase.	  Evidences	  supporting	  this	  hypothesis	  show	  that	  a	  longer	  G1	  phase	  is	  causally	  linked	  with	  differentiation,	  since	  forced	  modulation	  of	  the	  length	  of	  G1	  phase	  can	  influence	  the	  cell	  division	  choice	  (Lange	  et	  al.,	  2009).	  On	  the	  other	  hand,	  it	  has	  also	  been	  shown	  that	  self-­‐renewing	  VZ	  NPCs	  generally	  show	  a	  longer	  S	  phase	  than	  their	  differentiating	  counterpart	  (Arai	  et	  al.,	  2011).	  Our	  observations	  are	  in	  apparent	  contradiction	  with	  the	  “cell	  cycle	  length	  hypothesis”	  recounted	  above:	  in	  Jmjd3	  KO	  NPCs,	  a	  longer	  cell	  cycle	  is	  associated	  with	  an	  increased	  propensity	  for	  self-­‐renewal.	  However,	  differently	  from	  what	  has	  been	  shown	  in	  other	  instances,	   the	   lengthening	   of	   the	   cell	   cycle	   in	   our	   case	   is	   generalized	   and	   not	  restricted	   to	   a	   specific	   cell	   cycle	   phase.	   In	   fact,	  we	   observe	  both	   a	   longer	   G1	  and	   a	  longer	  S	  phase	  in	  the	  preferentially	  self-­‐renewing	  Jmjd3	  KO	  NPC	  population.	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We	  were	  not	  able	  to	  clarify	  whether	  the	  increased	  cell	  cycle	  length	  is	  causally	  linked	  to	  the	  preference	  for	  self-­‐renewal,	  or	  whether	  the	  two	  phenomena	  are	  both	  caused	  by	  the	   lack	   of	   Jmjd3	   but	   do	   not	   bear	   a	   causal	   impact	   on	   each	   other.	   However,	   we	  confirmed	   the	   correlation	   between	   the	   two	   phenomena	   in	   different	   in	   vitro	  and	   in	  
vivo	   settings,	   and	   we	   furthermore	   showed	   that	   re-­‐expression	   of	   Jmjd3	   can	   rescue	  both	   the	   phenotypes.	   We	   therefore	   believe	   that	   these	   solid	   observations	   can	  contribute	   to	   the	  growing	  body	  of	  evidences	   that	  conflate	   into	   the	  “cell-­‐cycle	   length	  hypothesis”,	  and	  provide	  advancement	  to	  the	  field.	  	  Jmjd3	   is	   a	   lysine-­‐specific	   demethylase	   that	   can	   influence	   the	   level	   of	   expression	   of	  target	  genes	  based	  on	  its	  ability	  to	  demethylate	  H3K27	  and	  counteract	  the	  effects	  of	  the	  PRC2	  repressive	  complex.	  In	  order	  to	  link	  the	  absence	  of	  Jmjd3	  to	  the	  phenotype	  of	   cell	   cycle	   lengthening	   and	   increased	   self-­‐renewal	   of	   VZ	   NPCs,	   we	   sought	   to	  characterize	  the	  transcriptional	  effects	  that	  the	  loss	  of	  Jmjd3	  is	  able	  to	  cause	  in	  such	  cell	  types.	  RNAseq	  analysis	  on	  in	  vitro-­‐cultured	  NPCs	  revealed	  a	  molecular	  signature	  deriving	   from	   the	   loss	   of	   Jmjd3	   that	   is	   consistent	   with	   the	   phenotype	   that	   we	  observed	   in	   vivo	   and	   in	   vitro.	   Indeed,	   the	   Notch	   and	   Wnt	   pathways,	   which	   are	  involved	  in	  defining	  the	  symmetry	  of	  NPC	  cell	  division	  in	  the	  VZ,	  were	  among	  the	  top	  enriched	  pathways	  according	  to	  our	  analysis:	  hyperactivation	  of	  both	  these	  pathways	  has	  been	  associated	  with	   increased	  self-­‐renewal	  of	  neural	   stem	  cells	  and	  a	   reduced	  propensity	  to	  undergo	  neural	  differentiation.	   Intriguingly,	  genes	  or	  pathways	   linked	  to	   cellular	   proliferation	   or	   cell	   cycle	   progression	   were	   not	   significantly	   altered	   in	  Jmjd3	   KO	  NPCs.	   However,	   we	   found	   that	   genes	   involved	   in	   the	   glycolysis	   pathway	  were	  significantly	  upregulated,	  together	  with	  a	  pronounced	  downregulation	  of	  a	  gene	  encoding	  for	  a	  subunit	  of	  the	  mitochondrial	  ATP	  synthase	  machinery	  (Atp5g1).	  These	  data	  might	  suggest	  that	  there	  is	  a	  reduction	  in	  the	  phosphorylative	  oxidation	  capacity	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of	  Jmjd3	  KO	  cells	  followed	  by	  an	  upregulation	  of	  the	  anaerobic	  glycolysis	  pathway.	  In	  turn,	  this	  general	  metabolic	  alteration	  might	  be	  causatively	  linked	  to	  the	  lengthening	  of	  the	  cell	  cycle	  that	  we	  observed	  in	  vivo	  and	  in	  vitro	  in	  the	  absence	  of	  Jmjd3.	  	  Capitalizing	  on	  our	  extensive	  in	  vivo	  screening	  of	  the	  developing	  mouse	  brain,	  on	  the	  detailed	  characterization	  of	  the	  brain	  stem	  cell	  compartment	  both	  in	  vivo	  and	  in	  vitro,	  and	  on	  the	  molecular	  analysis	  of	  the	  expression	  level	  of	  the	  whole	  transcriptome,	  we	  propose	  that	  loss	  of	  Jmjd3	  causes	  upregulation	  of	  the	  Notch	  and	  Wnt	  pathways	  and	  a	  reduced	  mitochondrial	   activity,	   resulting	   in	   an	   increased	   self-­‐renewal	   and	   a	   longer	  cell	   cycle	   in	   the	   VZ	   NPCs.	   This,	   in	   turn,	   leads	   to	   aberrant	   expansion	   of	   the	   stem	  compartment	  and	  a	  reduction	  in	  the	  neuronal	  output.	  Hypothesizing	   that	   Jmjd3	   exerts	   these	   effects	   through	   its	   activity	   as	   a	   H3K27	  demethylase,	  and	  hence	  through	  transcriptional	  dysregulation	  of	  direct	  target	  genes,	  we	  sought	  to	  investigate	  the	  binding	  of	  Jmjd3	  to	  chromatin	  in	  proliferating	  VZ	  NPCs.	  Unfortunately,	  despite	  our	  efforts	  to	  develop	  monoclonal	  antibodies	  suitable	  for	  ChIP	  and	  IP	  applications,	  we	  were	  not	  able	  to	  setup	  a	  reliable	  ChIPseq	  protocol	  for	  Jmjd3,	  and	   we	   thus	   complemented	   our	   analysis	   with	   publicly-­‐available	   data	   on	   Jmjd3	  binding	   in	  neural	   stem	  cells	   generated	  by	  other	   labs,	   that	  we	   re-­‐analyzed	   in-­‐house.	  We	  identified	  a	  subset	  of	  13	  genes	  that	  might	  be	  direct	  targets	  of	  Jmjd3,	  but	  we	  were	  not	  able	  to	  pinpoint	  a	  target	  that	  would	  explain	  the	  downstream	  dysregulation	  of	  the	  Wnt,	  Notch	  and	  Glycolysis	  pathways	  and	  the	  brain	  phenotype.	  We	  speculate	  that	  this	  is	   due	   to	   the	   fact	   that	   the	   publicly	   available	   dataset	   has	   been	   generated	   on	   neural	  stem	  cells	  that	  have	  been	  obtained	  and	  cultured	  using	  a	  protocol	  different	  from	  ours,	  thus	  resulting	   in	  a	  chromatin	  state	   that	  cannot	  be	   faithfully	  compared	  with	   the	  one	  that	  we	  obtained	  using	  our	  protocol.	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In	   order	   to	   overcome	   this	   setback	   and	   to	   gain	   detailed	  mechanistic	   insights	   on	   the	  action	   of	   Jmjd3	   in	   embryonic	   NPCs,	   we	   seek	   to	   generate	   our	   own	   Jmjd3	   ChIPseq	  binding	  profiles	  in	  NPCs	  and	  to	  correlate	  them	  with	  the	  transcriptomic	  data	  that	  we	  obtained	   from	   the	   same	   cell	   type.	   To	   do	   so	   without	   having	   to	   use	   anti-­‐Jmjd3	  antibodies,	   which	   have	   proven	   unreliable	   for	   ChIP	   applications	   in	   our	   hands,	   we	  generated	   a	  mouse	   strain	   that	   harbors	   a	  BAC	   containing	   a	  Venus-­‐tagged	  version	  of	  Jmjd3.	  The	  presence	  of	  the	  whole	  genomic	  region	  allows	  for	  a	  physiological	  control	  of	  gene	  expression,	  such	  that	  the	  level	  of	  the	  fused	  protein	  should	  hence	  mirror	  that	  of	  the	   wild	   type	   protein,	   and	   the	   Venus	   tag	   represents	   a	   suitable	   substrate	   for	   IP	  applications.	  We	  are	  currently	  in	  the	  process	  of	  obtaining	  offspring	  from	  the	  founder	  mouse	   of	   this	   colony:	  we	   are	   confident	   that	  we	  will	   be	   able	   to	   identify	   a	   subset	   of	  direct	   targets	  of	   Jmjd3	   in	  a	  short	   time	   frame,	  and	   to	  provide	  a	  detailed	  mechanistic	  explanation	  of	  the	  role	  of	  Jmjd3	  in	  regulating	  cell	  cycle	  progression	  and	  self-­‐renewal	  in	  NPCs	  of	  the	  developing	  brain.	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